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Abstract 
Endometriosis is a chronic inflammatory disorder associated with pelvic pain and 
infertility that affects ~176 million reproductive age women worldwide. It is defined 
by the presence of endometrial-like tissue outside the uterus (lesions). The aetiology 
of endometriosis is not fully understood however we know that menstrual effluent is 
refluxed into the peritoneal cavity during menstruation in 90% of women, and it is 
hypothesised that in some women this tissue can adhere to form lesions (Sampsons 
theory). Current management of endometriosis is unsatisfactory and there is an 
unmet need for new treatments. Macrophages play a key role in the growth, 
vascularisation and innervation of endometriosis lesions. We know from other 
diseases such as cancer that macrophages with differential origins and phenotypes 
play distinct roles in disease development, however our current knowledge of 
macrophage origins, recruitment pathways and phenotype in endometriosis is 
limited. In this thesis I aimed to define the origin of lesion-resident macrophages, the 
recruitment pathways active in disease and assess lesion macrophage phenotypic 
heterogeneity using the Edinburgh mouse model of endometriosis. This mouse model 
mimics the retrograde reflux of menses material by stimulating an artificial 
menstruation-like event in mice, whereby this tissue is collected and injected into the 
peritoneal cavity of recipient mice. I hypothesised that lesion resident macrophages 
have multiple origins, that CCL2 is an important chemokine for macrophage 
recruitment and that multiple macrophage populations exist within endometriosis 
lesions that have differential phenotypic profiles. 
I used Csf1r-EGFP mice (MacGreen; macrophages express green fluorescent 
protein) to characterise the origins of lesion resident macrophages. Endometriosis 
was induced in WT mice using donor endometrial tissue from Csf1r-EGFP mice. 
16% of lesion macrophages were GFP+ endometrial-derived macrophages and the 
remaining 84% were GFP- infiltrating macrophages of recipient origin. To assess 
infiltration of tissue-resident large peritoneal macrophages (LPM) and monocyte-
derived small peritoneal macrophages (SPM) into lesions, I adoptively transferred 
LPM or SPM (isolated from Csf1r-EGFP mice) into the peritoneal cavity of 
endometriosis mice. GFP+ LPM infiltrated lesions however GFP+ SPM were not 
identified within lesion tissue. Using Ly6C, F4/80 dual immunofluorescence I 
identified both Ly6C+ monocytes and Ly6C+ F4/80+ monocyte-derived 
macrophages in lesions.  
Mice with endometriosis exhibited a ~3 fold increase of peritoneal macrophages 
expressing CCR2 (receptor for chemokine (C-C) motif ligand 2 (CCL2)) compared 
to sham controls and 53% of lesion resident macrophages expressed CCR2. To 
assess the importance of CCR2 in the development of endometriosis lesions, 
endometriosis was induced in CCR2 knockout mice compared to WT. CCR2 
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knockout mice developed a similar number of endometriosis lesions to WT mice and 
exhibited an influx of Ly6C+ monocytes into the peritoneal cavity, which also 
infiltrated into lesions. Notably, endometriosis lesions from CCR2 knockout animals 
had fewer F4/80+ macrophages. CCL2 knockout mice developed more 
endometriosis lesions than WT and demonstrated similar infiltration of Ly6C+ 
monocytes and F4/80+ macrophages into lesion tissue compared to WT. Importantly, 
CCL2 knockout mice had an increase in CD45+ leukocytes within the peritoneal 
cavity which could have attributed to the difference observed in lesion number.  
Initially, I performed flow cytometry analysis on lesion tissue to assess phenotypic 
heterogeneity and demonstrated that multiple macrophage populations were present, 
based on differential expression of CCR2, MHC II, CX3CR1 and CD86. I also 
observed that endometrial macrophage phenotypic heterogeneity was lost upon 
incorporation into lesions, suggesting macrophage reprogramming upon 
incorporation into the lesion microenvironment. To gain further granularity into the 
phenotypic heterogeneity of lesion macrophages, using single-cell RNA-sequencing, 
I performed unbiased transcriptional profiling of CD45+ cells in lesions (6006 cells), 
donor endometrial tissue (1306 cells) and peritoneal lavage cells from sham (5645 
cells) and endometriosis mice (6720 cells). Clustering analysis identified 5 lesion-
resident macrophage populations that had differential transcriptomic profiles. 
Comparison of lesion-resident macrophage populations with macrophage clusters 
from endometrial tissue and the peritoneum confirmed that lesions contained 
macrophages from different origins. 
Collectively, these results indicate that lesion resident macrophages are derived from 
multiple origins and that 5 different macrophage populations exist within lesions that 
have differential transcriptomic profiles. Macrophage/monocyte recruitment may be 
in part mediated by the CCL2/CCR2 signalling pathway but when this pathway is 
disrupted in our model of endometriosis there appears to be compensation such that 
monocytes are still recruited to the peritoneal cavity and lesions. Herein, I provide an 
important insight into macrophage biology in endometriosis and provide a platform 
for further studies that aim to identify disease-specific macrophage populations that 
could potentially be targeted for clinical benefit.  
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Lay Summary 
Endometriosis is a common disease that affects 1 in 10 women of reproductive age. 
Endometriosis is characterized by the growth of the lining of the uterus (the 
endometrium) outside the uterus, usually within the abdominal cavity. The growth of 
these endometrial-like tissue deposits (lesions) is associated with chronic pelvic pain 
and infertility. We don't fully understand why the disease occurs, however a popular 
theory is that menstrual material that is re-gurgitated into the abdominal cavity 
through the fallopian tubes during menstruation, adheres  to the lining of the 
abdominal cavity to form lesions. Current treatment options for endometriosis are 
ineffective and new therapies are desperately needed. Immune cells are involved in 
regulating the health of our tissues, however in some disease states they can become 
dysregulated, thus contributing to disease. In endometriosis, immune cells called 
macrophages encourage the growth and development of endometriosis lesions. We 
know from other diseases, such as cancer, that macrophages can contribute to 
disease, and that targeting dysregulated macrophages could provide benefit for 
patients. However, current knowledge about macrophages in the context of 
endometriosis is limited, and more research is required to understand their role and 
complexity in disease.  
In this thesis my aims were to understand where macrophages within endometriosis 
lesions come from (their origins), to investigate how they are recruited to lesions, and 
to assess whether multiple macrophage populations exist which could potentially 
play different roles in the disease. To answer these questions I used a mouse model 
of endometriosis. This model uses a hormonal schedule which mirrors the human 
menstrual cycle, triggering an artificial menstruation-like event in the mice. This 
menses-like tissue is collected and injected into the abdominal cavity of recipient 
mice, which go on to develop human-like endometriosis lesions.  
I found, using tracing experiments where macrophages were fluorescently labelled, 
that macrophages within lesions were derived from three different origins. 
Macrophages from donor endometrial tissue made up 16% of the lesion macrophage 
population and the remaining 84% of macrophages were derived from macrophages 
that had infiltrated into the tissue (from the recipient). I characterised that these 
infiltrating populations consisted of macrophages from the abdominal cavity and 
from precursor cells in the blood (monocyte-derived macrophages).  
Macrophages respond to signals known as chemokines. I was interested in a specific 
chemokine known as chemokine (C-C motif) ligand 2 (CCL2)  because it is the main 
chemokine used by monocytes and macrophages to move into tissues. I demonstrated 
that the receptor for CCL2 (CCR2) was expressed by 53% of lesion macrophages 
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and that mice with endometriosis also had increased levels of macrophages that 
expressed CCR2 in the abdominal cavity. 
To study how macrophages are attracted to endometriosis lesions I used mice that 
were genetically modified such that the genes encoding CCR2 or CCL2 were deleted 
from the their genome. Endometriosis lesions from CCR2 knockout mice had a 
similar number of macrophage precursor cells (monocytes) but a reduced number of 
macrophages compared to unmodified mice (wild type; WT), suggesting that CCR2 
is required for macrophage but not monocyte recruitment to lesions. CCL2 knockout 
mice developed endometriosis lesions which had a similar number of both 
monocytes and macrophages compared to WT. These experiments show that whilst 
CCL2 may be important for recruitment of monocytes and macrophages in our 
mouse model, when it is knocked out, another chemokine is able to compensate for 
this loss and still cause the recruitment of monocytes and macrophages to lesions. 
These results do indicate however, that signalling through CCR2, perhaps by another 
chemokine which binds to CCR2, does appear to be important for the recruitment of 
macrophages to lesions. Overall, a number of different chemokines may be able to 
cause the movement of monocytes and macrophages into lesions.  
Many different ‘types’ of macrophages exist and they can modify the functions they 
perform based on local signals in the tissue where they reside. By analysing the 
genetic material of single cells to determine what genes they express I could 
demonstrate that there are five different ‘types’ of macrophages present in 
endometriosis lesions. This information suggests that these different ‘types’ of 
macrophages could play different roles in endometriosis, however further research is 
required to confirm this. 
In summary, I have demonstrated that endometriosis lesion resident macrophages 
have differential origins, can be recruited via chemokines / receptors other than 
CCL2/ CCR2 and that there are multiple ‘types’ of macrophages present in lesions. 
This research provides an important platform for future studies and reveals that 
macrophage biology in endometriosis is more complex than previous research 
suggests.  
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Abstract: 
Peritoneal macrophage dynamics in a mouse model of endometriosis. 
Chloe Hogg, Andrew W Horne, Jeffrey Pollard, Erin Greaves 
MRC Centre for Reproductive Health, University of Edinburgh, Edinburgh, Scotland 
Introduction: Endometriosis is a chronic inflammatory disorder characterised by the 
presence of endometrial-like tissue (lesions) outside the uterus, most commonly in 
the peritoneal cavity. Macrophages are critical for growth and angiogenesis in 
endometriosis lesions, however little is known about the origins or activation status 
of these cells. In the peritoneal cavity macrophages exist as two populations; large 
peritoneal macrophages (LPM; high in number and associated with 
immunosurveillance and homeostasis) and small peritoneal macrophages (SPM; 
usually low in number but increase with inflammation). We aimed to discern whether 
mice with induced endometriosis have altered numbers of peritoneal macrophages 
and whether these subsets are incorporated into endometriosis lesions. 
Methods: Using our established mouse model of endometriosis (including naïve 
(n=8) and sham+E2 (n=6) controls for comparison), peritoneal lavage using 7ml 
DMEM was performed and peritoneal macrophage subsets were analysed by flow 
cytometry using F4/80 (LPM) and MHC II (SPM) expression, to delineate 
macrophage populations. Dual immunofluorescence was performed on mouse lesions 
using large and small peritoneal macrophage markers, GATA6 and F4/80, and 
RELMα and MHC II, respectively.  
Results: Flow cytometry revealed that there was no significant difference in LPM 
between sham+E2 (10554 cells/μl) compared to naïve mice (5382 cells/μl; p=0.097). 
Mice with endometriosis had higher numbers of LPM than naïve mice but lower 
numbers than sham mice (7299 cells/μl). A similar non-significant trend was 
observed with SPM. Heterogeneity in numbers and ratios of LPM and SPM in 
endometriosis mice was seen with some animals exhibiting an increased SPM: LPM 
ratio. Immunofluorescence identified that 48% (±SEM 4%) of cells in endometriosis 
lesions express F4/80 (n=10 lesions from n=7 animals), and of these 2% (±SEM 1%) 
co-express GATA6. 
Conclusions: Heterogeneity in the numbers and ratios of LPM and SPM was 
observed in endometriosis mice. We speculate that lesion number, distribution and 
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relative activity of lesions could contribute to this heterogeneity. Our data also 
suggests that large peritoneal macrophages do not significantly contribute to the 
lesion-resident macrophage population.   
 
Submitted for: 
• Royal College of Obstetricians and Gynaecologists Annual Academic 
Meeting - Royal College of Obstetricians and Gynaecologists, London - 9th – 
10th Feb 2018 
• The British Society for Immunology: Edinburgh Immunology Group Summer 
Symposium - University of Edinburgh - 24th - 26th April 
Abstract: 
Exploring the role of macrophage sub-populations in the aetiology of 
endometriosis  
Chloe Hogg, Andrew W Horne, Jeffrey Pollard, Erin Greaves 
MRC Centre for Reproductive Health, University of Edinburgh, Edinburgh, Scotland 
Introduction: Endometriosis is a chronic inflammatory disorder, associated with 
debilitating pain and infertility, characterised by endometrial-like tissue (lesions) 
outside the uterus. The aetiology of endometriosis is poorly understood.  Tissue-
resident macrophages are a heterogeneous population of immune cells that fulfil 
tissue-specific functions. Macrophages are elevated in peritoneal fluid of women 
with endometriosis compared to women without disease, and endometrium tissue-
resident macrophages (ETRM) are present in endometriosis lesions.  We explored 
the role of ETRM, peritoneal and monocyte-derived macrophages (MDM) in 
endometriosis lesion development.  
Methods: Using our validated in-house mouse model of endometriosis, we used dual 
immunofluorescence to investigate the proliferative capacity of ETRM (Ki67+, 
GFP+; ETRM labelled with GFP) and to identify large peritoneal macrophages 
(F4/80+, GATA6+) in endometriosis lesions. To assess the role of MDM, we used 
the same mouse model comparing CCR2 -/- (deficient in MDM) and wild-type mice, 
and assessed the resulting numbers of endometriosis lesions and quantified peritoneal 
macrophage populations by flow cytometry.  
Results:Co-expression of GFP+ macrophages with the proliferation marker Ki67 in 
endometriosis lesions indicated their potential to self-renew. Only 4% of 
endometriosis lesion-resident macrophages were GATA6+ F4/80+large peritoneal 
macrophages.CCR2 -/- mice developed endometriosis lesions, and had more 
peritoneal Ly6C+ macrophages compared to sham CCR2 -/- mice (P=0.03). 
Conclusions: ETRM may play a key role in endometriosis lesion biology and the 
presence of endometriosis induces recruitment of monocytes through a CCR2-
independent mechanism. Targeting ETRM, or preventing the influx of ‘pro-disease’ 
macrophage populations into lesions, could be a novel approach for treating 
endometriosis.  
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Introduction: Endometriosis is a chronic inflammatory disorder, associated with 
debilitating pelvic pain and infertility and is characterised by the growth of 
endometrial-like tissue (lesions) outside the uterus. The aetiology of endometriosis is 
poorly understood however macrophages are important for growth, vascularization 
and innervation of lesions. Our research has shown that macrophages in lesions have 
different ontogenies, however the contribution of monocyte-derived macrophages to 
this population is unknown. We hypothesised that inhibition of recruited monocytes 
would reduce development of lesions.   
Methods: Endometriosis was induced in WT(n=6) and CCR2 -/- (n=6) mice 
(deficient in monocyte-derived macrophages) using our in-house model. Peritoneal 
and lesion macrophage populations were assessed by flow cytometry and 
immunofluorescence.  
Results: CCR2 -/- mice developed the same number of lesions as WT. Interestingly, 
CCR2 -/- mice with endometriosis had an increase (p<0.05) in monocytes in the 
peritoneal cavity compared to controls. In WT mice 17% (±SEM 6%) of total cells 
within lesions were monocyte-derived macrophages, 3% (±SEM1%) were 
monocytes and 8%(±SEM 2%) were mature macrophages. This was further 
confirmed by immunofluorescent staining.  
Conclusions: The presence of lesions in the peritoneal cavity induces extravasation 
of monocytes independent of CCR2. Monocytes and monocyte-derived macrophages 
are a significant proportion of cells in endometriosis lesions.  
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Endometriosis is a common chronic inflammatory disorder associated with 
debilitating chronic pelvic pain and infertility that affects ~176 million women 
worldwide. It is defined by the presence of endometrial-like tissue outside the uterus 
(endometriosis lesions), commonly on the pelvic peritoneum. The current 
management of women with endometriosis is unsatisfactory and there is an unmet 
clinical need for new medical treatments. Immune cells, called macrophages, play a 
role in the growth, vascularization and innervation of endometriosis lesions, and 
offer a potential therapeutic target. We have previously shown that lesion-resident 
macrophages are a heterogeneous population, consisting of tissue-resident 
endometrial macrophages, as well as macrophages originating either from the 
peritoneal cavity or derived from peripheral blood monocytes. The exact contribution 
of peritoneal and monocyte-derived macrophages is unknown. The objective of this 
study was to define the role of these macrophage populations in endometriosis using 
our in-house mouse model. To assess infiltration of tissue-resident large peritoneal 
macrophages (LPM) into lesions, we used dual immunofluorescence for LPM 
markers F4/80 and GATA6. 4% (±SEM 2%) of lesion-resident macrophages co-
expressed these markers suggesting they were indeed LPM (n=10). To assess the 
incorporation of monocyte-derived macrophages into lesions, we interrogated mouse 
lesions by flow cytometry (n=6). 17% (±SEM 6%) of total cells within lesions were 
F4/80hi, Ly6C+monocyte-derived macrophages, 3% (±SEM 1%) were F4/80-, 
Ly6C+ monocytes and 8%(±SEM 2%) were F4/80hi, Ly6C- mature macrophages. We 
validated our findings using dual immunofluorescence for F4/80 and Ly6C. Since 
monocyte-derived macrophages represented a significant number of cells in lesions 
we postulated that they might play an important role in lesion development. In order 
to investigate this, we used C-C chemokine receptor type 2 (CCR2) -/- mice, which 
are deficient for the chemokine (C-C motif) ligand 2 (CCL2) receptor. CCL2 is a key 
chemokine responsible for the extravasation of monocytes into the peritoneal cavity, 
therefore these mice are deficient in monocytes and monocyte-derived macrophages 
in this cavity. We induced endometriosis in both wild-type (n=6) and CCR2 -/- (n=6) 
mice and assessed the number of lesions that developed. There was no difference in 
the number of lesions recovered from CCR2 -/- mice compared to WT. CCR2 -/- 
mice with endometriosis had an increase (p=0.03) in monocytes in the peritoneal 
cavity compared to sham controls (n=8). This suggests that lesions produce a strong 
chemotactic signal that stimulates the extravasation of monocytes, which in this 
model is independent of CCR2. Our on-going work aims to characterise which 
chemokine is responsible for the extravasation of monocytes in our model and assess 
whether blocking this pathway could stop endometriosis lesions developing. In 
summary, we have shown that lesion-resident macrophages have different origins, 
and include endometrial, peritoneal and monocyte-derived macrophages. We have 
also demonstrated that lesions cause the extravasation of monocytes into the 
peritoneal cavity in a CCR2-independent manner. Thus, monocyte-derived 
macrophages may play an important role in endometriosis lesion development, and 
future therapies that target infiltration of monocytes may be of benefit in the 
treatment of women with endometriosis.  
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Introduction: Endometriosis is a chronic inflammatory estrogen-dependent disorder 
defined by the presence of endometrial-like tissue outside the uterus (lesions), 
estimated to affect ~176 million women worldwide. Current treatment options are 
unsatisfactory and there is an unmet need for new medical therapies. Macrophages 
play a role in the growth, vascularization and innervation of lesions, and offer a 
potential therapeutic target. However, the phenotype of macrophages in 
endometriosis lesions is underexplored. We hypothesised that endometriosis 
macrophages possess a lesion-specific phenotype that is independent of ontogeny. 
Methods: We induced endometriosis in WT mice using donor ‘menses’ endometrial 
tissue from Csf1r-EGFP mice (macrophages express GFP), allowing us to distinguish 
GFP+ endometrial macrophages in the resulting lesions. Lesions and peritoneal 
lavage were analysed by flow cytometry. 
Results: 16% (SEM± 4%) of macrophages in lesions were GFP+ endometrial 
macrophages (N=6). These cells had a homogeneous phenotype (CX3CR1+ CCR2+ 
MHC II- CD86+). Of the GFP- host derived macrophages 28.4% (SEM± 3%) had 
the same phenotype as the endometrial macrophages. We also identified another four 
phenotypes of GFP- macrophages that were MHC11+ and CCR2-. Each population 
accounted for 10% of total macrophages. Macrophage phenotypes in lesions were 
consistent across animals. We found more CCR2+ macrophages in the peritoneal 
cavity of mice with endometriosis compared to naive (p=0.005) and sham animals 
(p=0.01) (N=6). The number of macrophages expressing CCR5, CD200, CD86, 
MHC II and CX3CR1 was similar in peritoneal macrophages from endometriosis 
mice compared to sham mice. 
Conclusions: The phenotype of lesion-resident macrophages appears to be largely 
independent of origin and consistency across animals suggests that a predominant 
'lesion-specific' macrophage signature exists. We suggest that, once incorporated into 
lesions, macrophages obtain a defined, pro-disease phenotype in response to local 
micro-environmental clues. Other macrophage phenotypes are present but the 
dynamics of these cells currently remains unknown. This data indicates that 
macrophages in lesions possess a predictable phenotypic signature and contributes to 
the aim of developing macrophage-targeted therapies for women with endometriosis.  
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Endometriosis is a chronic inflammatory disorder associated with pelvic pain and 
infertility that affects ~176 million reproductive age women worldwide. It is defined 
by the presence of endometrial-like tissue outside the uterus (lesions). Current 
management is unsatisfactory and there is an unmet need for new treatments. 
Macrophages play a key role in the growth, vascularization and innervation of 
endometriosis lesions, however our knowledge of macrophage origins, phenotype 
and heterogeneity in endometriosis is limited. We aimed to define the origin of 
lesion-resident macrophages and assess phenotypic heterogeneity using our unique 
mouse model. To assess infiltration of tissue-resident large peritoneal macrophages 
(LPM) into lesions, we adoptively transferred LPM (isolated from Csf1r-EGFP mice) 
into the peritoneal cavity of endometriosis mice. GFP+ cells were identified by 
immunohistochemistry in lesions after 2 weeks (n=4). To assess infiltration of 
Ly6Chi monocytes into lesions we performed Ly6C, F4/80 dual immunofluorescence. 
We identified both Ly6C+ monocytes and F4/80+ mature macrophages in lesions, 
which was also validated using flow cytometry (n=6). Next, we induced 
endometriosis in WT mice using donor endometrial tissue from Csf1r-EGFP mice; 
we identified that16% (SEM± 4%) of lesion macrophages were GFP+ endometrial-
derived macrophages (n=6). Using single-cell RNA-seq, we performed unbiased 
transcriptional profiling of CD45+ cells in lesions (6006 cells), donor endometrial 
tissue (1306 cells) and peritoneal lavage cells from sham (5645 cells) and 
endometriosis mice (6720 cells). Clustering analysis identified 4 lesion-resident 
macrophage populations. Comparison of lesion-resident macrophage populations 
with macrophage clusters from endometrial tissue and the peritoneum confirmed that 
lesions contained macrophages from different origins. In summary, we demonstrate, 
for the first time, that macrophages in endometriosis lesions are heterogeneous in 
both ontogeny and transcriptional profile. We believe that this observed 
heterogeneity could be translated into clinical applications, such as targeted therapy 
for endometriosis-associated pain. 
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1.1 Endometriosis 
1.2 The clinical problem   
Endometriosis is defined by the presence of endometrial-like tissue outside the 
uterus, typically on the peritoneal wall of the pelvic cavity. The condition is 
estimated to affect 6-10% of women of reproductive age (Giudice, 2010) and up to 
50% of infertile women (Meulemanet al., 2009). Endometriosis is associated with 
debilitating chronic pelvic pain, infertility, dyspareunia (painful intercourse), 
dysmenorrhea (painful menstruation), dysuria (painful urination) and dyschezia 
(painful bowel movements). These symptoms can effect mental, physical and social 
wellbeing and negatively impact on quality of life (Dunselman et al., 2014). The 
prevalence of endometriosis in women with chronic pelvic pain is 71-87% (Hansen, 
Chalpe and Eyster, 2010). Women with endometriosis may experience cyclic and/or 
non-cyclic pain which can be referred to other areas of the body for example the legs 
(Walch et al., 2014). Endometriosis is also associated with reduced pregnancy rates 
and this is partly attributed to low oocyte number and quality as well as defective 
implantation in the uterus (Simón et al., 1994; Garrido et al., 2002; Xu et al., 2015). 
Poor pregnancy outcomes are also associated with the disease, including preterm 
labour, pre-eclampsia, miscarriage and intrauterine growth restriction (Saraswat et 
al., 2017). Endometriosis has a significant socioeconomic impact, costing the UK an 
estimated £8.5 billion pounds each year, with societal cost being mostly attributed to 
loss of productivity (Simoens et al., 2012; Nnoaham et al., 2013). Diagnosis from 
onset of symptoms can take an average of 6.7 years. Generally, a diagnosis of 
endometriosis is achieved by laparoscopic evaluation of the pelvis however imaging 
techniques such as transvaginal sonography and magnetic resonance imaging may be 
utilised to diagnose deep infiltrating lesions or endometriomas (Bazot and Daraï, 
2017; Bedaiwy et al., 2017; Agarwal et al., 2019). 
 
Endometriosis lesions are defined as ectopic endometrial-like tissue containing 
glands and stroma, however recent re-evaluation of disease definition suggests that 
fibrosis and smooth muscle cells are more consistent characteristics of lesions 
(Vigano et al., 2018). Lesions are also infiltrated with blood vessels and nerves, and 
are most commonly observed on the ovaries, pelvic peritoneum and rectovaginal 
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septum (Capobianco et al., 2011; Burney and Giudice, 2012; Greaves et al., 2015). 
Endometriosis is a heterogeneous disease which consists of three sub-types: 
superficial peritoneal, deep (infiltrating) and ovarian (“endometriomas”), where more 
than one sub-type can exist in the same patient and superficial peritoneal 
endometriosis is the most common form of disease (Mahmood and Templeton, 1991; 
Johnson et al., 2017). Disease classification currently takes into account lesion size, 
location, extent of lesion infiltration into tissue and the presence of adhesions and is 
classed from stage I (minimal) to stage IV (severe) (Canis et al., 1997). Whilst this 
system is useful for assessing extent of disease within the peritoneal cavity, 
classification of disease does not predict symptom severity, pregnancy success or 
relapse after surgery (Vercellini et al., 2006; Ek et al., 2015). Other classification 
systems have attempted to predict symptomatic factors such as the endometriosis 
fertility index (EFI) (Adamson and Pasta, 2010) and Enzian classification for deep 
endometriosis (Haas et al., 2013). A consensus study by the World Endometriosis 
Society on the classification of endometriosis concluded that, until a better 
classification system is developed, patients would benefit from using multiple 
classification systems dependent on their concerns and needs (r-ASRM, EFI and 
Enzian classifications) (Johnson et al., 2017). The heterogeneity of endometriosis 
and lack of correlation between disease phenotype and symptoms makes the 
development of an appropriate classification system challenging.   
Current treatments for endometriosis aim to alleviate endometriosis-associated pain 
and/or to treat infertility associated with the disease and include surgical and medical 
management (Giudice, 2010; Johnson and Hummelshoj, 2013). Ovarian suppression 
limits activity and growth of lesions, leading to reduced pain symptoms. Common 
methods of ovarian suppression include oral contraceptives and gonadotrophin-
releasing hormone (GnRH) agonists (Al Kadri et al., 2009). Whilst ovarian 
suppression may alleviate pain symptoms, treatment is also contraceptive and 
therefore inappropriate for women wanting to conceive. Additionally, GnRH 
agonists are associated with side effects such as memory loss, insomnia and hot 
flushes in a recent study of endometriosis patients with long term use (Gallagher et 
al., 2018). Treatments can also include non-steroidal anti-inflammatory drugs such as 
ibuprofen (Brown et al., 2017), however long-term pain management for women 
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with endometriosis often encompasses a combination of treatments. As well as 
medical therapy, laparoscopic surgery to remove lesions can provide symptom relief 
in some patients, however up to 50% of women experience a relapse of symptoms 
within two years after surgery (Deura and Harada, 2014; Bedaiwy et al., 2017). 
Infertility treatments are an option for women with endometriosis wishing to 
conceive. These treatments include assisted reproductive technologies such as in 
vitro fertilisation and controlled ovarian hyperstimulation, as well as laparoscopic 
excision of lesions (Lessey, 2000; Devroey, 2003; Vlahos, Economopoulos and 
Fotiou, 2010; Deura and Harada, 2014). Current treatment options lack significant 
clinically proven benefit and aim at alleviating symptoms, rather than treating 
disease (Dunselman et al., 2014). Consequently, there is a compelling clinical need 
for new non-hormonal treatments that have fewer side effects and effectively treat 
endometriosis over a life course, without the need for repeated surgeries or 
suppression of fertility. 
 
Figure 1.1. Endometriosis is a chronic inflammatory disorder. Endometriosis is 
characterised by the presence of endometrial-like tissue found outside the uterus, 
most commonly in the peritoneal cavity. Endometriosis lesions are characterised by 
the presence of endometrial stromal cells and glands and are vascularised and 
innervated by nerves. 
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1.1.2 Aetiology and natural history 
Understanding of endometriosis aetiology is currently limited and a number of 
theories exist which attempt to explain disease pathogenesis. It is being increasingly 
recognised that different sub-types of endometriosis may arise from differential 
causal factors, however evidence for these theories still remains elusive (Burney and 
Giudice, 2012; Gordts, Koninckx and Brosens, 2017). A summary of current key 
theories of endometriosis aetiology is provided below. 
1.1.2.1 Sampson's theory 
The most widely accepted theory was postulated in 1927 by John Sampson, who 
observed that during menstruation, menses material can reflux back up the fallopian 
tubes and into the pelvic cavity, a physiological process known as ‘retrograde 
menstruation’. Although this process is thought to occur in ~90% of women, only in 
some women does refluxed endometrial tissue adhere to the visceral or parietal 
peritoneum, forming lesions (Sampson, 1927). Women with endometriosis are 
thought to have higher volumes of refluxed menstrual blood, which supports this 
theory (Halme et al., 1984). Women with congenital outflow obstruction have higher 
rates of endometriosis, as well as women with cervical stenosis or a uterine septum, 
where menstrual outflow is partially compromised (Sanfilippo et al., 1986; Nawroth 
et al., 2006). In a non-human primate model, obstruction of menstrual outflow results 
in endometriosis lesions in the peritoneal cavity (D’Hooghe et al., 1994). The 
location of endometriosis lesions in the peritoneal cavity also supports the retrograde 
menstruation theory, with lesions frequently forming in the left hemisphere of the 
pelvis, attributed to decreased fluid movement in this area due to the placement of 
the sigmoid colon (Al-Fozan and Tulandi, 2003). Thus, refluxed endometrial tissue 
may remain in the left hemisphere of the pelvis for longer periods of time allowing 
implantation of endometrial deposits. This was demonstrated for both peritoneal 
lesions and endometrioma, with endometrioma being more common on the left ovary 
(Al-Fozan and Tulandi, 2003). However, whilst this hypothesis explains the presence 
of endometrial tissue in the peritoneal cavity, it does not account for the fact that 
only some women develop endometriosis when we consider retrograde menstruation 
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as a common physiological event (Sampson, 1927). Thus, other factors must be 
involved in endometriosis aetiology.  
1.1.2.2 Neonatal uterine bleeding 
Another theory based on the dissemination of cells from the uterus into the peritoneal 
cavity is the theory of neonatal retrograde reflux of endometrial stem/progenitor 
cells. This theory is based on the fact that 5-10% of neonates experience uterine 
bleeding, and thus retrograde bleeding is also possible (Brosens and Benagiano, 
2013). During retrograde neonatal bleeding, stem/progenitor cells could implant into 
the peritoneal wall where they may remain dormant until sexual maturity is reached, 
where elevated estrogen levels could then cause the proliferation and growth of 
already seeded endometrial cells. Gordts et al hypothesised that superficial peritoneal 
disease could form as a result of ‘activation' of endometrial cells during puberty, and 
deep infiltrating lesions are a delayed stage of disease resulting from gradual growth 
of previously superficial lesions. They also suggest that the progression from 
superficial to deep infiltrating disease could be regulated by genetic/epigenetic 
factors (Gordts, Koninckx and Brosens, 2017). Whilst this theory represents a 
plausible mechanism of lesion formation, current evidence is lacking and proof that 
endometrial stem/progenitor cells are present in the peritoneal tissue of pre-
pubescent girls is absent.  
1.1.2.3 Coelomic metaplasia 
Whilst a number of hypotheses are based on the dissemination of endometrial cells 
into the peritoneal cavity via retrograde menstruation, it is also thought that some 
lesions, for example endometriomas, arise from transformation of non-endometrial 
cells. Coelomic metaplasia is a hypothetical physiological event whereby 
endometriosis lesions arise as the result of metaplastic differentiation of the coelomic 
epithelium into endometrial cells (Konrad et al., 2019). The coelomic metaplasia 
theory is supported by the fact that endometriosis lesions can be found in women 
with hysterectomy, meaning retrograde menstruation is redundant and lesions must 
be formed by another mechanism (Soliman et al., 2017). The formation of 
endometriosis lesions in sites outside the peritoneal cavity also supports this theory, 
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where lesions have been found on the pericardium and the pleura (Jablonski et al., 
2009; Rousset-Jablonski et al., 2011). Endometriosis lesions have also rarely been 
identified in men (Martin and Hauck, 1985). Whilst this evidence is supportive of the 
coelomic metaplasia theory, the mechanisms by which non-endometrial cells could 
be stimulated to differentiate into endometrial-like cells are unknown. This theory 
also does not explain why endometriosis is usually limited to the peritoneal cavity, 
and that incidence does not increase with age, as with other metaplastic diseases 
(Konrad et al., 2019).  
1.1.2.4 Heritability 
It has long been appreciated that endometriosis has a heritable aspect due to high 
familial incidence of the disease (Simpson et al., 1980; Treloar et al., 1999; Nouri et 
al., 2010). Genome-wide association studies (GWAS) employ a hypothesis-free 
approach to identify genetic variants in diseased and healthy populations. A meta-
analysis of eight GWAS studies elucidated six loci associated with endometriosis 
(Rahmioglu et al., 2014). Genes implicated in disease included those involved in the 
regulation of epithelial cells and hormone metabolism, specifically genes involved in 
regulating hormone responses in tissues (Nyholt et al., 2012; Sapkota et al., 2017). 
Functional studies into the roles of genes associated with incidence of endometriosis 
however are required to infer as to the downstream biological pathways they might 
affect (Rahmioglu et al., 2014). Thus, genetic predisposition to endometriosis is 
likely to contribute to disease aetiology, however current understanding of the 
functional role of genes implicated in disease is lacking.  
1.1.2.5 Immune cell dysregulation 
Ectopic endometrial cells elicit an immune response in the peritoneal cavity and are 
exposed to a variety of different cytokines, chemokines and hormones as a result of 
this. Organs in the peritoneal cavity are bathed in peritoneal fluid, a fluid formed 
from ovarian exudate (Koninckx et al., 1980) and plasma transudate (Oral, Olive and 
Arici, 1996). Alterations in immune cell populations have been observed in the 
peritoneal fluid of women with endometriosis; specifically, women with 
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endometriosis have more peritoneal macrophages (Haney, Muscato and Weinberg, 
1981), neutrophils and dendritic cells (Tariverdian et al., 2009).  
Dysregulation of immune cell function in the peritoneal cavity have been reported in 
women with endometriosis. For example, a decrease in NK cell cytotoxicty has been 
observed in peritoneal NK cell populations of women with endometriosis 
(Oosterlynck et al., 1991; Jeung, Cheon and Kim, 2016), and disease severity is 
positively correlated with NK cell cytotoxic killing capacity (Ho et al., 1995). 
Dysregulation of peritoneal macrophage phagocytic capacity is also implicated in 
disease (Wu et al., 2005). In order to develop endometriosis lesions, ectopic 
endometrial cells must evade immune clearance in the peritoneal cavity. It is possible 
that de-regulation of immune cell function in the peritoneal cavity in endometriosis 
patients leads to an immunosuppressed environment that is permissive to the survival 
of refluxed endometrial tissue during retrograde menstruation. It is hypothesised that 
this can lead to the subsequent invasion of the peritoneal wall and formation of 
lesions. However, whether immune cell dysregulation is a pre-requisite for disease 
development or is a consequence of the presence of lesions in the peritoneal cavity is 
unknown (Izumi et al., 2018). A correlation between endometriosis and autoimmune 
disorders such as inflammatory bowel disease and multiple sclerosis exists, 
suggesting that global immune cell changes in women with endometriosis could 
predispose to development of immune-mediated diseases (Jess et al., 2012; Tiniakou, 
Costenbader and Kriegel, 2013). 
1.1.2.6  Hormonal regulation 
Endometriosis is known to be regulated by ovarian sex steroids. Early age at 
menarche is a risk factor for development of endometriosis, suggesting increased 
exposure to estrogen may incur increased risk of disease (Nnoaham et al., 2012). 
Endometriosis lesions over-express aromatase, a steroidogenic enzyme required for 
estrogen synthesis (Zeitoun et al., 1998). In a co-cultures system, estradiol increases 
the production of prostaglandin-E2 in endometrial stromal cells. Prostaglandin-E2 in 
turn increases aromatase activity through cAMP dependent activation of the 
aromatase promote II, further increasing estradiol levels (Noble et al., 1997). This 
positive feedback loop creates an estrogen-rich local environment. In a baboon 
- 9 - 
 
model of endometriosis, aromatase inhibition attenuated peritoneal lesion growth, 
demonstrating the importance of local estrogen synthesis in peritoneal lesion 
development (Langoi et al., 2013). Similarly, in a mouse model of surgically induced 
peritoneal endometriosis, estradiol treatment significantly increased lesion size (Zhao 
et al., 2014). Treatment with an ERβ antagonist inhibited lesion growth in a mouse 
model of endometriosis, suggesting that the pro-proliferative effects of estradiol are 
at least in part mediated through ERβ (Han et al., 2015). Interestingly, macrophages 
in endometriosis lesions in a pre-clinical mouse model predominantly expressed ERβ 
(Greaves et al., 2015). Estrogen has been shown to have a pro-proliferative effect on 
immune cells such as macrophages, also modulating their phenotype and function 
(Pepe et al., 2017), suggesting an interplay between estrogen and immune cell 
dysregulation may exist in endometriosis. This link has been demonstrated in 
inflammatory diseases such as asthma, where estrogen signalling has been shown to 
modulate allergic inflammation in the lung (Keselman and Heller, 2015; Keselman et 
al., 2017). 
Ectopic endometrial tissue also exhibits progesterone resistance (Attia et al., 2000). 
Endometriotic lesions have reduced progesterone receptor expression when 
compared with eutopic endometrium, and have an absence of progesterone receptor-
B (Attia et al., 2000). In the eutopic endometrium, progesterone signalling normally 
stimulates epithelial cells to produce 17β-hydroxysteriod dehydrogenase (17β-HSD), 
which metabolises estradiol (He et al., 2016). In the absence of progesterone 
receptors, 17β-HSD-2 is not synthesized and thus estradiol cannot be metabolised 
and levels remain high, in turn stimulating the growth of lesions (Noble et al., 1997; 
Zeitoun et al., 1998; Osiński et al., 2018). 
Taking this evidence together, it seems likely that endometriosis aetiology is a 
complex interaction between many different risk factors. Differential risk factors 
may be implicated in different forms of disease, however current understanding of 
these factors is poorly understood.  
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Figure 1.2. Theories for the aetiology of endometriosis 
1.1.3 Pre-clinical mouse models for studying endometriosis 
Pre-clinical models of endometriosis are an important platform required for studies 
into endometriosis pathophysiology. In vivo models are an attractive option for 
research aimed at understanding disease pathogenesis. They offer the ability to test 
therapeutic compounds, measure functional outcomes and have increased 
translational potential compared with an in vitro setting, dependent on the research 
question being investigated. Spontaneous endometriosis only occurs in humans and 
higher primates including baboons (Merrill, 1968) and rhesus monkeys (MacKenzie 
and Casey, 1975). Higher primate models of endometriosis are utilised, however due 
to cost and ethical concerns, mouse models are more frequently used. The high 
number of transgenic lines available in mice also makes them an ideal platform for 
mechanistic studies. However, mice do not menstruate or naturally develop 
endometriosis, thus endometriosis must be artificially induced. One exception which 
must be noted is the spiny mouse, which has been shown to menstruate and therefore 
offers a convenient non-primate model of menstruation, though research in this 
species is relatively new (Bellofiore et al., 2017). Below is a summary of some of the 
more commonly utilised mouse models of endometriosis in common laboratory 
strains. 
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1.1.3.1  Heterologous mouse models 
Heterologous mouse models are based on the transplantation of human tissue into 
nude mice with a mutation in forkhead box protein N1 (FOXN1) or severe combined 
immunodeficient mice which are homozygous for DNA-dependent protein kinase 
(Prkdc). Transplantation of human tissue into these immunocompromised mice 
permits the survival and growth of human tissue without mounting a significant 
immune response. The ability to propagate patient samples allows functional studies 
to be performed in an in vivo setting but with human tissue, thus providing 
translational benefit over the use of mouse tissues. These models commonly involve 
transplanting human endometrial tissue either into the peritoneal cavity (Bruner et 
al., 1997) or subcutaneously (Hull et al., 2012). Immortalized human epithelial and 
stromal cell lines can also be utilised in a similar model system (Banu et al., 2009). 
Whilst these mouse models are useful pre-clinical platforms, the requirement for 
immunodeficient mice makes these models problematic for studying the immune 
system and the absence of specific immune cells may affect disease pathophysiology.  
1.1.3.2  Autologous mouse models 
In the autologous mouse model of endometriosis, one horn of the uterus is ligated, 
removed and then cut into sections and sutured onto the peritoneal cavity or 
mesenteric cascade of the same mouse (Bilotas et al., 2010). This process is 
beneficial as it negates a rejection response in the peritoneal cavity. Endometriosis-
like lesions formed in this model are of a pre-defined size and location, making this 
model an ideal platform for testing therapeutic compounds or mechanistic studies 
which rely on lesion size as their primary outcome. This increases reproducibility 
across studies and more accurately determines the effect of a treatment on disease 
development. However, transplantation of full thickness uterus including 
myometrium is less reflective of endometriosis lesions seen in women, when we 
consider the retrograde menstruation theory where only the endometrial lining is 
refluxed into the peritoneal cavity (Sampson, 1927). Suturing of the uterus in the 
peritoneum also creates artificial inflammation, which may cause changes in immune 
cells and create artefacts which are in fact attributed to the suturing process and not 
the presence of disease.  
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1.1.3.3  Homologous mouse models 
Homologous (syngenic) models of endometriosis involve isolation of the endometrial 
lining from the uterus and injection of endometrial tissue fragments into the 
peritoneal cavity of a recipient mouse (Capobianco et al., 2011; Yuan et al., 2017a). 
Mice are commonly supplemented with estrogen prior to collection of endometrial 
tissue (Yuan et al., 2017a) or tissue is collected during estrus (Burns et al., 2012), in 
the knowledge that estrogen is known to stimulate the growth of lesions (Zhao et al., 
2014). This represents a more physiologically relevant model as it mimics the 
dissemination of endometrial cells into the peritoneal cavity. The use of a donor and 
recipient mouse also allows mechanistic studies where either the donor or recipient 
may be genetically modified, also permitting lineage tracing studies. However, this 
model does not account for the fact that mouse endometrial tissue may not reflect the 
true cellular complement of refluxed menses endometrial tissue in women. Thus, the 
endometrial tissue used in this model may induces a differential immune response 
within the peritoneal cavity, a factor which may influence the development of 
endometriosis-like lesions in this model, forming lesions which may have a different 
cellular make-up to those observed in patients.  
In order to produce a model that aims to recapitulate the process of retrograde 
menstruation, the Edinburgh team developed a unique mouse model of endometriosis 
where an artificial menstruation-like event is induced in donor mice. This generates 
'menses-like' tissue which can then be collected and injected into the peritoneal 
cavity of recipient mice (Greaves et al., 2014). Artificial menstruation in mice is 
achieved through the removal of the ovaries to deplete circulating hormone levels 
and subsequent exposure to a hormonal schedule which mimics a truncated human 
menstrual cycle (Cousins et al., 2016). Mice first receive estradiol injections which 
mimic the estrogen dominated phase of the menstrual cycle. The mice then receive a 
progesterone implant which increases global progesterone levels, mimicking the 
progesterone dominated phase of the human menstrual cycle, as well as a 
decidualisation stimulus into the uterus, in the form of an intrauterine oil injection. 
Progesterone withdrawal is then stimulated by removal of the progesterone implant, 
followed by concomitant endometrial breakdown. The endometrial lining is then 
- 13 - 
 
scraped away from the myometrial wall and injected into the peritoneal cavity of a 
recipient mouse (Greaves et al., 2014).  
This model represents an ideal platform for studying endometriosis pathophysiology 
as it more closely mimics retrograde menstruation, the most widely accepted 
aetiology of endometriosis. It negates the need to suture endometrial fragments and 
bypassing any creation of artificial inflammation. The injection of tissue into the 
peritoneal cavity means lesions may form at a more 'natural' location rather than a 
pre-determined one (as with suturing) and the syngenic design also allows genetic 
manipulation of either the donor or recipient mouse for mechanistic and lineage 
tracing studies. Endometriosis lesions produced using this model are vascularised, 
innervated and infiltrated by macrophages, features of endometriosis lesions in 
women (Greaves et al., 2014).  
 
Figure 1.3. Schematic demonstrating timings and procedures of the Edinburgh 
mouse model of endometriosis. Donor mice are ovariectomized and receive 
hormonal treatments which mimic the estrogen dominated (proliferative) and 
progesterone dominated (secretory) phases of the human menstrual cycle, producing 
mouse ‘menses’-like endometrium for injection into the peritoneal cavity of recipient 
mice, which develop endometriosis lesions that phenocopy those seen in women 
(Greaves et al., 2014).  
 
1.2 Macrophages have diverse phenotypes and functions 
1.2.1 Macrophages are mononuclear phagocytes 
Macrophages are immune cells which belong to the mononuclear phagocyte system, 
a family of professional phagocytes which includes dendritic cells and monocytes. 
Macrophages are able to respond to inflammatory events in the body and mount an 
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innate immune response, phagocytosing pathogens, apoptotic cells and debris. They 
are also important for antigen presentation and secretion of cytokines/chemokines to 
modulate the function of other immune cell subsets in the body, either in a pro or 
anti-inflammatory manner. Tissue macrophages colonise specific tissues in the body 
and are specially adapted to perform homeostatic functions within their tissue niche. 
For example, macrophages in the central nervous system (microglia) are crucial for 
myelination of neurons and shape neuronal development and function (Lloyd and 
Miron, 2016). Macrophages in the bone (osteoclasts) are specialised in bone 
resorption for bone remodelling (Bellido, 2014). Macrophages therefore play critical 
roles in maintaining tissue integrity and fighting infection in the body, and 
dysregulation of macrophage function has been linked to a number of autoimmune 
and chronic inflammatory diseases such as multiple sclerosis(Bogie, Stinissen and 
Hendriks, 2014), rheumatoid arthritis (Udalova, Mantovani and Feldmann, 2016), 
fibrosis (Wang et al., 2017) and cancer (Noy and Pollard, 2014).  
1.2.2 Macrophage ontogeny 
Macrophages are derived from three key populations; macrophages originating from 
the yolk sack of the embryo, from the foetal liver and in adults, haematopoiesis in the 
bone marrow. The earliest macrophages arise from erythro-myeloid progenitors 
(EMPs) produced during primitive haematopoiesis in the extra-embryonic yolk sack 
at embryonic day (E)7.5 and 8.25. After blood circulation is established, EMP 
derived macrophages seed foetal tissue. Excluding microglia, these macrophages are 
partially or fully replaced by monocytes originating from the foetal liver, which 
differentiate into macrophages in tissues. Foetal liver monocytes are derived from 
either haematopoietic stem cells or EMPs generated in the yolk sack or the placenta 
or umbilical cord. Foetal liver monocyte-derived macrophages can persist into 
adulthood and form the tissue resident macrophage population, undergoing self-
renewal, for example in the peritoneum, spleen, lung, skin and liver. In other organs, 
tissue macrophages derived from foetal liver monocytes are gradually replaced by 
recruited monocytes from the bone marrow. This process occurs in tissues such as 
the gut and dermis (Schulz et al., 2012; Hashimoto et al., 2013; Gomez Perdiguero et 
al., 2015; Hoeffel et al., 2015; Mass et al., 2016). 
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Moreover, haematopoiesis in the bone marrow begins at around day E17.5. The bone 
marrow provides a niche for haematopoietic stem cells, where they undergo 
symmetrical division to autonomously self-renew or, in response to environmental 
cues, perform asymmetrical division producing lineage specific cells which include 
common myeloid progenitor cells (Knoblich, 2001; Yamashita et al., 2010). These 
common myeloid progenitor cells differentiate into granulocyte-macrophage 
progenitor cells, eventually giving rise to monocytes which can then leave the bone 
marrow and enter the circulation.  
 
In humans, peripheral blood monocytes form three populations based on differential 
expression of CD14 and CD16. Populations of CD14hi CD16lo and CD14lo CD16hi 
cells predominate with an intermediate population of CD14hi CD16hi cells also 
present.  The CD14hi CD16lo subset are the most abundant in the blood and are 
known as 'classical' monocytes. Under inflammatory conditions, classical monocytes 
can extravasate into tissues where they differentiate into macrophages or dendritic 
cells (Ginhoux and Jung, 2014) and fulfil  functions such as clearance of apoptotic 
bodies, stimulating angiogenesis and restoring integrity of tissues (Geissmann et al., 
2010).CD14lo CD16hi cells constitute the non-classical monocytes. Non-classical 
monocytes also exhibit extravasation into tissues during inflammation, however this 
is seen later on in the inflammatory process and these monocytes exhibit a bias 
towards differentiating into wound-healing like macrophages (Olingy et al., 2017). A 
key role of the non-classical monocyte population is to patrol the blood vessels along 
the endothelial cell layer, providing immunosurveillance of vasculature and the 
surrounding tissues (Auffray et al., 2007). Classical monocytes also patrol tissues 
and play a homeostatic role in steady state conditions, without differentiating into 
macrophages (Jakubzick et al., 2013). Moreover, classical and non-classical 
monocytes in humans are widely accepted to be analogous to Ly6Chi classical and 
Ly6Clo non-classical monocytes in mice and exhibit significant homology at 
transcriptional analysis (Randolph et al., 2009; Ingersoll et al., 2010). Classical 
monocytes can be classified as Ly6Chi CX3CR1lo CD43loCCR2hi, and non-classical 
monocytes as Ly6Clo CX3CR1hi CD43hiCCR2lo, with all monocyte populations being 
CD11bhi F4/80int (Ginhoux and Jung, 2014). As in humans, classical monocytes 
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extravasate into tissues under inflammatory conditions and non-classical monocytes 
patrol blood vessels performing immunosurveillance (Auffray et al., 2007). Under 
steady state conditions, Ly6Chi monocytes can down-regulate Ly6C and adopt a 
Ly6Clonon-classical phenotype (Yona et al., 2013). Extravasation of Ly6Chi 
monocytes into tissues in response to inflammation is mediated by chemokine (C-C 
motif) ligand 2 (CCL2) binding to its receptor, C-C chemokine receptor type 2 
(CCR2). CCR2 knockout mice show inhibited recruitment of classical monocytes to 
sites of inflammation (Lu et al., 2002). As endometriosis is known to stimulate 
chronic inflammation in the peritoneal cavity, Ly6Chi classical monocytes could play 
a role in endometriosis pathophysiology ,though their role in disease is currently 
unknown.  
 
1.2.3 Macrophage phenotype 
 
Macrophages respond to their local microenvironment and change both their 
transcriptome and phenotype in response to local signals (Wynn, Chawla and 
Pollard, 2013). Historically, macrophages have been divided into either ‘M1’ 
classically or ‘M2’ alternatively activated cells. Classically activated macrophages 
are associated with inflammation, and express numerous pro-inflammatory markers. 
M2 macrophages are associated with homeostasis, wound healing and 
immunomodulation (Mantovani et al., 2004). In vitro studies commonly use 
stimulation with granulocyte-macrophage colony-stimulating factor (GM-CSF) and 
the cytokine IFN-γ (Interferon γ) to generate classically associated macrophages, and 
stimulation with macrophage colony-stimulating factor (M-CSF) and the cytokines 
interleukin-4 (IL-4) and interleukin-10 (IL-10) to generate alternatively activated 
macrophages (Rey-Giraud, Hafner and Ries, 2012).  Whilst this classification system 
is a useful tool for identifying macrophages at extremes of activation, it is now 
appreciated that macrophages exhibit a broad spectrum of phenotypes that are tissue 
and disease specific, and the 'M1' and 'M2' system cannot truly recapitulate the 
complex myriad of local growth factors and cytokines which modulate macrophage 
phenotype where M1/M2 markers often co-exist (Qian and Pollard, 2010; Martinez 
and Gordon, 2014). Transcriptional analysis of mouse tissue resident macrophage 
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populations demonstrates minimal overlap in mRNA expression, reflecting a 
divergence in gene expression patterns (Gautiar et al., 2012). This heterogeneity 
reflects the ability of macrophages to modulate their gene expression in response to 
local tissue signals, becoming specialised to their tissue niche, be that in a healthy or 
diseased state. In disease, macrophages may modulate their phenotype dependent on 
disease stage or severity, and the mechanisms behind this are crucial for 
understanding their exact role in pathogenesis. A prominent research drive therefore 
has been to define macrophage phenotypes in disease states, with the potential of 
modulating macrophage phenotype or specifically targeting dysregulated 
macrophages for clinical benefit (Johnson and Newby, 2009; Wynn, Chawla and 
Pollard, 2013; Noy and Pollard, 2014; Udalova, Mantovani and Feldmann, 2016). 
 
Figure 1.4. Macrophages are mononuclear phagocytes. Tissue macrophages are 
seeded during foetal life from the foetal liver and yolk sack and undergo self-
renewal. In adults, monocyte precursors extravasate from the bone marrow into the 
circulation, where they can then extravasate into tissues and differentiate into 
macrophages. In tissues, macrophages modulate their phenotype dependent on local 
cytokines and growth factors to specific tissue or disease associated phenotypes.  
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1.2.4 Macrophages in the peritoneal cavity 
 
1.2.4.1 Mouse 
Peritoneal cavity macrophages are present in the peritoneal fluid which bathes 
peritoneal organs and are one of the most studied macrophage populations in mice, 
largely due to their ease of isolation. Two subsets of peritoneal macrophages are 
recognised in mice based on differential expression of F4/80 and MHC II. The tissue 
resident, so called 'large' (due to their larger size) peritoneal macrophages (LPM) are 
F4/80hi, MHC IIlo and the monocyte-derived 'small' peritoneal macrophages (SPM) 
are F4/80lo MHC IIhi (Ghosn et al., 2010). F4/80hi, MHC IIlo LPM are the most 
abundant macrophage population in the peritoneal cavity at steady state and form the 
tissue resident population. LPM are highly phagocytic and are important for 
immunosurveillance and homeostasis in the peritoneal cavity (Ghosn et al., 2010) 
and for mediating recruitment and maintenance of B1 B cells, as well as being  
linked to regulation of intestinal immunity (Jackson-Jones and Bénézech, 2018). 
LPM undergo self-renewal in the peritoneal cavity. The proliferative capacity of 
LPM is regulated by GATA-binding factor 6 (Gata6), a transcription factor uniquely 
expressed by LPM in the peritoneal cavity, which also regulates macrophage 
phenotype (Rosas et al., 2014). In mice, LPM consist of primarily embryonic-derived 
cells, however monocyte-derived macrophages replace embryonic-derived LPM over 
time, a process which is highly sex and age dependent, and slower in females. Ly6Chi 
monocytes enter the peritoneal cavity in a CCR2-dependent manner and differentiate 
into a transient F4/80lo MHC IIhi population (SPM), before differentiating into tissue 
resident F4/80hi MHC IIlo cells (Bain et al., 2016). Thus the LPM constitute both 
embryonic and monocyte-derived cells whereby these two populations have been 
shown to be transcriptionally distinct from each other (Bain et al., 2016). 
Whilst LPM in the peritoneal cavity are highly characterised, the heterogeneity and 
complement of the SPM population is less well defined.  Commonly defined as 
F4/80lo MHC IIhi, SPM can be sub-divided based on expression of CD11c and 
CSF1R into three populations, CD11chi CSF1Rhi, CD11chi CSF1Rlo and CD11clo 
CSF1Rhi (Bain et al., 2016). Differentiation into SPM is regulated by the 
transcription factor interferon regulatory factor 4 (IRF4) (Kim et al., 2016). Bain et 
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al demonstrated that production of the immuno-regulatory cytokine resistin-like 
molecule (RELM)α and expression of CD206 (mannose receptor) were markers of 
the SPM population in the peritoneal cavity (Bain et al., 2016). SPM are implicated 
in the inflammatory response in the peritoneal cavity which is discussed in section 
1.2.5 below, however their role in the steady state peritoneal cavity remains unclear 
(Cassado, D’Império Lima and Bortoluci, 2015). 
 
1.2.4.2 Human 
In humans, macrophages constitute 50% of peritoneal cavity leukocytes (Kubicka et 
al., 1996). Tissue resident peritoneal macrophages have been defined by high 
expression of complement receptor of the immunoglobulin superfamily (CRIg) and 
low expression of CCR2. These cells are highly phagocytic and more numerous in 
steady state, also displaying similar transcriptional profiles to the mouse LPM 
population (Irvine et al., 2016). Human monocyte-derived macrophages in the 
peritoneal cavity, anologous to F4/80lo MHC IIhi SPM in the mouse, have been 
defined as CRIglo, CCR2hi. This CRIglo, CCR2hi population in humans has a reduced 
phagocytic capacity and is lower in number compared to CRIghi CCR2lo tissue 
macrophages, consistent with characteristics of SPM in mice. It must be noted 
however that in humans, Gata6 was found to be more highly up-regulated in the pro-
inflammatory CRIglo CCR2hi population (Irvine et al., 2016), highlighting that key 
differences between human and mouse peritoneal macrophages exist, and further 
research is critically required to clarify these differences.  
 
1.2.5 Peritoneal cavity macrophages in inflammation  
Under inflammatory conditions, LPM respond to inflammatory stimuli in a 
phenomenon known as the macrophage disappearance reaction (Barth et al., 1995). 
In mice the LPM compartment undergoes a dramatic reduction in peritoneal cavity 
numbers largely by migration to the omentum, mediated by retinoic acid and Gata6 
(Okabe and Medzhitov, 2014). Mechanistic studies in human are challenging and 
therefore knowledge of this physiological process in humans is minimal. Our 
knowledge of this process therefore stems largely from mouse models which will be 
the focus of this section. The degree of loss in the LPM population is highly 
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dependent on the dose of inflammatory stimuli and has been studied in a number of 
inflammatory models in mice, such as LPS, zymosan or thioglycollate induced 
peritonitis (Davies et al., 2011; Gautier et al., 2013; Liao et al., 2016). LPM which 
persist during inflammation have been hypothesised to play a regulatory role in the 
peritoneal cavity by secretion of IL-10, an anti-inflammatory cytokine which has also 
been shown to regulate inflammatory SPM number (Liao et al., 2016). LPM also 
play a key role in clearance of apoptotic cells during inflammation (Gautier et al., 
2013), demonstrating high expression of T-cell immunoglobulin and mucin domain 
containing 4 (Tim4) which recognises phosphatidyl-serine on apoptotic cell bodies 
(Wong et al., 2010). Upon resolution of inflammation, the reduced LPM peritoneal 
population increases its proliferative capacity through a colony stimulating factor 1 
receptor (CSF1R) mediated mechanism to restore LPM number (Davies et al., 2011). 
Interestingly, LPM have been shown to infiltrate the liver by a non-vascular route in 
response to the damage-associated molecular pattern molecule (DAMP) ATP, where 
they play a key role in regeneration and tissue repair in the liver after sterile injury, 
modulating their phenotype in response to local tissue microenvironmental cues 
(Wang and Kubes, 2016). This migration implies that LPM have the ability to 
execute wound repair and tissue regeneration in visceral organs, however it is 
unknown whether LPM infiltrate or play a role in endometriosis lesions. The 
abundance and behaviour of LPM in women with endometriosis is unknown. 
However, as women with endometriosis experience inflammation in the peritoneal 
cavity and inefficient clearance of refluxed endometrial tissue, it is possible that 
perturbations of LPM exist that create a permissive environment for the formation of 
lesions. These mechanisms however have not been explored.  
 
Furthermore, with a reduction of LPM numbers a concurrent increase in SPM and 
inflammatory Ly6Chi monocytes is observed in a number of mouse models of 
peritoneal inflammation (Barth et al., 1995). SPM exhibit a pro-inflammatory 
response when challenged with LPS in vitro, producing high levels of chemokine (C-
C motif) ligand 5 (CCL5), chemokine (C-C motif) ligand 3 (CCL3) and tumor 
necrosis factor-α (TNF-α), as opposed to LPM which produce G-CSF and GM-CSF 
under LPS stimuli (Cassado, D’Império Lima and Bortoluci, 2015).  In an in vivo 
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model of peritonitis, SPM also produce high amounts of pro-inflammatory cytokines 
including TNF-α, interleukin-1β (IL-1β) and IFN-γ (Rückerlet al., 2017), and are 
critical for clearance of bacterial infection in the peritoneal cavity after bacterial 
challenge in the mouse (Cassado et al., 2011). The ability of SPM to respond to 
inflammatory stimuli by producing pro-inflammatory cytokines enables rapid 
response to immunological challenge in the peritoneal cavity. At resolution of 
inflammation, SPM have been shown to undergo apoptosis (Gautier et al., 2013) but 
can also  migrate to local draining lymph nodes (Bellingan et al., 1996). SPM 
however have also been shown to persist in the cavity and can eventually 
differentiate into F4/80hi MHC IIlo cells (Yona et al., 2013), suggesting that 
inflammation has the potential to alter the complement of peritoneal cavity 
macrophage populations, even after homeostasis has been restored. The multiple 
fates of SPM reflect the heterogeneity in this cell compartment, and the roles of SPM 
sub-populations in inflammation are still largely undefined. The SPM composition in 
women with endometriosis has not been investigated, and although peritoneal 
macrophage depletion leads to decreased lesion formation in mice (Bacci et al., 
2009), the constitution and roles of peritoneal macrophage sub-populations in 
endometriosis has not been assessed. 
 
1.5 Macrophages play diverse roles in health and disease 
Macrophages have been shown to play instrumental roles in development, 
maintenance and progression of a number of diseases (Wynn, Chawla and Pollard, 
2013). Peritoneal cavity macrophage perturbations and dysregulation are linked to a 
number of adverse clinical outcomes. An increase in peritoneal macrophages was 
associated with negative outcomes in patients with peritonitis (Liao et al., 2017), and 
dysregulation of peritoneal macrophages has been linked to acute pancreatitis, where 
peritoneal macrophages produce increased levels of pro-inflammatory cytokines to 
exacerbate disease (Shrivastava and Bhatia, 2010). Macrophages have also been 
implicated in the formation of adhesions, a common complication after abdominal 
surgery (Burnett et al., 2006). Peritoneal cavity macrophages are therefore intricately 
linked to disease in the peritoneal cavity in humans, including in endometriosis 
patients (Haney, Muscato and Weinberg, 1981).  
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Although endometriosis is a benign disease a number of parallels have been drawn 
between the condition and cancer. Macrophages are unambiguously at the centre of 
the pathophysiology of both diseases. The significant progress in cancer-associated 
macrophage research therefore serves as an ideal platform to inform studies within 
the endometriosis field. 
Macrophage infiltration in tumours has been shown to be a predictor of poor clinical 
outcomes in malignancy (Zhang et al., 2012; Candido and Hagemann, 2013), 
attributed to the fact that macrophages promote initiation, progression and metastasis 
in most cancers (Qian and Pollard, 2010). In the last decade a major focus has been 
to define macrophage populations which constitute the tumour resident population. 
In a mouse model of breast cancer, Ly6Chi inflammatory monocytes are recruited to 
metastatic sites in a CCR2/CCL2 mediated mechanism to form tumour associated 
macrophages (TAMs). Inhibition of CCL2/CCR2 signalling with an anti-CCL2 
antibody inhibited monocyte recruitment thereby inhibiting metastasis and 
prolonging survival of the mice (Qian et al., 2011). Similarly, mouse models of 
Lewis lung carcinoma demonstrated that TAMs were derived from CCR2 driven 
recruitment of Ly6Chi monocytes and blockage of CCL2 decreased tumour growth 
(Sawanobori et al., 2008; Cortez-Retamozo et al., 2012). Depletion of Tie2+ 
monocytes/macrophages in nude mice harbouring human glioma tumours was 
demonstrated to cause tumour regression (De Palma et al., 2005). The role of Ly6Chi 
monocytes is therefore instrumental in a number of cancers and the CCR2/CCL2 axis 
has been implicated in many instances, particularly in metastatic disease (Lim et al., 
2016). Notably, women with endometriosis show an up-regulation of CCL2 in 
peritoneal fluid and ectopic endometrial cells isolated from lesions over-produce the 
CCL2 ligand (Pizzo et al., 2002; Li et al., 2012). Whether or not this recruitment 
pathway is implicated in endometriosis is currently unknown. 
Furthermore, tissue resident macrophages have also been implicated in cancer 
pathophysiology and can contribute to the TAM population. For example, in a mouse 
model of pancreatic ductal adenocarcinoma, Zhu et al demonstrated using a 
parabiosis model that TAMs were derived from both embryonically derived tissue 
resident macrophages as well as from circulating Ly6Chi monocytes. During tumour 
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development embryonically derived macrophages expanded via in situ proliferation 
and had a pro-fibrotic role in tumours. Use of a CSF1R neutralizing antibody 
alongside clodronate liposome treatment to deplete tissue resident macrophages lead 
to a reduction in tumour size and increased the survival of the mice. Monocyte-
derived macrophages however played a key role in antigen presentation. Use of 
CCR2 knockout mice or a CCR2 inhibitor to inhibit recruitment of Ly6Chi 
monocytes did not affect tumour growth (Zhu et al., 2017). This study highlights the 
importance of defining the ontogeny of TAMs in order to decipher which 
populations are fundamentally required for tumour growth, with the aim of 
improving clinical outcomes.  
Whilst TAMs may have multiple origins, it has been demonstrated that the tumour 
microenvironment can modulate macrophage phenotype to promote malignancy, 
suggesting that origin may not wholly define phenotype when macrophages are 
exposed to cytokines and growth factors locally in the tumour. A number of different 
macrophage populations within tumours have been described which play differential 
roles and have different phenotypes. For example, populations of invasive 
macrophages, perivascular macrophages, metastasis associated macrophages, 
angiogenic macrophages (which notably are Tie2+) and immunosuppressive 
macrophages which secrete high levels of IL-10 have been described (Qian and 
Pollard, 2010).  Detailed profiling of hepatocellular carcinoma biopsies demonstrated 
the presence of various macrophage sub-types in tumours which had both pro and 
anti-tumoral properties (Wu and Zheng, 2012). It is unknown whether lesion resident 
macrophages in women with endometriosis exhibit phenotypic heterogeneity, as 
current studies have largely evaluated single activation markers in an 
immunohistochemical approach (Bacci et al., 2009).  
1.3 Macrophages in the endometrium 
The endometrium undergoes cyclic proliferation, differentiation, shedding 
(menstruation) and repair in response to ovarian-derived estrogen and progesterone 
during the menstrual cycle. In the normal cycling endometrium, an  influx of 
macrophages occurs during the secretory and menstrual phases, along with a 
concomitant increase in macrophage-derived cytokines and proteases (Critchley et 
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al., 2001). Evidence from a mouse model of menstruation identified an influx of 
classical monocytes which differentiated into macrophages in the endometrium 
during the repair phase of the menstrual cycle (Cousins et al., 2016). Monocyte 
extravasation from blood vessels into the endometrium has been shown to be 
regulated by CCL2 (Arici, MacDonald and Casey, 1995; Jones, Kelly and Critchley, 
1997) and CX3C chemokine receptor 1 (CX3CR1) (Kitayaet al., 2004). The influx of 
macrophages into the endometrium is syngeneic to the plethora of key roles they are 
thought to play in modulating endometrial differentiation, breakdown and repair. 
During the proliferative phase macrophages have been postulated to play a role in 
regeneration and proliferation of the functional layer of the endometrium and express 
activation and adhesion markers CD54, CD69 and CD71 (Eidukaite and Tamosiunas, 
2004). Macrophages play a role in initiating menstruation by secreting matrix 
metallopeptidases (MMPs) (Zhang et al., 2005). Specifically, secretion of MMP-12, 
MMP-9 and MMP-14 are required for the breakdown of the functional layer of the 
endometrium during menstruation (Salamonsen, Zhang and Brasted, 2002; Curry and 
Osteen, 2003; Jeziorska et al., 2004). Macrophages are also implicated in regulating 
gland remodelling and angiogenesis by production of vascular endothelial growth 
factor (VEGF) (Sharkey et al., 2000; Garry et al., 2010). Macrophages are therefore 
key players in augmenting dynamic remodelling and repair in the endometrium.  
In addition, regulation of endometrial macrophage function is also in part achieved 
by hormone signalling. Endometrial macrophages express estrogen receptor-β (ER-
β) (Bombail et al., 2008). In response to estrogen, macrophages increase their 
proliferative capacity and undergo phenotypic changes to adopt a phenotype which 
represents a more 'wound healing-like' population (Pepe et al., 2017). Estrogen 
signalling can therefore accelerate the wound healing process and this is in part 
instrumented by increasing the production of macrophage derived proteases, MMPs, 
fibroblast growth factor, VEGF and cytokines such as resistin like alpha (RELMα) 
(McLaren et al., 1996; Rochefort et al., 2001; Campbell et al., 2014; Pepe et al., 
2017). Interestingly, growth of endometriosis lesions is stimulated in mice by 
treatment with estrogen (Zhao et al., 2014), and growth is also inhibited by treatment 
with an ERβ antagonist (Han et al., 2015), suggesting that mechanisms active within 
the endometrium which stimulate tissue repair and remodelling may also play key 
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roles in modulating the growth and development of endometriosis lesions. 
Endometrial macrophages do not express the progesterone receptor (Stewart, Bulmer 
and Murdoch, 1998), however macrophage gene expression is significantly altered in 
response to progesterone (Cheng et al., 2007), suggesting an indirect method of 
regulation. Interestingly, exposure to cortisol was demonstrated to increase 
expression of angiogenic genes such as CXCL2, CXCL8, and VEGFC in 
macrophages in vitro, suggesting that local cortisol levels could be important for 
regulating angiogenesis within the remodelling endometrium (Thiruchelvam et al., 
2016). Macrophages are therefore intricately involved in physiological changes 
occurring in the endometrium and this is regulated by exposure to local cytokines, 
growth factors and hormones which modulate their phenotype, function and 
recruitment throughout the menstrual cycle.  
 
1.4 The role of macrophages in endometriosis 
1.4.1 Macrophages are involved in the growth, vascularisation and innervation 
of lesions  
Endometriosis lesions from women are highly infiltrated by CD68+ macrophages 
which are present within the stroma of the tissue and can also be found in close 
proximity to glands (Bacci et al., 2009; Greaves et al., 2014). Patients have an 
increased number of peritoneal macrophages (Haney, Muscato and Weinberg, 1981) 
which exhibit a dysregulated phenotype. In women with endometriosis, peritoneal 
macrophages have reduced phagocytic capacity due to low levels and activity of 
matrix metalloproteinase 9, which is required for extracellular matrix degradation 
and is regulated by prostaglandin E2 (PGE2) (Wu et al., 2005). In a co-culture 
system, in the presence of endometrial stromal cells isolated from ectopic 
endometrial tissues, monocyte-derived macrophages secreted IL-10 and TGF-β, 
which in turn suppressed cytotoxicity and viability of NK cells (Yang et al., 2017), 
suggesting that macrophages are immunosuppressive in the presence of ectopic 
endometrial stromal cells and can act to suppress NK cells in the peritoneal cavity. 
Whilst peritoneal macrophages are dysregulated in women with endometriosis, 
endometrial macrophages have also been shown to exhibit differential properties. 
Reflecting on the theory of retrograde menstruation, where endometrial tissue is 
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refluxed into the peritoneal cavity to form lesions in some women (Sampson, 1927) 
the presence of macrophages in refluxed endometrial tissue in women has the 
potential to augment disease development in the peritoneal cavity. A number of 
studies have demonstrated perturbations in macrophage populations in the eutopic 
endometrium of endometriosis patients. Women with endometriosis have more 
endometrial macrophages which express lower levels of the 'wound-healing' marker 
CD163 compared to women without disease, however the exact mechanisms behind 
these alterations are unknown (Berbic et al., 2009; Takebayashi et al., 2015). 
Analogous to this, increased levels of CCL2 can be observed in the endometrium of 
women with disease which corresponds to disease severity, suggesting increased 
influx of monocytes in disease (Jolicoeur et al., 1998). Increased matrix 
metalloproteinase-9 (MMP-9) co-localised with CD68+ macrophages in the 
endometrium of women with endometriosis is indicative of an increase in the number 
of macrophages implicated in tissue remodelling. This was suggested to possibly 
enhance the ability of ectopic endometrial tissue deposits to implant in the peritoneal 
cavity (Collette et al., 2006). Whilst evidence of macrophage dysregulation in the 
eutopic endometrium of women with endometriosis exists, the role of endometrial 
macrophages in endometriosis has not been defined as functional studies in this area 
are lacking.  
 
Studies in women have strongly implied a role for macrophages in endometriosis, 
however mechanistic studies, mostly in mouse models, have significantly improved 
our understanding of macrophage biology in disease. Studies to date have largely 
focussed on defining the role of macrophages in syngenic mouse models using 
various cell depletion approaches. A commonly utilised depletion method uses 
liposomes encapsulating bisphonates. These liposomes are taken up by phagocytic 
cells which are then degraded within the cell, releasing bisphonate and causing 
subsequent cell death. This method therefore selectively depletes phagocytic cells 
and is non-toxic to non-phagocytic cells, and has been commonly used to deplete 
phagocytic macrophage populations (Rooijen and Sanders, 1994). In a syngenic 
mouse model of disease, Bacci et al used clodronate liposomes and a monoclonal 
anti-F4/80 antibody to deplete/inhibit peritoneal macrophage function in mice with 
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induced endometriosis and demonstrated that both treatments caused a reduction in 
growth and blood vessel formation in lesions (Bacci et al., 2009). Adoptive transfer 
of in vitro generated 'pro-inflammatory' (stimulated with IFN-γ), 'anti-inflammatory' 
(stimulated with macrophage-colony-stimulating factor and IL-10) or 'non-polarized' 
(stimulated with macrophage-colony-stimulating factor) macrophages lead to 
differential effects on lesion development. 'Non-polarized' macrophages had no 
effect on lesion number or weight, however adoptive transfer of pro-inflammatory 
macrophages reduced lesion weight. Conversely, adoptive transfer of anti-
inflammatory macrophages caused an increase in lesion weight. The authors noted 
that lesion architecture was also disrupted in mice which had received adoptive 
transfer of pro-inflammatory macrophages (Bacci et al., 2009). Together, this data 
suggests that anti-inflammatory macrophages may be important for the growth and 
development of lesions and pro-inflammatory macrophages have an antagonistic 
effect, clearing ectopic endometrial tissue and disrupting lesion architecture. Whilst 
this data provides an important insight into the roles of macrophage phenotypes in 
endometriosis, the use of the M1/M2 paradigm is perhaps a slightly simplistic 
approach and the exact phenotype of macrophages in endometriosis and their role in 
disease is currently unknown. Capobianco et al identified Tie-2 expressing 
macrophages that infiltrated mouse and human lesions. Depletion of Tie-2+ 
macrophages was achieved using a bone marrow chimera from mice expressing a 
suicide gene (herpes simplex virus type 1 thymidine kinase) expressed under control 
of the Tie2 promoter into wild-type mice. After treatment with ganciclovir (an anti-
viral drug), bone-marrow derived Tie2+ cells were selectively depleted and growth of 
endometriosis lesions was inhibited, with loss of neovascularisation and glandular 
organisation in the resultant lesions (Capobianco et al., 2011). Sekiguchi et al 
demonstrated that VEGFR1 knockout mice had smaller and less vascularised lesions 
than WT in a mouse model where sections of uterus were sutured onto the peritoneal 
wall. Using bone marrow chimeras they demonstrated that VEGFR1+ cells in lesions 
were bone marrow derived CD11b+ macrophages, although the authors did not 
account for the fact that CD11b can also be expressed on monocytes, neutrophils, 
eosinophils and some subsets of dendritic cells (Hey, Tan and O’Neill, 2016). WT 
endometriosis mice were also treated with clophosome N which depleted phagocytic 
- 28 - 
 
cells in the peritoneal cavity at the time of endometriosis induction, and 
demonstrated that growth and angiogenesis in lesions was reduced (Sekiguchi et al., 
2019a). A similar study using liposomal bisphosphonate to deplete phagocytic 
peritoneal populations also demonstrated reduced growth of endometriosis lesions in 
a rat model (Haber et al., 2009). It seems clear therefore that in experimental models 
of endometriosis, depletion of peritoneal phagocytic macrophage populations inhibits 
growth and angiogenesis of induced lesions.  
 
In vitro studies have aimed at assessing the interaction between endometrial stromal 
cells and macrophages in disease. In a co-culture system, culture of endometrial 
stromal cells with autologous macrophages isolated from women with endometriosis 
increased the invasive and clonogenic ability of stromal cells (Chan et al., 2017). Co-
culture with ectopic endometrial stromal cells was also shown to decrease the 
phagocytic capacity of macrophages and increased the survival and proliferation of 
stromal cells compared to eutopic endometrial stromal cells in a study by Mei et 
al(Mei, Chang and Sun, 2017). A similar effect was also reported by Shao et al 
(Shao et al., 2016). Reciprocal signalling therefore appears to be occurring between 
ectopic endometrial stromal cells and macrophages, which could contribute to their 
survival and the formation of endometriosis lesions in the peritoneal cavity, however 
the precise mechanisms are yet to be elucidated and the specific macrophage 
populations involved are unknown. 
 
Furthermore, a role for macrophages in neurogenesis in endometriosis lesions has 
been established in the literature, suggesting a role for macrophages in the generation 
of endometriosis-associated pain. Indeed, nerve infiltration in lesions is positively 
correlated with higher reported pain scores in women (McKinnon et al., 2012). 
Cholinergic, adrenergic, sensory Aδ and C nerve fibres have been identified in 
lesions (Tokushige et al., 2006; Arnold et al., 2012), and macrophages are densely 
populated in areas of high nerve density (Tran et al., 2009; Greaves et al., 2015). 
Greaves et al reported that in response to estradiol, nerve fibres secreted CCL2 and 
CSF-1 which attracted macrophages, which in turn secreted neurotrophin 3 and 
brain-derived neurotrophin factor, stimulating neurogenesis (Greaves et al., 2015).  
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We have also recently published that macrophage-derived insulin-like growth factor-
1 (IGF-1) is a key signal for nerve outgrowth and sensitization in endometriosis. 
Depletion of peritoneal macrophages by clodronate liposomes reversed abnormal 
pain behaviour in mice with induced endometriosis and notably reduced the number 
of lesions in the peritoneal cavity, providing a direct link between macrophages and 
endometriosis-associated pain/lesion development. Mechanistically we demonstrated 
that in vitro, macrophages treated with peritoneal fluid from women with 
endometriosis had an up regulation of IGF-1 at the mRNA level. Macrophage-
derived IGF-1 increased the growth of embryonic rat dorsal root ganglion explants 
and this was reversed by an IGF-1 inhibitor. Similarly, we demonstrated that IGF-1 
inhibition by the small molecule inhibitor linsitinib in our mouse model could 
reverse abnormal pain behaviours (Forster et al., 2019). Taken together, we 
demonstrated that macrophages are implicated in neurogenesis and the generation 
endometriosis-associated pain symptoms, and this is at least in part mediated by IGF-
1.The reciprocal signalling that occurs between macrophages and nerve fibres 
therefore appears critical in regulating neurogenesis in lesions and 
neuroinflammation is a key driver of endometriosis pathophysiology. 
 
1.4.2 Macrophage ontogeny and phenotype in endometriosis  
Whilst a role for macrophages in endometriosis pathophysiology is established, the 
ontogeny and phenotype of endometriosis-associated macrophages is still poorly 
understood. Greaves et al demonstrated in a mouse model of endometriosis that 
lesion resident macrophages are derived from both the endometrium and infiltrating 
macrophage populations (Greaves et al., 2014). These infiltrating macrophage 
populations are likely to constitute peritoneal or monocyte-derived macrophages 
infiltrating from the peritoneal cavity, however the exact origins of these populations 
is currently unknown. Using bone marrow chimeras Sekiguchi et al demonstrated 
that CD11b+ cells from the bone marrow infiltrate and accumulate in endometriosis 
lesions in a mouse model (Sekiguchi et al., 2019b). These cells could represent a 
monocyte/ macrophage population, however as mentioned previously, the possibility 
that CD11b+ cells could be neutrophils, eosinophils and or certain subsets of 
dendritic cells was not taken into account (Hey, Tan and O’Neill, 2016). Capobianco 
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et al demonstrated that bone marrow derived Tie2+ cells infiltrated endometriosis 
lesions in a mouse model, again demonstrating that bone marrow derived cells could 
infiltrate from blood vessels, however the possibility that other immune cells could 
express Tie2 was not taken into account (Capobianco et al., 2011). It appears 
therefore that bone marrow derived monocytes/macrophages infiltrate endometriosis 
lesions, however current studies fail to specifically identify the infiltrating 
populations. Whether peritoneal macrophages (LPM and SPM) infiltrate lesions is 
currently unknown.  
 
Furthermore, the phenotype of macrophages in endometriosis lesions has long been 
described as being wound healing and 'M2-like', however few studies have taken into 
consideration the complexities of macrophage phenotype, where pro-inflammatory 
and wound-healing like markers often co-exist in response to complex signals from 
the local tissue microenvironment (Martinez and Gordon, 2014). In humans, lesion 
resident macrophages express the scavenger receptors CD163 and CD206, associated 
with haemoglobin scavenging and silent clearance of debris (Bacci et al., 2009). 
Cominelli et al also identified CD163+ CD206+ macrophages in superficial lesions 
from women, which also expressed high levels of matrix metalloproteinase-27, 
associated with tissue remodelling (Cominelli et al, 2014). Duan et al characterised 
nitric oxide synthase (iNOS+) pro-inflammatory and CD163+ wound healing-like 
macrophages in mouse endometriosis lesions (Duan et al., 2018). In a rhesus 
macaque model of endometriosis, lesions were highly infiltrated by CD163+ 
macrophages (Smith et al., 2012). Johan et al examined infiltrating macrophage 
phenotype over time in endometriosis lesions in a heterologous mouse model and 
found that macrophage phenotype was progressively altered over time. Macrophages 
initially expressed pro-inflammatory markers iNOS and major histocompatibility 
complex II (MHC II), however at 7 and 14 days post lesion induction a higher 
proportion of macrophages expressed arginase 1 and CD204 (scavenger receptor A), 
which are more associated with a tissue remodelling phenotype (Johan et al., 2019a). 
This study therefore demonstrates that macrophage phenotype in endometriosis 
lesions is dynamic and progressively changes as lesions develop in the peritoneal 
cavity. However, as with previous studies, the small number of markers assessed 
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makes it difficult to truly re-capitulate the complex phenotype of macrophages in the 
tissue. Whilst macrophages in endometriosis lesions possessing a 'wound healing' 
like phenotype is synergistic with their role in growth and angiogenesis in lesions, a 
more comprehensive analysis of macrophage phenotype in endometriosis lesions is 
required.  It is also unknown whether different phenotypes exist within endometriosis 
lesions which could play differential roles in pathology, and identifying these 
populations is key for understanding which macrophage populations are driving 
pathology.  
 
1.4.3 Cytokines and chemokines implicated in macrophage dysregulation in 
endometriosis 
Perturbations in cytokine levels in peritoneal fluid, serum and ectopic endometrial 
tissue of women with endometriosis have been reported, possibly reflective of 
increases in peritoneal immune cell populations and dysregulation of their functions 
(May et al., 2010; Borrelli, Abrão and Mechsner, 2014). A number of factors relate 
to macrophage function and some of the roles these cytokines/chemokines are 
currently known to play in inflammatory diseases and the proven or potential role 
they may play in endometriosis are summarized in Table 1.1. Whilst we know that 
women with endometriosis have differential cytokine profiles to women without 
disease, the roles these cytokines play in endometriosis is largely unknown. 
Cytokines which have been involved in functional studies include CCL2, IL-6 and 
IL-8. Ming-Qing et al demonstrated that ectopic endometrial stromal cells (lesions) 
isolated from women secreted more CCL2 compared to respective eutopic 
endometrial stromal cells, and that CCL2 was able to encourage survival and 
invasiveness of endometrial stromal cells  in vitro, suggesting that CCL2 may 
mediate macrophage-stromal cell signalling to stimulate disease (Li et al., 2012). In a 
similar manner, macrophages cultured in conditioned medium from cultured ectopic 
endometrial cells isolated from women secreted high levels of IL-6 which increased 
the migration of endometrial stromal cells, suggesting that IL-6 could also be playing 
a role in macrophage-stromal cell reciprocal signalling (Woo et al., 2017). IL-8 is a 
chemokine secreted by macrophages which is chemotactic for neutrophils and was 
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shown to play a role in angiogenesis in a mouse model of endometriosis, whereby 
IL-8 signalling was mediated by hypoxia (Hsiao et al., 2014).  
 
Cytokines up-regulated in the peritoneal fluid of women with endometriosis are 
implicated in macrophage recruitment and survival. For example, CSF-1 signalling 
plays an instrumental role in eliciting and regulating tumour associated macrophages 
in a number of cancers (Hume and MacDonald, 2012), but there have been no studies 
on CSF-1 in endometriosis to date. CCL2 and CCL5 are also implicated in the 
recruitment of macrophages to breast cancer tumours (Svensson et al., 2015), 
however we don't currently understand how macrophages are recruited to 
endometriosis lesions.  
 
 
Table 1.1. Cytokine and chemokine levels in endometriosis patients and their 
possible role in disease 
 
 
Similarly, perturbations in cytokines and chemokines have also been reported in 
animal models of endometriosis. Of relevance to this thesis, Greaves et al reported 
that induced endometriosis lesions in the Edinburgh mouse model of endometriosis 
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show an up-regulation of the macrophage chemotactic factors CCL5 and CCL2 
compared to adjacent healthy peritoneum (Greaves et al., 2014). Notably, CCL2 is 
up-regulated both in women with disease and in the Edinburgh mouse model. In the 
future it will be important to understand the mechanisms which mediate macrophage 
recruitment and phenotypic modulation in disease as interference of these pathways 
may inhibit pro-disease macrophage populations and provide clinical benefit for 
women.  
1.6  Macrophage targeted therapies 
Macrophages offer an attractive therapeutic target due to their instrumental role in a 
number of pathologies (Noy and Pollard, 2014). Inhibition of macrophage signalling 
or recruitment, as well as re-education of disease-associated macrophages to a 
'healthy' phenotype could be of clinical benefit to patients where macrophages are 
implicated in disease pathophysiology. Identification of pathological macrophage 
populations and a detailed understanding of their regulation, recruitment and 
phenotype is therefore a fundamental step before the development of therapeutics 
which specifically target disease-associated macrophages is possible.  
Due to the intricate involvement of macrophages in many cancers, macrophage-
targeted therapies have received much attention in the literature and a number of in 
vivo studies and clinical trials have demonstrated efficacy in using macrophage-
mediated treatments to improve clinical outcomes (Noy and Pollard, 2014). A subset 
of studies have targeted proliferation of tumour associated macrophages in an effort 
to alleviate tumour burden and improve clinical outcomes. Strachen et al 
demonstrated that targeting the CSF1-receptor with a small molecule inhibitor 
attenuated the turnover rate of tumour-associated macrophages (TAMs) and 
decreased tumour growth in mouse models of breast and cervical cancer(Strachan et 
al., 2013). A phase I trial demonstrated a significant reduction in macrophage 
number in solid tumours after anti-CSF1R treatment (Gomez-Roca et al., 2019), and 
CSF1R inhibition showed an improvement in clinical outcomes including 
improvement of symptoms in patients with diffuse-type giant cell tumours (Ries et 
al., 2014). Inhibiting macrophage proliferation therefore appears to be of clinical 
benefit in cancer models and subsets of cancer patients. Future treatments may 
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specifically target disease-associated macrophage populations, as CSF1 is a key 
regulator of macrophage proliferation and survival in most tissues (Stanley and 
Chitu, 2014). The proliferative capacity of endometriosis lesion-resident 
macrophages is currently unknown, thus further research is required to determine 
whether this treatment strategy would be of benefit to women with endometriosis.  
 
Another potential mechanism of therapeutic intervention could involve blocking 
recruitment of pathogenic macrophage populations. TAMs in pancreatic ductal 
adenocarcinoma were shown to be recruited via a CCL2/CCR2 mechanism from the 
bone marrow (Mitchem et al., 2013). A phase 1b trial in pancreatic cancer patients 
utilised a CCR2 inhibitor alongside chemotherapy and demonstrated a reduction in 
macrophage infiltration into tumours compared to chemotherapy alone (Wang-
Gilliamet al., 2015). Although this was only a small trial of 47 patients, it provides 
proof of concept that TAM infiltration can be inhibited in patients when the 
recruitment mechanisms of disease-associated macrophages are defined. A similar 
approach may therefore be useful in blocking infiltration of macrophages into 
endometriosis lesions, however the mechanisms which regulate recruitment into 
lesions are currently poorly understood. 
Whilst progression in macrophage targeted therapies is promising, current therapies 
do not specifically target dysregulated macrophages but have the potential to affect 
macrophage populations throughout the whole body. For example, use of a CCR2 
inhibitor in pancreatic cancer patients significantly reduced the number of circulating 
CCR2+ inflammatory monocytes (Wang-Gilliam et al., 2015). These immune 
modulating treatments have the potential to produce toxicity due to the global effects 
on the immune system. As our understanding of macrophages in disease progresses, 
it is increasingly recognised that macrophage origins and heterogeneity in disease are 
crucial areas of research before specific, targeted treatments can be designed (Wynn, 
Chawla and Pollard, 2013). A further body of research which more critically 
describes macrophage sub-populations, active recruitment mechanisms and 
phenotype in an endometriosis setting is therefore critically required before 
macrophage-targeted treatments may be a possibility for women with endometriosis.  
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1.7 Summary 
 
Macrophages are abundant in endometriosis lesions and have been shown to be 
critical for the growth, development, vascularisation and innervation of lesions and 
generation of pain symptoms in vivo (Bacci et al., 2009; Capobianco et al., 2011; 
Greaves et al., 2015; Forster et al., 2019).  In the Edinburgh mouse model of 
endometriosis, endometrial macrophages persist in decidualised endometrial tissue 
and contribute to the lesion resident population, however the role of this population 
in lesion development is unknown. The majority of lesion macrophages are derived 
from infiltrating populations but the complement of these infiltrating populations 
remains un-defined (Greaves et al., 2014). In cancer studies, differential targeting of 
recruited monocyte-derived or tissue resident tumour associated macrophages can 
have obvious differential effects on tumour growth (Zhu et al., 2017). Understanding 
the exact ontogeny of endometriosis lesion resident macrophages is therefore an 
important step before the roles of these populations in disease can be deciphered.  
 
The macrophage recruitment pathways active in endometriosis are currently 
unknown. We know for example that tumour associated macrophages in mouse 
models of breast cancer are recruited via CCL2 and that this recruitment process 
facilitates the growth of tumours (Qian et al., 2011). Endometriosis lesions in human 
and mice are highly infiltrated by F4/80+ macrophages (Greaves et al., 2014), 
however the mechanism of their recruitment into lesion tissue is poorly understood.  
 
The phenotype of macrophages within endometriosis lesions has previously been 
defined as 'M2' like with few markers such as CD206 and Tie-2 being identified 
(Bacci et al., 2009). However, we know in a tumour setting that multiple macrophage 
populations can exist which exhibit phenotypic heterogeneity, and these populations 
play differential roles in disease development (Quatromoni and Eruslanov, 2012). It 
is currently unknown whether multiple macrophage populations exist within 
endometriosis lesions. Current endometriosis research relies on the 'M1' and 'M2' 
dogma and has therefore largely failed to appreciate the complexity of macrophage 
phenotype and explore the possibility that multiple populations may exist. 
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Despite the number of growing investigations on the role of macrophages in 
endometriosis, data on macrophage origins, recruitment pathways and phenotypic 
heterogeneity in lesions is lacking. A more in-depth evaluation of lesion 
macrophages in light of current knowledge of the complexities of macrophage 
biology is required. Defining these aspects of lesion macrophage biology is a critical 
first step in the development of therapies which could potentially target lesion 
resident macrophage populations or prevent their influx into lesions to provide 
clinical benefit for women. 
 
 
Figure 1.5. Endometriosis lesions are infiltrated by blood vessels, nerves and 
macrophages. Lesion resident macrophages are derived from macrophages 
originating from the endometrium and recruited macrophages. Macrophages 
interact with blood vessels and nerves to stimulate their growth. Signalling also 
occurs between macrophages and stromal cells, which increases their clonal 
expansion and invasive properties. Women with endometriosis have increased 
peritoneal fluid levels of IL-8, CCL5, IL-6, IL-1, TNF-α, IL-16, CSF-1, CCL2, and a 
lower concentration of IL-13. CSF-1, CCL2 and IL-6 levels are also up-regulated in 
endometriosis lesions. 
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1.8 Hypothesis and aims  
I hypothesised that host-derived endometriosis lesion-resident macrophages have 
different origins and are recruited via CCR2, and that endometriosis-associated 
macrophages exhibit phenotypic heterogeneity.  
My aims were to: 
1. Determine the origin of macrophages in endometriosis lesions 
2. Explore the role of CCR2-CCL2signalling in macrophage recruitment in 
endometriosis 
3. Determine phenotypic heterogeneity of macrophages in endometriosis lesions 
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Chapter 2 – Materials and methods 
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2.1 Animals  
2.1.1 General husbandry and ethics 
All animal work was licensed and carried out in accordance with the UK Home 
Office Animal Experimentation (Scientific Procedures) Act 1986. This work was 
performed under my personal licence (PIL; I7F2EEADD). Categories A and B 
(modules 1-3) were acquired from the University’s Accreditation Board, Cambridge 
2014, and category C (module 4) was acquired from the Scottish Accreditation 
Board, Edinburgh 2016. All of the work was carried out under the project licence 
(PPL) of Dr Erin Greaves (70-8731). The work was performed by myself unless 
otherwise stated. Bioresearch and Veterinary Services provided general day-to-day 
animal husbandry in the University of Edinburgh animal facility Little France 2 
(LF2), where all of the work in this thesis was carried out. The pathogens known to 
be present in LF2 are entamoeba, trictrichomonas and mouse norovirus. Where mice 
were imported into the unit, a week’s acclimatisation period was allowed before any 
procedures were undertaken. Mice had access to food and water ad libitum and were 
kept at an ambient temperature and humidity of 21°C and 50% respectively. Light 
was provided 12 hours a day from 7am-7pm. Mice were typically housed in groups 
of 4-6 in clear, solid bottom cages. Clinical signs were monitored as well as weight 
of the mice. Where a 10% weight loss was recorded and/or adverse effects were 
observed, mice were humanely euthanized. The mouse model of endometriosis is 
classed as a moderate procedure, however actual severity was also recorded. Mice 
were culled by exposure to rising concentrations of CO2 and cervical dislocation used 
as confirmation of death. 
2.2 Mouse model of endometriosis 
Estradiol-17β (Merck, Dorset, UK) 
Sesame oil (Merck) 
Progesterone (P4, Merck) 
PBS tablets (Merck) 
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Estradiol valerate (Merck) 
Non-surgical embryo transfer device (ParaTechs, Kentucky, USA) 
Silastic® laboratory tubing (DowCorningTM, Michigan, USA) 
Scalpel 
Our in-house mouse model of endometriosis provides an ideal platform for 
investigating the pathophysiology of endometriosis by mimicking the process of 
retrograde menstruation (Greaves et al., 2014), one leading theory for the 
development of endometriosis (Sampson, 1927). Moreover, the model is ideal for our 
studies into the role of macrophages in endometriosis because the model is generated 
in mice with an intact immune system. The design also allows for the use of 
transgenic strains either in the donor or recipient mouse group, as long as donor and 
recipient strains are on the same genetic background.  
The process of retrograde menstruation is simulated by inducing endometrial 
differentiation (decidualization) and breakdown in mice (Cousins et al., 2014), 
allowing the transfer of ‘menses’-like endometrial tissue into the peritoneal cavity of 
recipient mice which go on to develop lesions which phenocopy those seen in 
women with endometriosis (Greaves et al., 2014). Specifically, donor mice were 
induced to undergo a menses-like event by manipulating hormonal exposure. On day 
0 mice were ovariectomised and allowed to recover for 7 days, prior to receiving 
subcutaneous injections of 100ng estradiol-17β in 0.1ml sesame oil for 3 consecutive 
days from day 7 to 9. This mimics the estrogen dominated (proliferative) phase of the 
human menstrual cycle. This was then followed by a 3 day break and a further 3 days 
of 5ng estradiol-17β on days 13, 14 and 15. On day 13 mice also received a 
subcutaneous progesterone implant at the time of injection, made from Silastic® 
laboratory tubing. Days 13-15 mirror the progesterone dominated (secretory) phase 
of the menstrual cycle. A decidualization stimulus was given by introducing 20μl 
sesame oil into the lumen of the uterus via the cervix on day 15 using a non-surgical 
embryo transfer device. On day 19 (4 days after decidualization stimulus) the 
progesterone pellet was removed to induce progesterone withdrawal - a process vital 
for endometrial breakdown. Donor mice were culled 4 hours post withdrawal of 
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progesterone and the endometrial tissue was collected in the process of being shed 
from the decidualized horn: ‘menses’ endometrial tissue was recovered from the uteri 
of donor mice by opening each horn of the uterus longitudinally and scraping the 
endometrial tissue away with a scalpel. Approximately 40mg of tissue (equivalent to 
one uterine horn) was suspended in 0.2ml PBS, passed through an 18 gauge needle to 
slightly disperse the tissue and injected by two injections (each 0.1ml), either side of 
the umbilicus into the peritoneal cavity of recipient mice. Recipients had been 
previously ovariectomised and primed with a single subcutaneous injection of 500ng 
estradiol valerate (EV) 3 days prior to receiving tissue. Recipient mice received EV 
injections three times a week from tissue injection for the duration of the experiment. 
Lesions were allowed to develop over 1, 2 or 3 weeks after which the animals were 
sacrificed. Where appropriate naïve and/or sham (ovariectomy + intraperitoneal 
injection of PBS + EV) controls were included.  
2.3 Transgenic mouse lines 
2.3.1 C57 BL/6JOIaHsd  
Wild-type C57BL/6JOIaHsd female mice were purchased from Harlan (Harlan 
Sprague Dawley Inc, Bicester, UK) at 8-12 weeks of age. This is an inbred, 
commonly used laboratory strain and was particularly useful in my studies utilizing 
the syngeneic mouse model of endometriosis because many transgenic lines are 
constructed on the C57BL/6 genetic background. All transgenic mice used were on a 
C57BL/6 genetic background unless otherwise stated.  
2.3.2 ROSA26-rtTA:tetO-Cre:Csf1rflox/flox 
Colony stimulating factor 1 receptor (Csf1r) conditional knock out (ROSA26-
rtTA:tetO-Cre:Csf1rflox/flox) mice were used to study the role of endometrial 
macrophages in lesion development. This mouse strain has a conditional (floxed) 
knockout allele for Csf-1 receptor (Csf1r), reverse tetracycline-controlled 
transactivator (rtTA), and tetracycline-responsive promoter operated Cre (tetO-Cre). 
The Cre-Loxp system for targeted deletion of genes is described in figure 2.1. The 
floxed allele of Csf1r in these triple mutants was knocked out by Cre recombinase 
after treatment with the tetracycline analog doxycyclinehyclate (2μg/ml in 5% 
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sucrose water; Merck) causing Csf1r expressing macrophage populations to be 
depleted (Li et al., 2006). Macrophage depletion was confirmed using flow 
cytometry. 
 
Figure 2.1. The Cre-Loxp system for selected depletion of genes. Schematic of the 
Cre – LoxP system for targeted deletion of genes. This system makes it possible to 
delete selected genes in specific cell types in adult mice. Firstly, 34 base pair LoxP 
sites are inserted either side of a gene of interest. These LoxP sequences contain 
specific 13 base pair regions that the Cre recombinase enzyme, isolated from 
bacteriophage P1, can recognize. The Cre recombinase enzyme is able to catalyse 
DNA recombination. In the presence of Cre, a recombination event occurs between 
the two LoxP sites, causing the gene of interest to be cut from the DNA. DNA ligase 
then re-joins the DNA such that transcription can occur, however with negation of 
the selected gene.  
 
2.3.3 B6.Cg-Tg(Csf1r-EGFP)1Hume/J 
B6.Cg-Tg(Csf1r-EGFP)1Hume/J (hereby referred to as ‘MacGreen’) mice were used 
for fate-mapping experiments aimed at tracking macrophage infiltration into 
endometriosis lesions. MacGreen mice express enhanced green fluorescent protein 
(EGFP) under control of the c-fms gene, encoding for CSF-1 receptor (CSF-1r), thus 
macrophage populations expressing CSF-1 receptor can be identified by EGFP 
expression (Sasmono et al., 2003). 
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2.3.4 B6.129S4-Ccr2 tm1Ifc/J 
B6.129S4-Ccr2 tm1Ifc/J (C-C chemokine receptor type 2 (Ccr2) -/-) mice were used 
to study the role of monocytes and monocyte-derived macrophages in endometriosis 
lesion development. These were gifted from Steve Jenkins (Centre for Inflammation 
Research, UoE) and bred in house. Ccr2-/- mice have a homozygous mutation in the 
Ccr2 gene, which was achieved by replacing the entire coding region except the first 
39 nucleotides and 5' untranslated region (Boring et al., 1997). These mice have 
reduced monocytes, monocyte-derived macrophages and small peritoneal 
macrophages in the peritoneal cavity and a low number of circulating Ly6Chi 
monocytes due to an inability for monocytes to extravasate from the bone marrow 
and from blood vessels, processes regulated by CCR2 (Boring et al., 1997). 
2.3.5 B6.129S4-Ccl2 tm1Rol/J 
B6.129S4-Ccl2 tm1Rol/J (Chemokine (c-c motif) ligand 2 (Ccl2) knock out) mice 
were used to study the role of CCL2 in the development of endometriosis lesions in 
mice. Ccl2 knockout mice contain a mutation in the SCYA2 gene encoding the CCL2 
ligand. Ccl2 KO mice have normal peritoneal macrophage numbers but reduced 
recruitment of monocytes and monocyte-derived macrophages into the peritoneal 
cavity under inflammatory conditions (Lu et al., 2002).  
2.3.6 FVB-Tg(CAG-luc,-GFP)L2G85Chco/J 
FVB-Tg(CAG-luc,-GFP)L2G85Chco/J mice were purchased from Jackson 
Laboratories (Stock no: 008450|L2G85; hereby referred to as CAG-luc) on an FVB 
background. CAG-luc mice were bred in-house and used to monitor the 
establishment of endometriosis lesions over time using bioluminescent imaging 
(described in 2.4). CAG-luc mice exhibit global expression of firefly luciferase under 
control of the CAG promoter. Upon subcutaneous injection of luciferin (150mg/kg), 
luciferin is oxidised in the presence of luciferase and produces energy in the form of 
light (Cao et al., 2004). Donor CAG-luc mice were used to generate endometrial 
tissue, which was injected into the peritoneal cavity of recipient wild type mice such 
that lesions exhibited bioluminescence under stimulation of luciferin. 
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2.4 In vivo bioluminescent imaging 
PhotonIMAGERTM (Biospace Lab, Nesles la Vallée, France) 
D-luciferin potassium salt (ThermoFisherScientfic) 
M3 vision software (Biospace Lab) 
Bioluminescent lesions were visualized in vivo using a PhotonIMAGERTM. 
Endometriosis mice were injected with 150mg/kg0.1ml luciferin subcutaneously 
before imaging, such that only vascularized endometriosis lesions were visualized. 
Mice were anaesthetized and imaged for 7 minutes on both their front and back. 
Fluorescent images were visualized using M3 vision software. 
2.5 Genotyping 
2.5.1 Ear notch digestion and DNA quantification 
50µl 25mM NaOH 0.2mM EDTA made up in dH20 
50mM Tris-HCL made up in dH20 
TechneⓇDRI.blockⓇheater (Merck) 
Nanodrop One (ThermoScientific, Madison, USA) 
Ear notches were stored at -20°C. On the day of genotyping, ear notches were 
thawed and DNA extraction achieved by incubation of the notches with 50µl 25mM 
NaOH 0.2mM EDTA made up in dH20 at 95°C on a Techne
ⓇDRI.blockⓇheater for 
20 minutes. After incubation, 50µl 50mM Tris-HCL made up in dH20 was added to 
the ear notches and briefly vortexed. DNA from each ear notch was quantified by 
spectrophotomic analysis using a Nanodrop One and standardized to 100ng/μl by 
diluting in nucleic acid free dH2O.  
2.5.2 Polymerase chain reaction (PCR) 
MyTaqTM Red Mix master mix (Bioline, London, UK) 
Forward and reverse primers (Table 2.1) 
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BioerLifeECOTM thermal cycler (Alpha Laboratories, Eastleigh, UK) 
A PCR reaction (final volume 25μl) was prepared to amplify the desired gene 
product. 12.5µl MyTaqTM Red MixPCR master mix, 10.5µl water, 0.5μl forward and 
reverse primers (at 20µM) and 1μl DNA were added to the reaction. The reaction 
was briefly vortexed and placed into a BioerLifeECOTM thermal cycler. The thermal 
cycling conditions were: initial denaturation at 96°C for 2 minutes, followed by 35 
cycle of denaturation at 95°C for 20 seconds, annealing at 57°C for 20 seconds, 
extension at 72°C for 30 seconds. The final extension was at 72°C for 7 minutes.  
 
Table 2.1. Table of primers used for genotyping 
2.5.3 Gel electrophoresis and visualisation of DNA  
Agarose (Bioline, London, UK) 
10 x TAE buffer (48.4g Tris Base, 11.4ml acetic acid, 3.7g EDTA made up in dH20) 
100 base pair DNA ladder (500μg/ml) (New England Biolabs, Hitchin, UK) 
U:Genius3 (Syngene International Limited, Cambridge, UK) 
PCR products were subject to gel electrophoresis on a 2% agarose gel (with 10μl gel 
red) made with 10x TAE buffer diluted 1:10 in dH20. The products were separated  
at 150 mVa for 40 minutes. A 100 base pair DNA ladder was added either side of the 
samples for visualization of the appropriate DNA band. The gel was then imaged 
using U:Genius3.  
2.6 Flow cytometry and fluorescence activated cell sorting (FACS) 
2.6.1 Peritoneal lavage fluid collection 
Dulbecco’s modified eagle medium (DMEM) (Gibco, Inninchan, Scotland)  
26 gauge needle  
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10 ml syringe 
15ml Falcon tube  
Peritoneal lavage cells were collected by injecting 7ml ice cold DMEM into the 
peritoneal cavity of mice followed by gentle massage and retrieval into a 15ml 
Falcon tube. The samples were then centrifuged at 500 relative centrifugal force (rcf) 
for 7 minutes and the supernatant discarded. The pellet was then taken forward for 
red blood cell lysis. 
2.6.2. Tissue collection and digestion 
DMEM 
Liberase DL (Roche, Welwyn Garden City, UK) 
Liberase TL (Roche) 
DNAse (Merck) 
PBS tablets (Merck) 
Flow buffer (PBS + 2% BSA) 
15ml Falcon tube 
50ml tubes 
Scalpel  
Water bath set to 37°C (Scientific Laboratory Supplies, Coatbridge, UK) 
100μM filters (Falcon, USA) 
Flow cytometry was performed on both decidualised endometrial tissue and 
endometriosis lesions from mice. For decidualised endometrial tissue, mice were 
induced to undergo a ‘menses’-like event as previously described (Cousins et al., 
2014). On day 19, P4 pellets were removed and 4 hours later, the mice were culled. 
The uterine horn was opened longitudinally and the decidualised endometrial tissue 
scraped away using a scalpel, and placed in 2ml ice-cold DMEM. For endometriosis 
- 47 - 
 
lesions, lesions were induced to form in mice as previously described (Greaves et al., 
2014). 2 weeks post injection of tissue, lesions were dissected, pooled from each 
mouse and placed in 2ml ice-cold DMEM. Prior to digestion, endometrium or lesions 
were cut into small pieces using a scalpel. The tissue was then transferred to a 15ml 
tube and the volume adjusted to 4ml with serum free PBS.  40μl 26U/ml Liberase 
DL, 80μl 13U/ml Liberase TL and 40μl 15mg/ml DNAse enzymes were added. The 
tissue was incubated for 45 minutes in a 37°C water bath, and vortexed every 5 
minutes. For single cell RNA sequencing samples, the samples were not vortexed 
throughout the protocol but pipetted up and down to mix, so as to minimise damage 
to cells. To stop the digestion 10 ml flow buffer (PBS + 2% BSA) was added, and 
the samples were filtered through 100μM filters into 50ml tubes. The volume was 
adjusted to 20ml with flow buffer and the samples centrifuged at 500g for 7 minutes.  
2.6.3 Red blood cell lysis and blocking of excess binding sites 
10 X RBC lysis buffer (Biolegend, London, UK) 
Anti CD16/CD32 blocking antibody (BD Pharminogen, Wokingham, UK) 
Flow buffer (PBS + 2% BSA) 
After centrifugation, peritoneal lavage, endometrial or lesion resident cells 
underwent red blood cell lysis by incubation with 3ml 10 X RBC lysis buffer diluted 
1:10 in dH20 for 10 minutes. Excess binding sites on cells were then blocked for 30 
minutes at 4°C with 2μl (1:500) of anti CD16/CD32 blocking antibody added to the 
cells in 1ml flow buffer. The cells were vortexed every 10 minutes. 
2.6.4 Fluorescent staining of cells 
LunaTM dual fluorescence cell counter (Labtech, Sussex, UK)  
Fluorochrome conjugated antibodies (Table 2.2) 
BrilliantTM Stain Buffer (BD Horizon, Wokingham, UK) 
4′,6-diamidino-2-phenylindole(DAPI) (Merck) 
123count eBeadsTM (eBioscience, Inninchan, Scotland) 
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Cells were counted using a LunaTM dual fluorescence cell counter and adjusted to 1 
million cells/ml before staining with a cocktail of antibodies selected based on 
spectral overlap properties (Figure 2.2). See Table 2 for a list of all antibodies used. 
Where more than one BrilliantTM Violet (BV) fluorochrome was used, 50μl 
BrilliantTM Stain Buffer was added to the sample to negate non-specific interactions 
between the BV polymer dyes, which can affect spread of the data and introduce 
artefact populations. Samples were then stained with 1μl 1:400 DAPI (original stock 
5mg/µl, final concentration 0.0125mg/µl) diluted in dH20 before analysis for 
live/dead differentiation. 100μl of 123count eBeadsTM were added to each sample for 
accurate determination of cell counts (cells/μl) during analysis. 
 
Figure 2.2. Spectral analysis used to design flow cytometry panels. Spectral 
analyser used for designing flow cytometry antibody panels. The peaks shown 
represent the emission spectrum of each fluorochrome. Each panel is designed such 
that there is minimal overlap between the peaks. The more overlap the more difficult 
it is to perform compensation and efficiently determine the fluorescence of a given 
cell population. Figure adapted from www.biolegend.com/spectralanalyzer. 
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Table 2.2. Table of antibodies used for flow cytometry and FACS 
2.6.5 Flow cytometry  
OneCompeBeads (Thermo Fisher Scientific, Madison, USA) 
6 laser LSR Fortessa (Becton Dickinson, New Jersey)  
BD FACS DIVATM software (BD Biosciences, San Jose, USA) 
123count eBeadsTM (eBioscience, Inninchan, Scotland) 
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Stained samples were analysed on a 6 laser LSR Fortessa in the QMRI flow 
cytometry facility. Each experiment was compensated using single stained OneComp 
beads for each fluorochrome in the cocktail using the automatic compensation tool 
on BD FACS DIVATM software and a fully stained sample to validate compensation 
parameters. Where positive and negative cell populations were not clearly 
distinguishable, fluorescence minus one was performed for delineation of 
populations. For fluorescence minus one, every antibody apart from the antibody 
against the un-distinguishable population in question was added to the sample. This 
allowed identification of cells that were truly positive for the antibody and auto 
fluorescent populations identified, allowing accurate gating of positively stained 
populations. 
2.6.6 Data analysis 
Data analysis was performed using FlowJo® 10.2 software (Tree Star Inc, Ashland, 
USA). Unstained samples were used for visualization of positively stained 
populations and fluorescence minus one controls included as appropriate when 
gating was not clear. Cells which stained positively for DAPI were negated from 
analysis as only dead cells incorporate DAPI into their DNA (figure 2.3A). Doublets 
were excluded from the analysis by gating out cells with a high side scatter (height) 
compared to side scatter (area) (figure 2.3B). Eosinophils, B cells, T cells and NK 
cells were removed by gating out cells positive for siglec F, CD19, CD3 and CD335 
antibodies respectively (lineage gate) which were all conjugated to the same 
fluorochrome (FITC or APC) (figure 2.3C). Cell populations were then enumerated 
by positive gating on desired populations as well as the 123count eBeadsTM added to 
the sample (figure 2.3D). Absolute cell counts were determined using the equation: 
Cells/μl count = (cell count ÷ eBead count) x eBead batch concentration. 
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Figure 2.3. Flow cytometry gating strategy. A: Dead cells were excluded from the 
analysis by gating around cells which were negative for DAPI. B: Doublets (cells 
stuck together) were excluded from the analysis by excluding cells with a high SSC-H 
to SSC-A ratio. C: Eosinophils, B cells, T cells and NK cells were negated from the 
analysis using the lineage gate. D: 123count eBeads were visualised using 
fluorescence in the PE-Cy7 and AF700 channels and gated for accurate enumeration 
of cells/μl of a given population. E: Example of gating on a CD11b+ F4/80+ 
macrophage population. 
 
2.6.7 Fluorescence-activated cell sorting (FACS) 
FACS Fusion (Becton Dickinson, New Jersey)  
BD FACS DIVATM software (BD Biosciences, San Jose, USA) 
Red blood cell lysis, Fc blocking and fluorescent staining were performed as 
previously described and samples sorted into pure cell populations based on cell 
surface marker expression using a FACS Fusion (Becton Dickinson, New Jersey). 
Cell sorting is achieved using a stream of sheath fluid which separates out cells into a 
single cell suspension, and an electrostatic separation technique whereby cells are 
given a charge and separated based on that charge. Cells first enter the system into 
the stream of sheath fluid, which causes separation of single cells into a stream. At 
the interrogation point, lasers hit the cells and the fluorescence, reflective of cell 
surface marker expression, is determined, much the same as with flow cytometry. 
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Using BD FACS DIVATM software the cells of interest are selected. A pizoelectrical 
crystal creates oscillations at the end of the stream of cells, causing each cell at the 
end of the stream to be isolated in a droplet of fluid. This droplet can be given either 
a negative or positive charge, and is collected at charged magnetic collection 
columns, thus allowing collection of a specified cell of interest based on cell surface 
marker expression. Dead cells and doublets were excluded from analysis as 
previously described. BD FACS DIVATM software was used for visualization and 
gating of cell populations for sorting.  
2.7 Histology and immunohistochemistry 
2.7.1 Tissue fixation and processing  
Xylene  
4% neutral buffered formaldehyde (NBF) in PBS 
Leica TP 1050 processor (Leica Biosystems, Newcastle upon Tyne, UK) 
Microm HM 315 microtome (Leica Biosystems, Wetzlar, Germany) 
Positively charged glass slides (CellPath, Newtown, Wales) 
Ethanol solutions in water (95-70% ethanol) 
At tissue collection, tissues were placed in 4% neutral buffered formaldehyde (NBF) 
for 24 hours and stored in 70% ethanol thereafter. Tissue was embedded in wax 
blocks by the Shared University Research Facility (SURF) histology staff using the 
Leica TP 1050 processor. For sectioning, wax blocks were chilled on ice before 
being cut into 5μm sections on a hand operated MicromHM 315 microtome. The 
sections were floated on warm water before being placed on a positively charged 
glass slides and incubated for 24 hours at 55°C. On the day of staining, slides were 
first dewaxed in xylene for 10 minutes. Slides were then re-hydrated by incubation in 
gradually decreasing concentrations of ethanol for 20 seconds each (95-70%).  
2.7.2 Haematoxylin and eosin staining of lesions 
Harris’s haematoxylin (Triangle Biomedical Sciences) 
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Acid alcohol (1% HCL in 70% v/v ethanol) 
Scott’s tap water (20g MgSO4, 3.5g sodium bicarbonate in 1 litre distilled H20) 
Eosin (Triangle Biomedical Sciences) 
Ethanol solutions in water (95-70% ethanol) 
Xylene Glass coverslips (VWR, Poole, UK) 
Pertex® (Cell Path, Hemmel Hempstead, UK) 
After dewaxing and re-hydration, samples were incubated for 5 minutes in Harris’s 
haematoxylin for nuclear staining. Sections were then washed in tap water and 
placed in 1% acid alcohol for 10 seconds. After being washed in water, samples were 
then incubated in Scott’s tap water for 30 seconds. To add a cytoplasmic stain, 
samples were incubated in eosin for 30 seconds. Dehydration was then achieved by 
incubation in gradually increasing concentrations of ethanol (70-95%) and the 
samples cleared by incubation in xylene for 10 minutes. The slides were then 
mounted with glass coverslips using Pertex®. 
2.7.3 Cytokeratin and vimentin immunohistochemistry  
Tris-buffered saline (6.05g Tris, 8.76g NaCl in 1L H20, PH 7.5) 
0.01M citrate buffer (25ml 0.1M citrate in 225ml H20) 
3% H202 (Merck) in methanol 
Streptavidin and Biotin block (Vector, Peterborough, UK) 
Blocking serum (1:4 NGS:PBS, 5% BSA) 
Primary antibodies (table 4) 
Goat anti-mouse biotinylated secondary antibody (Merck) 
ImmPRESSⓇ horse radish peroxidase (HRP)-conjugated anti-rabbit secondary 
antibody (Vector, Peterborough, UK) 
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Streptavidin horseradish peroxidase  (Santa Cruz Biotechnology, Heidelberg, 
Germany) 
3,3-diaminobezidine (DAB) (Vector, Peterborough, UK) 
Harris’s haematoxylin (Triangle Biomedical Sciences) 
Instant PotⓇ(IP-LUX50) pressure cooker 
Pertex® 
Immunodetection of cytokeratin and vimentin was performed on endometriosis 
lesions from mice for identification of epithelial and stromal cells respectively. After 
dewaxing and re-hydration the slides were washed in tap water and Tris-buffered 
saline (6.05g Tris, 8.76g NaCl in 1L H20, PH 7.5). Antigen retrieval was performed 
by immersing slides in 0.01M citrate buffer (25ml 0.1M citrate in 225ml H20) and 
exposing them to pressurised heating for 5 minutes in an Instant PotⓇ pressure 
cooker. After antigen retrieval slides were allowed to cool for 30 minutes before 
being washed in tap water. To block endogenous peroxidase, slides were incubated 
in 3% H202in methanol for 15 minutes and washed in Tris-buffered saline (TBS) for 
2 x 5 minutes. A streptavidin block was applied to the sections for 15 minutes and 
slides washed 2 x 5 minutes in TBS. A biotin block was then applied for 15 minutes 
and slides washed in TBS 2x for 5 minutes. Slides were then incubated for 30 
minutes with blocking serum (1:4 normal goat serum (NGS): PBS, 5% BSA). After 
blocking, either cytokeratin (1:2000) or vimentin (1:600) primary antibodies were 
incubated with the sections overnight, diluted in blocking serum. Controls where 
primary antibody was omitted were incubated in blocking serum only overnight. 
After overnight incubation slides were washed 2 x 5 minutes in TBS before adding 
secondary antibodies. For the cytokeratin stain a goat anti-mouse biotinylated 
secondary antibody was diluted 1:500 in blocking serum and added to the slides. For 
the vimentin stain one drop of ImmPRESSⓇ HRP conjugated anti-rabbit antibody 
was added to the slides. These secondary antibodies were incubated with the sections 
for 30 minutes. Slides were then washed 2x 5 minutes  in TBS. Streptavidin 
horseradish peroxidase (HRP) was then diluted 1:1000 in TBS and added to the 
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sections being stained for cytokeratin for 30 minutes. At this stage vimentin slides 
were left in TBS as they had already received a HRP-conjugated secondary antibody 
(1 step detection as opposed to 2 step for cytokeratin). All of the slides were then 
visualized by incubation with 3,3-diaminobezidine (DAB) for 10 minutes before 
stopping the reaction in water. Sections were then counterstained with haematoxylin 
for 5 minutes, dehydrated and mounted using Pertex®. 
2.7.4 Immunohistochemical stain imaging 
PROVIS microscope (Zolympus Optical, London, UK) 
AxiocamHRc (Zeiss) camera 
ZEN 2.3 pro software (Carl Zeiss, Hertfordshire, UK) 
Cytokeratin, vimentin and haematoxylin and eosin stains were imaged using a 
PROVIS microscope. An AxiocamHRc (Zeiss) camera was used to capture images 
using ZEN 2.3 pro software. 
2.7.5 Immunofluorescence 
0.01M citrate buffer (25ml 0.1M citrate in 225ml H20) 
Instant PotⓇ(IP-LUX50) pressure cooker 
1mg/ml trypsin from porcine pancreas (Merck) 
3% H202 in methanol 
Tris-buffered saline (6.05g Tris, 8.76g NaCl in 1L H20, PH 7.5) 
Blocking serum (1:4 normal goat serum (NGS): PBS, 5% BSA)  
Primary antibodies (table 4) 
ImmPRESSⓇ HRP-conjugated anti rabbit/rat secondary antibodies (Vector) 
Tyramide Signal Amplification kit (PerkinElmer, Buckinghamshire, UK) 
DAPI (Merck) 
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PermaFluorTM (Thermo Fisher Scientific) 
Dual immunofluorescence was used to identify monocyte and macrophages present 
in mouse endometriosis lesions. For dual immunofluorescence, sections were 
dewaxed and re-hydrated prior to antigen retrieval by either incubation in 0.01M 
citrate buffer and heating in an Instant PotⓇ pressure cooker for 5 minutes (GATA6, 
Ly6C and GFP) or incubation for 10 minutes at room temperature in 1mg/ml trypsin 
from porcine pancreas made up in dH20 (F4/80). Endogenous peroxidases were 
blocked using 3% H202 in methanol and slides washed for 2 x 5 minutes in TBS. 
Slides were then immersed in blocking serum (1:4 normal goat serum (NGS): PBS, 
5% BSA) for 30 minutes. After blocking excess binding sites slides were incubated 
in primary antibodies F4/80 (1:600), GATA6 (1:3000), GFP (1:2000) or Ly6C 
(Abcam,1:100) diluted in blocking serum overnight. Controls with no primary 
antibody were incubated in blocking serum overnight. imPRESSⓇ HRP-conjugated 
secondary antibodies were then added to the sections (anti-rat for F4/80 and Ly6C, 
anti-rabbit for GATA6 and anti-mouse for GFP) for 30 minutes and visualized using 
Tyramide Signal Amplification, which was added to the slides for 7 minutes 
(tyramide reagent diluted 1:50 in diluent). At this stage the slides were then stained 
for a secondary antibody by repeating the protocol as previously described. In brief, 
antigen retrieval, blocking of endogenous peroxidases and blocking of excess 
binding sites was achieved. The second primary antibodies were then added to the 
slides and incubated overnight. Slides were incubated with secondary antibodies and 
visualized using Tyramide Signal Amplification, using a different fluorochrome for 
detection of the second antibody. The slides were then washed 2 x 5 minutes in TBS 
and incubated with the nuclear stain DAPI diluted 1:500 in TBS for 10 minutes. 
Slides were finally washed in TBS for 5 minutes and mounted with glass coverslips 
using PermaFluorTM. 
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Table 2.3. Table of primary and secondary antibodies used in 
immunohistochemistry and immunofluorescence. 
2.7.6 Imaging of immunofluorescent stains 
Fluorescent images were captured using a Zeiss LSM 780 confocal microscope (Carl 
Zeiss, Hertfordshire, UK). 
2.7.8 Image analysis 
2.7.8.1 Fiji analysis 
For cell counting of F4/80 GATA6 dual immunofluorescent stains, 4 random images 
at x63 objective were taken from each lesion and images quantified using Fiji plugin 
‘Cell Counter’. Total nuclei were counted, as well as cells positive for respective 
markers. Values were expressed as % of total DAPI+ cells.  
2.7.8.2 Definiens architect XDTM analysis 
For F4/80 Ly6C dual immunofluorescent stains and single GFP stains, image 
analysis was carried out by Dr Daniel Soong using Definiens Architect XDTM 
software. Tissue sections were first classified as either lesion, haemorrhage, fat or 
peritoneum. Areas of haemorrhage and fat were removed from the analysis and 
lesion and peritoneal tissue taken forward for cell counting. The total number of cells 
were counted as well as the number of cells positive for respective antibodies on the 
sections. Areas of lesion and peritoneum were counted separately.  
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2.8 Statistical analysis 
Statistical analysis was carried out in GraphPad Prism 7.02. Data was first analysed 
for normality using an Anderson Darling normality test. If data were normal, either 
an ANOVA with a Tukey's post-hoc test (more than 2 samples) or a t-test (2 
samples) was performed. If data was not normal, non-parametric statistical tests were 
used, either Kruskal-Wallis with a Dunn's post hoc test (more than 2 samples) or a 
Mann-Whitney U test (2 samples). In the case where a study had a small n number 
(e.g. 3 mice), non-parametric tests were utilised and data presented as median and 
range in order to reduce the likelihood of type 2 errors (false negatives). Otherwise, 
data was presented as mean and standard error of the mean (SEM). Statistical 
significance was reported at p=<0.05.   
2.9 Single cell RNA sequencing 
2.9.1 Barcoding of samples using the chromium controller 
PBS + 2% FBS 
TC20TM automated cell counter (Bio-Rad Laboratories, California, USA) 
Chromium controllerTM(10x genomics, Leiden, Holland) 
ChromiumTM single cell A chip (10x genomics) 
10xTM gasket (10x genomics) 
Single Cell 3’ Gel Bead Strip (10x genomics) 
C1000 touchTMthermal cycler (Bio-Rad Laboratories, California, USA) 
RT reagent mix (10x genomics) 
RT primer (10x genomics) 
Addative A (10x genomics) 
RT enzyme mix (10x genomics) 
Nuclease free water (Thermo Fisher Scientific) 
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Partitioning oil (10x genomics) 
200,000 CD45+ cells were sorted into 1ml PBS + 2% FBS using a FACS Fusion.  
Cells were then centrifuged at 500g for 5 minutes and re-suspended in 1ml PBS + 
2% FBS and counted using a TC20TM automated cell counter. Cell number and 
viability were assessed and samples with a viability over 70% were taken forward for 
barcoding. Cells were centrifuged again at 500rcf for 5 minutes and re-suspended in 
50μl PBS + 2% FBS. Cells were barcoded using a Chromium ControllerTM. 
Barcoding refers to the process which tags all of the RNA in each cell, giving each 
cell a unique oligonucleotide identifier which can be retrieved during analysis, thus 
enabling gene expression analysis at a single cell resolution. The 10xTM GemCodeTM 
technology uses a pool of ~750,000 barcodes. Each cell is partitioned into a 
nanoliter-scale Gel Bead-In Emulsion (GEM) with a single barcode. Cells are 
introduced to the system at a limiting dilution, such that 90-99% of GEMs contain no 
cell. This ensures that only a single cell is incorporated into each GEM and thus only 
a single cell will have the same barcode. After the RNA of each cell is tagged by a 
barcode, the GEMs are lysed and primers containing a 16 nucleotide 10x barcode, a 
10 nucleotide Unique Molecular Identifier (UMI, tags each sample), an IlluminaⓇR1 
sequence (primer required for sequencing, referred to as read 1) and a poly-dT 
primer sequence are mixed with the tagged RNA and Master Mix.  
This barcoding process was achieved first by creating a reaction mix by adding 50μl 
RT reagent mix, 3.8μl RT primer, 2.4μl additive A and 10μl RT enzyme mix added 
to a PCR tube on ice. 25μl nuclease free water was added to the master mix, as well 
as 7μl  cells. This was gently mixed and 90μl carefully added into row 1 on the single 
cell A chip. In row 2, 40μl Single Cell 3’ Gel Beads (incorporated into the GEMs) 
was slowly added, being careful not to introduce air bubbles. 270μl partitioning oil 
was then added in two lots of 135μl into row 3. This is required to produce the oil 
droplets which form the GEMs. A 10xgasket was then used to cover the chip and the 
chip loaded onto the Chromium ControllerTM, which was run on a set protocol for 6 
minutes. After running on the Chromium ControllerTM, samples were incubated in a 
thermal cycler in order to generate cDNA. The samples were taken through the 
following protocol: 53°C for 45 minutes, 85°C for 5 minutes, held at 4°C thereafter. 
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2.9.2 Library preparation 
Library preparation refers to the process of preparing the samples for IlluminaⓇ 
bridge amplification sequencing. This was a 1.5 day process which cleaned the 
samples to get rid of reagents and primers, amplified cDNA to generate sufficient 
product, size selected to optimize the cDNA amplicon size and added the primers 
required for IlluminaⓇsequencing.  
2.9.2.1 Post GEM-reverse transcription clean up and cDNA amplification 
C1000 touchTM thermal cycler (Bio-Rad, California, USA) 
DynaBeads® MyOne™ Silane Beads (Thermo Fisher Scientific) 
10xTM Magnetic Separator (10x genomics) 
80% ethanol (Merck) 
Nuclease free water (Thermo Fisher Scientific) 
Elution solution (10x genomics) 
cDNA amplification reaction mix (10x genomics) 
Clean-up was performed to remove leftover primers and biochemical reagents from 
the post GEM reaction mixture, used to generate cDNA. In order to remove these 
reagents, DynaBeads® MyOne™ Silane Beads (hereby referred to as DynaBeads®) 
were used. The cDNA binds to the beads, allowing separation of the cDNA from 
leftover reagents and primers. The samples were mixed with 200μl DynaBeadsⓇ for 
5 minutes, after which they were placed on a 10XTMMagnetic Separator until the 
supernatants became clear, indicating that the beads had accumulated at the magnet. 
This allowed the supernatants, containing excess reagents and primers, to be 
discarded, leaving only the cDNA left on the beads. 150μl freshly prepared 80% 
ethanol in nuclease free water was then used to wash the beads twice for 3 seconds. 
35.5μl elution solution was then added to the beads and the tubes placed onto the 
10XTM Magnetic Separator for 1 minute. The supernatants now contained the purified 
cDNA and were taken forward for PCR. PCR was performed in order to generate 
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sufficient cDNA for library construction. cDNA was amplified by incubation with 
65µl cDNA amplification reaction mix provided by 10x and the following protocol 
run on a thermal cycler: 98°C for 3.15 minutes, 67°C for 20 seconds, 72°C for 1 
minute (repeated for 10 cycles), then 72°C for 1 minute and held at 4°C thereafter.   
2.9.2.2 Post cDNA amplification reaction cleanup 
Qubit 3 fluorometer bioanalyzer (Invitrogen, California, USA) 
SPRIselect Reagent Kit (Beckman Coulter, California, USA) 
10XTM Magnetic Separator (10x genomics) 
80% ethanol (Merck) 
Nuclease free water (Thermo Fisher Scientific) 
EB Buffer (Qiagen, Hilden, Germany) 
This stage of the protocol removed any leftover reagents from the cDNA 
amplification reaction mix and ensured that only the purified cDNA product was 
taken forward through the protocol. The same concept was utilised as in section 
2.9.2.1 however instead of DynaBeadsⓇ, SPRIselect Reagent Kit (SPRI beads) was 
used, another type of magnetic beads. 60μl SPRI beads were added to the samples, 
incubated for 5 minutes and then placed on the 10XTM Magnetic Separator until the 
solutions were clear. The supernatants were discarded and the beads washed with 
200μl 80% ethanol in nuclease free water for 30 seconds twice. The ethanol was 
removed and the tubes, still in the 10XTM Magnetic Separator, were incubated at 
room temperature for 2 minutes. The samples were taken off the 10xTM Magnetic 
Separator and 40.5μl EB buffer added to the samples and incubated for 2 minutes at 
room temperature. Samples were then placed back on the 10xTM Magnetic Separator 
until the solutions were clear, and 40μl supernatant containing the purified cDNA 
taken forward through the protocol. At this point the amount of cDNA was 
enumerated using a Qubit 3 fluorometric bioanalyzer to ensure a sufficient cDNA 
yield (>30ng/μl is optimal). 
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2.9.2.3 Fragmentation, end repair and A-tailing 
C1000 touchTM thermal cycler (Bio-Rad, California, USA) 
Fragmentation buffer (10x genomics) 
Fragmentation enzyme blend (10x genomics) 
SPRIselect Reagent Kit (Beckman Coulter, California, USA) 
10xTM Magnetic Separator (10x genomics) 
80% ethanol (Merck) 
Nuclease free water (Thermo Fisher Scientific) 
EB Buffer (Qiagen, Hilden, Germany) 
This process selects for cDNA of specific sizes in order to optimize the cDNA 
amplicon size. This gets rid of cDNA which is too small or too large, and thus is 
called double sided size selection. This process assumes that cDNA of interest will 
be within a specific size range. cDNA underwent fragmentation, end repair (blunts 
the fragmented DNA) and A-tailing (adds an adenosine to the 3’ end of the DNA). 
This was achieved by adding 5μl fragmentation buffer, 10μl fragmentation enzyme 
blend and 35μl purified cDNA to a PCR tube. This mix was transferred to a pre-
cooled thermal cycler and underwent the following cycle: 32°C for 5 minutes 
(fragmentation stage), 65°C for 30 minutes (end repair and A-tailing) and held at 4°C 
thereafter. After the reaction, the samples were taken through a protocol which 
ensured that only cDNA of the desired size was selected. 30μl SPRI beads were 
added to the samples and incubated at room temperature for 5 minutes. The tubes 
were then placed on the 10xTM Magnetic Separator until the solutions became clear. 
At this point, cDNA of interest was in the supernatant fraction. 75μl supernatant was 
transferred to new tubes. 10μl SPRI beads were then added to the samples and 
incubated for a further 5 minutes, after which they were placed back on the 10xTM 
Magnetic Separator until the solutions were clear. 80μl supernatant was discarded 
and the beads washed with 125μl 80% ethanol in nuclease free water for 30 seconds, 
twice. 50.5μl EB buffer was then added to the tubes for 2 minutes, placed on the 
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10xTM Magnetic Separator until the solutions were clear and 50μl of the supernatant 
containing the cDNA placed into a new tube.  
2.9.2.4 Adaptor ligation and post ligation cleanup 
C1000 touchTM thermal cycler (Bio-Rad) 
Ligation buffer (10x genomics) 
DNA ligase (10x genomics) 
Adaptor mix (10x genomics) 
SPRIselect Reagent Kit (Beckman Coulter, California, USA) 
10xTM Magnetic Separator (10x genomics) 
80% ethanol (Merck) 
Nuclease free water (Thermo Fisher Scientific) 
EB Buffer (Qiagen, Hilden, Germany) 
Adaptor ligation is the process of adding known synthetic oligonucleotide sequences 
to the end of a cDNA molecule. In this protocol adaptor ligation adds primers 
required for IlluminaⓇbridge amplification sequencing. Adaptor ligation was 
achieved by adding 17.5μl nuclease free water, 20μl ligation buffer, 10μl DNA ligase 
and 2.5μl adaptor mix to 50μl of purified cDNA sample. This was incubated in a 
thermal cycler at 30°C for 15 minutes and 20°C for a further 15 minutes. To get rid 
of any excess reagents the samples were then cleaned using SPRI beads. 80μl was 
added to the samples and incubated for 5 minutes at room temperature. After 
incubation on the 10xTM Magnetic Separator until solutions became clear, the 
supernatant was then removed and the samples washed in 200μl 80% ethanol in 
nuclease free water 2 times for 30 seconds. The samples were allowed to air dry for 2 
minutes and 30.5μl EB buffer added. This was left for a further 2 minutes and the 
samples placed onto the 10xTM Magnetic Separator until the solutions were clear. 
30μl purified cDNA was then transferred to a new tube. 
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2.9.2.5 Sample index PCR 
C1000 touchTM thermal cycler (Bio-Rad, California, USA) 
PN220103 ChromiumTM i7 sample index plate (10x genomics) 
Nuclease free water (Thermo Fisher Scientific) 
Amplification master mix (10x genomics) 
SI-PCR primer (10x genomics) 
The sample index is an oligonucleotide which is added to each sample in order to be 
able to identify each individual sample after the sequencing. The sample index is 
provided on a PN220103 ChromiumTM i7 sample index plate, where each well 
contains a known oligonucleotide sequence, one of which is added to each sample. 
To achieve this, 8μl nuclease free water, 50μl amplification master mix, 2μl SI-PCR 
primer and 30μl purified cDNA sample was added to a PCR tube. 10μl of a 
Chromium i7 sample index was then added to each sample. The sample was then 
placed into a thermal cycler and the following protocol was run: 98°C for 45 
seconds, 98°C for 20 seconds, 54°C for 30 seconds, 72°C for 20 seconds, repeated 
~15 times (dependent on cDNA input), then 72°C for 1 minute and held at 4°C 
thereafter. 
2.9.2.6 Post sample index PCR double sided size selection 
SPRIselect Reagent Kit (Beckman Coulter, California, USA) 
10xTM Magnetic Separator (10x genomics) 
80% ethanol (Merck) 
Nuclease free water (Thermo Fisher Scientific) 
EB Buffer (Qiagen, Hilden, Germany) 
cDNA of desired sizes was selected for in the same manner as section 2.9.2.3. 60μl 
SPRI beads were added to the samples and incubated for 5 minutes. The samples 
were then placed on the 10xTM Magnetic Separator until the solutions were clear. 
- 65 - 
 
150μl supernatant, containing the purified cDNA, was transferred to a new tube. 20μl 
SPRI beads were added to the samples and incubated for 5 minutes. The samples 
were again placed on the 10xTM Magnetic Separator until the solutions were clear. 
165μl supernatant was removed and discarded. The samples were then washed with 
200μl 80% ethanol in nuclease free water for 30 seconds. This was repeated twice. 
35.5μl EB buffer was added to the samples and incubated for 2 minutes. After being 
placed on the 10xTM Magnetic Separator until the solution was clear, 35μl of the 
supernatant, containing the purified cDNA, was transferred to a new tube. The 
samples were then stored at -20°C until being sent for sequencing.  
 
Figure 2.4. Barcoding and library preparation of cDNA samples. A: Schematic of 
the cell barcoding process. The transcriptome of each cell is tagged with an 
oligonucleotide barcode, which is specific to each cell and can be identified during 
data analysis. Each cell is isolated in a nanoliter-scale Gel Bead-In Emulsion (GEM) 
with a 10x oligonucleotide barcode. In the GEM the cell is lysed and its RNA 
contents ligated with the 10x barcode. After this process, the GEMs are lysed and the 
oil removed from the now pooled tagged RNA. At the end of the barcoding process a 
pool of tagged RNA molecules from all of the cells is produced. B: The final 
sequence of a 10X library, ready for IlluminaⓇ sequencing by synthesis. The UMI 
(unique molecular identifier) is a 10 nucleotide sequence required to identify each 
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experiment. The read 1, read 2 and poly-dT primer sequence are sequences added to 
facilitate IlluminaⓇsequencing, as well as P5 and P7 which are required for bridge 
amplification during sequencing. The 10x barcode is the barcode added during 
barcoding of the samples which identifies each cell. The i8: 8 sample index is 
required to identify each sample during analysis. At the end of the library 
preparation process each cDNA molecule should contain all of these sequences, thus 
readying the cDNA for IlluminaⓇsequencing. Adapted from www.10xgenomics.com. 
 
2.9.2.7 Quality control of libraries 
Quality control (QC) was performed on the libraries by Dr Pam Brown in the Queens 
Medical Research Institute Biomolecular Core using a LabChip® GX Touch 24 
Nucleic Acid Analyzer (Perkin Elmer, Buckinghamshire, UK). QC data was assessed 
by Dr Beth Henderson (CIR) and all samples deemed of sufficient quality to take 
forward for sequencing. QC analysis was also carried out by Edinburgh Genomics 
before sequencing so as to ensure the samples were of sufficient quantity, this 
analysis is summarised in table 2.4. 
 
Table 2.4 Summary of QC analysis on single cell RNA sequencing samples. QC 
analysis was provided by Edinburgh Genomics. 
 
2.9.3 Illumina® sequencing of libraries 
Libraries were sent to Edinburgh Genomics and Illumina® sequencing by synthesis 
performed using a NovaSeq 6000 sequencing system (Illumina®, San Diego, USA).  
Illumina® sequencing relies on bridge amplification to amplify target cDNA in situ. 
This is achieved using a glass flowcell coated in two different types of 
oligonucleotides, which are complementary to P5 and P7 adaptors on the ends of the 
DNA added during library preparation. The adaptors on the DNA molecules bind to 
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the complementary oligonucleotide on the flowcell. Polymerases then amplifiy the 
DNA causing it to clonally expand, which form ‘bridges’ on the flowcell due to the 
fact that both ends of the DNA contain adaptors complementary to the two different 
types oligonucleotides (figure 2.5).Once amplification is complete, each individual 
DNA has generated a “cluster” of around 1000 copies on the flowcell. The DNA is 
then sequenced by incorporation of fluorescently-tagged nucleotides. Every time a 
nucleotide is added to the DNA molecule, the sample is excited by a laser and 
fluorescence is released and detected. Each base has a distinct fluorometric signature, 
thus the output of the sequencing is fluorescence. Base calling to transform the 
fluorescence output into a sequence of bases is performed which can then be taken 
forward to bioinformatics analysis. 
 
Figure 2.5. Illumina® bridge amplification sequencing. A. Schematic diagram of 
Illumina® bridge amplification of DNA.  The DNA forms bridges on the flowcell and 
is clonally amplified to create clusters of each DNA fragment. B. Diagram 
demonstrating the output of Illumina® sequencing by synthesis. Each dot on the 
diagram represents a cluster of clonally amplified DNA. As each nucleotide has a 
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fluorescently distinct signature, the sequence of the DNA can thus be determined in 
the base calling process. Adapted from www.illumina.com.   
 
2.9.4 Bioinformatics 
Bioinformatics analysis was performed by Edinburgh Genomics. Bioinformatics 
analysis ensured all of the reads were of sufficient quality and aligned them to a 
reference genome (C57 BL/6 mouse). In brief, analysis was carried out using 10X 
Genomics’ ‘Cellranger’ tool (version 2.0.1). FASTQ files were generated using 
‘Cellrangermkfastq’. ‘Cellranger count’ was executed for each sample, specifying 
the output location of ‘Cellrangermkfastq’, the supplied ‘SI-GA’ indices, and the 
transcriptome ‘refdata-cellranger-mm10-1.2.0’ as supplied by 10x. An aggregated 
final dataset was created using the ‘Cellrangeraggr’ command. The analysed files 
generated by Edinburgh Genomics were visualized in Loupe software and t-
distributed stochastic neighbor embedding (t-SNE) plots generated. Marker genes of 
specific immune cells were used to cluster immune cell populations in the samples 
accordingly. Loupe software was then used to interrogate gene expression in the 
Adgre1+Itgam+ Csf1r+ macrophage population.   
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Chapter 3 - Lesion resident 
macrophages are derived from 
endometrial,  peritoneal and 
monocyte-derived macrophages 
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3.1 Introduction 
Endometriosis is known to induce an inflammatory environment in the peritoneal 
cavity, for example women with endometriosis have increased concentrations of 
peritoneal pro-inflammatory cytokines (Giudice, 2010). Inflammation in the 
peritoneal cavity of mice is known to induce perturbations in peritoneal macrophage 
populations known as the ‘macrophage disappearance reaction’. In this phenomenon, 
homeostatic large peritoneal macrophage numbers rapidly decrease and pro-
inflammatory small peritoneal macrophage numbers increase in the peritoneal cavity 
(Ghosn et al., 2010). Yuan et al reported that in mice with induced endometriosis, 
they observed a decrease in large peritoneal macrophages and an increase in small 
peritoneal macrophages in the peritoneal cavity, consistent with the fact that 
endometriosis lesions are thought to stimulate inflammation in the peritoneal cavity 
(Dunselman et al., 2014). In the Edinburgh mouse model of endometriosis, we know 
that expression of CCL2 and CCL5 are increased in peritoneal tissue compared to 
control mice, suggesting that an inflammatory peritoneal environment exists in mice 
with induced disease (Hansen, Chalpe and Eyster, 2010). Whether perturbations in 
monocyte and macrophage populations in the peritoneal cavity of mice with induced 
endometriosis in the Edinburgh mouse model exist however is currently unknown.  
We know from studies in cancer that tumour macrophages originate from both 
recruited monocyte-derived populations and tissue-resident cells which are seeded 
during foetal life (Walch et al., 2014). In endometriosis lesions, we know that tissue-
resident endometrial macrophages persist in endometrial tissue and contribute to the 
lesion macrophage population and that recruited macrophages are also present 
(Simón et al., 1994; Garrido et al., 2002; Xu et al., 2015). Lesions are bathed in 
peritoneal fluid containing macrophages which could potentially be recruited to 
lesions. We also know that lesions are highly vascularised (Saraswat et al., 2017) 
meaning monocytes could extravasate from blood vessels into lesions where they 
could differentiate into macrophages. The origins of the recruited macrophage 
population in lesions however is unknown. 
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3.2 Aims and hypotheses 
I hypothesised that lesion macrophages are a heterogeneous population consisting of 
macrophages derived from eutopic endometrium as well as peritoneal and monocyte-
derived macrophages.  
The aims of this chapter were to: 
1. Characterise peritoneal monocyte/macrophage populations in mice with 
induced endometriosis 
2. Determine whether  peritoneal and monocyte-derived macrophages are 
recruited to endometriosis lesions 
3.3 Results 
3.3.4 Endometriosis lesions induced in mice exhibit heterogeneity  
Endometriosis lesions formed in the Edinburgh mouse model of endometriosis have 
been previously demonstrated to be macroscopically and microscopically 
heterogeneous, exhibiting histological similarity to lesions found in women (Simoens 
et al., 2012; Nnoaham et al., 2013). We also recently published that mice with 
endometriosis exhibit local and peripheral hyperalgesia, a key symptom associated 
with disease in humans (Bazot and Daraï, 2017; Bedaiwy et al., 2017; Agarwal et al., 
2019). In the experiments which contributed to this thesis, mouse endometriosis 
lesions were most commonly found on the peritoneal wall or attached to visceral fat. 
Peritoneal lesions were brown/black in colour and raised from the peritoneum, 
commonly invading all the way through the peritoneal wall (figure 3.1A(i)). Lesions 
found attached to visceral fat were brown/yellow in colour (figure 3.1A(ii)). Some 
peritoneal lesions were filled with fluid, which was usually a reddish colour 
indicating the presence of blood (figure 3.1A(iii)).  
We performed experiments using CAG-luciferase mice to identify when endometrial 
tissue became attached and vascularised in the peritoneal cavity. WT mice received 
donor endometrial tissue from CAG-luciferase mice with exhibit bioluminescent in 
the presence of luciferin. 24 hours after injection of endometrial tissue, WT recipient 
mice were injected subcutaneously with luciferin and imaged to identify 
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bioluminescent endometrial tissue. By injecting luciferin via a subcutaneous route, 
we assumed that luciferin could only reach the peritoneal cavity via the vascular 
system, thus endometrial tissue exhibiting bioluminescence must be vascularised. We 
identified concentric bioluminescent signals from all 5 mice identifying that by 24 
hours lesions had become attached and vascularised in the peritoneal cavity (figure 
3.1C).  
The median number of lesions recovered from WT mice was 1 at 1 week post 
injection of tissue, 1 at 2 weeks post injection of tissue and 2 weeks post injection of 
tissue and 2 at 3 weeks post injection of tissue.  
 
Figure 3.1. Endometriosis lesions induced in mice were attached to the peritoneal 
wall and fat and became established by 24 hours after injection of endometrial 
tissue. A: Images of common mouse endometriosis lesions. Lesions were found on 
the peritoneal wall and attached to fat. (i) typical peritoneal lesion which had 
adhered to visceral fat (ii) lesion attached to visceral fat (iii) black fluid-filled lesion 
on the peritoneal wall B: Bioluminescent imaging of mice which had received CAG-
Luc endometrial tissue injected into the peritoneal cavity 24 hours prior to imaging. 
Lesions exhibited bioluminescence upon subcutaneous injection with luciferin (n=5 
mice). C: The number of  lesions recovered from mice at 1 (n=6 mice), 2 (n=21 
mice) and 3 weeks (n=12 mice) after injection of endometrial tissue. Data are 
expressed as median values and was analysed by analysis of variance (ANOVA).  
 
Mouse endometriosis lesions were subject to haematoxylin and eosin (H+E) stain 
and analysed for the presence of glands and stromal cells using cytokeratin and 
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vimentin staining respectively. H+E stain revealed that mouse endometriosis lesions 
had significant heterogeneity in tissue architecture. Consistent features of lesions 
included dense purple staining indicative of stromal cells and brown staining 
indicating the presence of hemosiderin, a product of macrophage activity (figure 3.2, 
A-D). Some endometriosis lesions recovered were cystic and upon cytokeratin 
staining contained glands with a stained epithelial layer (21% of lesions), however 
not all lesions had positive staining for cytokeratin (figure 3.2, E, G, I). All 
endometriosis lesions stained positive for vimentin which identified stromal cells 
within the tissue (figure 3.2, F, H, J). 
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Figure 3.2. Mouse endometriosis lesions exhibited microscopic heterogeneity and 
all lesions stained positive for stromal cells but only a proportion of lesions had 
glands . H+E stain of endometriosis lesions recovered from mice (A-D). Mouse 
lesions exhibit heterogeneity at a macroscopic and microscopic level, in line with 
what is observed  in lesions recovered from women with endometriosis. Many lesions 
had brown staining, evidence of hemosiderin indicative of macrophage activity. 
Lesions were recovered from (A) fat associated with the uterus and (B-D) the 
peritoneum. A, adipose; G, gland; S, stroma; H, hemosiderin; BV, blood vessel. 
Cytokeratin staining on mouse endometriosis lesions identified epithelial cells and 
glandular compartments (E and G). Control where primary antibody was omitted 
showed no staining (I). Vimentin staining on mouse lesions demonstrated the 
presence of stromal cells (F and H). Control with no antibody showed no stromal 
cell staining. The minimal brown staining observed is likely hemosiderin (J). 
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3.3.5 Mice with endometriosis have increased peritoneal Ly6Chi monocytes 
I characterised peritoneal monocyte and macrophage populations in mice with 
induced endometriosis to determine the effect of the presence of lesions on the 
peritoneal immune environment. Naive mice, sham mice and mice with 
endometriosis were culled at 1, 2 and 3 week time points and peritoneal lavage 
analysed by flow cytometry. Large and small peritoneal macrophages were 
delineated based on expression of MHC II and F4/80, whereby large peritoneal 
macrophages were MHC IIlo F4/80hi and small peritoneal macrophages were MHC 
IIlo F4/80hi (figure 3.3A). At a 1 week time point sham mice exhibited an increase in 
the large peritoneal macrophage population compared to naive but not endometriosis 
mice. Naive, sham and endometriosis mice all had significantly more large than 
small peritoneal macrophages at a 1 week time point (figure 3.3B). At a 2 and 3 week 
time point, there were no differences in large peritoneal macrophages between the 
groups (figure 3.3C/D). I did not observe any significant changes in the small 
peritoneal macrophage population at any time points. Next I analysed Ly6Chi 
monocytes and Ly6C hi F4/80 hi cells transitioning from a monocyte to macrophage 
phenotype in the mice (figure 3.3E). There were no significant changes in the Ly6Chi 
F4/80hi population at any time point across the groups (figure 3.3F-H). There was 
however a significant increase in the Ly6Chi monocyte population in the 
endometriosis group compared to naive at 1 week and compared to sham at 2 weeks. 
At 3 weeks there was no significant increase in the Ly6Chi population in the 
endometriosis group.  
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Figure 3.3. Small and large peritoneal macrophage numbers were not altered in 
the peritoneal lavage fluid of mice with endometriosis however an increase in 
Ly6C+ monocyte numbers was observed. A: Flow plot demonstrating gating of 
mature peritoneal cavity macrophages (F4/80hi MHC IIlo) and monocyte-derived 
small peritoneal macrophages (F4/80lo MHC IIhi). B: 1 week after endometrial tissue 
injection sham mice exhibited an increase in F4/80hi MHC IIlo cells compared to 
naive which was not seen in endometriosis mice. C and D: No significant alterations 
in F4/80hi MHC IIlo or F4/80lo MHC IIhi cells were observed at 2 or 3 weeks post 
injection of endometrial tissue. E: Flow plot demonstrating gating of F4/80lo Ly6Chi 
monocytes. F: Mice with endometriosis exhibited an increase in F4/80lo Ly6Chi 
monocyte numbers 1 week after tissue injection compared to naive but not sham 
animals. G: At  2 weeksendometriosis mice had an increase in Ly6Chi monocytes 
compared to sham. H: No difference was seen in F4/80lo Ly6Chi monocyte numbers 
at 3 weeks. 1 week time point: Naïve  n=12 mice, sham n=6 mice, endometriosis n=6 
mice. 2 week time point: Naïve n=12 mice, sham n=6 mice, endometriosis n=8 mice. 
3 week time point: Naïve n=12 mice, sham n=8 mice, endometriosis  n=16 mice. 
Data are expressed as means ±SEM. Analysis of variance (ANOVA), *; P < 0.05, **; 
P < 0.01, and ***; P < 0.001.  
 
3.3.6 Endometrial macrophages constitute 16% of lesion macrophages 
To assess the contribution of endometrial-derived macrophages to the endometriosis 
lesion macrophage population, endometriosis was induced using MacGreen donor 
mice (macrophages are GFP+) and WT recipient mice (macrophages are GFP-) 
(figure 3.4A). GFP+ endometrial-derived macrophages were enumerated in the 
resultant endometriosis lesions using flow cytometry (figure 3.4B). Endometriosis 
lesions from each mouse were pooled in order to generate sufficient tissue for 
analysis. 16% (SEM± 4%) of lesion CD11b+ macrophages expressed GFP. The 
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remaining 84% (SEM±3%) were GFP- and thus were derived from the recipient 
mouse (figure 3.4C). 
 
Figure 3.4. Endometrial macrophages contribute to the endometriosis lesion 
resident macrophage population. A: Schematic demonstrating study design. B: Flow 
plot of GFP+ endometrial-derived CD11b+ cells in the endometriosis lesions of 
mice which had received donor endometrial tissue from MacGreen (Csf1r-EGFP) 
mice 2 weeks prior to cull (n=6 mice where lesions were pooled from each animal 
for analysis). C: GFP+ endometrial derived CD11b+ cells represented 16% (SEM± 
4%) of lesion CD11b+ macrophage populations, the remaining 84% (SEM±3%) 
were GFP-. Significantly more CD11b+ cells were derived from infiltrating 
macrophage populations compared with the endometrial-derived population 
(p=<0.0001) (analysed by student t test). Data are expressed as means ±SEM. 
 
3.3.7 Large peritoneal macrophages infiltrate lesions 
In order to assess the contribution of large peritoneal macrophages to endometriosis 
lesions, lesions were stained for the large peritoneal macrophage markers F4/80 and 
Gata6 (figure 3.5A). 48% (±SEM 4%) of cells in lesions expressed F4/80 and 4% 
(±SEM 2%) of these co-expressed the large peritoneal marker Gata6. A Gata6+ only 
population was also present in the tissue and this represented 8% (±SEM 2%) of total 
cells (figure 3.5B).  
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Figure 3.5. 4% of lesion resident F4/80+ cells co-expressed the large peritoneal 
macrophage marker Gata6. A.  Immunofluorescent stain of F4/80 and Gata6 on a 
mouse endometriosis lesion. Thick white arrow indicates a Gata6+ F4/80+ cell. Thin 
white arrows indicate single F4/80+ cells. B. 48% (±SEM 4%) of cells in lesions 
expressed F4/80. 2% (±SEM 1%) of cells co-expressed both F4/80 and Gata6 and 
these constituted 4% (±SEM 2%) of the F4/80 population. Cells only expressing 
Gata6 could also be detected and contributed to 8% (±SEM 2%) of total cells. 
Values expressed as % of total DAPI+ cells. N=10 lesions were stained which were 
isolated from n=7 animals. Data are expressed as means ± SEM. 
 
Large and small peritoneal macrophages were isolated from the peritoneal cavity of 
MacGreen mice using FACS of peritoneal lavage fluid isolated from the mice at cull. 
Large (F4/80 hi MHC II lo) and small (F4/80 lo MHC II hi) peritoneal macrophages 
were gated as previously described (figure 3.6B). Large or small peritoneal 
macrophages sorted by FACS were adoptively transferred into the peritoneal cavity 
of endometriosis mice (figure 3.6A). To confirm the propagation of viable 
macrophages into the peritoneal cavity, two weeks after adoptive transfer mice were 
culled and peritoneal lavage fluid analysed by flow cytometry for detection of GFP+ 
adoptively transferred cells. Viable GFP+ macrophages were detected in the 
peritoneal cavity of all mice which had received adoptive transfer and this population 
was absent in sham control mice (figure 3.6C).  
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Figure 3.6. GFP+ small or large peritoneal macrophages were adoptively 
transferred into the peritoneal cavity of endometriosis mice which persisted and 
survived in the cavity for 2 weeks . A: Schematic of study design. B: FACS plot of 
sorted GFP+ LPM (F4/80 hi MHC II lo) and small peritoneal macrophage (F4/80 lo 
MHC II hi) populations. C: Flow plots of GFP+ macrophages in mouse peritoneal 
lavage fluid. Live GFP+ macrophages were detected in all mice 2 weeks after 
adoptive transfer (n=12 mice), compared to sham animals where no GFP+ cells 
were detected (n=22 mice) (P=0.026, student t test).  
 
At the time of cull, endometriosis lesions were isolated and stained for GFP to assess 
infiltration of adoptively transferred GFP+ large or small peritoneal macrophages 
into the tissue. Lesions isolated from mice which had received GFP+ large peritoneal 
macrophages had an absence of GFP+ cells in peritoneal tissue surrounding the 
lesion, however GFP+ cells were observed within lesion tissue (figure 3.7A (i)). 
GFP+ cells within lesions aggregated around circular structures (figure 17A (ii)) and 
formed clusters within the tissue (figure 3.7A (iii)). GFP+ cells were also identified 
accumulated around areas with the histological phenotype of necrotic tissue which 
had a low abundance of DAPI+ cells (figure 3.7B).  
- 80 - 
 
 
Figure 3.7. GFP+ large peritoneal macrophages infiltrate endometriosis lesions 
and form clusters of cells in lesion tissue.. A: (i) GFP immunofluorescent stain on a 
mouse endometriosis lesion which had received adoptive transfer of GFP+ LPM into 
the peritoneal cavity. GFP+ cells were not observed in surrounding peritoneal tissue 
but were observed in lesion tissue. (ii) GFP+ large peritoneal macrophages formed 
clusters around circular structures within lesions. (ii) GFP+ large peritoneal 
macrophages formed a cluster of cells within lesion tissue. B: GFP+ large 
peritoneal macrophages accumulated at the edge endometriosis lesion tissue next to 
tissue which has the histological characteristics of necrotic tissue due to a low 
abundance of DAPI+ cells. N=12 mice.  
 
GFP staining on lesions from mice which had received adoptive transfer of small 
peritoneal macrophages revealed that GFP+ cells were not present in lesion tissue 
(figure 3.8A). GFP+ cells were only present in peritoneal tissue around the lesion 
(figure 3.8B).  GFP+ cells in the peritoneal tissue had a circular morphology 
consistent with the fact that small peritoneal macrophages are derived from 
monocytes, which exhibit a similar circular morphology.   
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Figure 3.8. GFP+ small peritoneal macrophages did not infiltrate mouse 
endometriosis lesions but accumulated in surrounding peritoneal tissue. A: 
Immunofluorescent GFP staining on a mouse endometriosis lesion which had 
received adoptive transfer of GFP+ small peritoneal macrophages. No GFP staining 
was observed in the lesion. B: GFP+ small peritoneal macrophages were observed 
in peritoneal tissue surrounding endometriosis lesion tissue but there were no GFP+ 
cells in the lesions. N = 12 mice. 
 
Thus, I have shown for the first time that large peritoneal macrophages but not small 
peritoneal macrophages infiltrate endometriosis lesions.   
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3.3.8 Ly6Chi monocytes and Ly6Chi F4/80hi monocyte-derived macrophages 
contribute to endometriosis lesions  
To ascertain whether Ly6Chi monocytes and Ly6Chi F4/80hi monocyte-derived 
macrophages contribute to the lesion microenvironment in our model, dual 
immunofluorescence for Ly6C and F4/80 was performed on endometriosis lesions 
biopsies from endometriosis mice. Ly6C+ monocytes, F4/80+ Ly6C+ monocyte-
derived macrophages and F4/80+ macrophages were present in endometriosis lesion 
tissue as well as in the peritoneum (figure 3.9A/B). The number of positive cells 
stained for the Ly6C and F4/80 markers was enumerated in the peritoneal and lesion 
tissue using Definiens Architect XDTM software. There were a similar number of 
Ly6C+ monocytes, F4/80+ Ly6C+ monocyte-derived macrophages and F4/80+ 
macrophages in peritoneal tissue compared with endometriosis lesion tissue, 
however there was a modest increase in the number of F4/80+ macrophages in the 
lesions (figure 3.9C).  
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Figure 3.9. Immunofluorescent staining on mouse endometriosis lesion and 
peritoneal tissue demonstrated infiltration of Ly6C+ monocytes and Ly6C+ F4/80+ 
monocyte-derived macrophages into tissue. A:  F4/80 and Ly6C dual 
immunofluorescence on mouse endometriosis lesion and peritoneal tissue. B: Ly6C+ 
cells (thick pink arrows), F4/80+ Ly6C+ cells (thick white arrows) and F4/80+ cells 
(thin white arrows) were present in endometriosis lesion tissue. C: Numbers of 
F4/80+, Ly6C+ and F4/80+ Ly6C+ cells in peritoneal tissue adjacent to lesions 
(n=6 lesions from n=6 mice) and lesion tissue (n=9 lesions from n=9 mice). There 
were no significant changes in cell number however a modest increase in F4/80+ 
cells was observed in endometriosis lesions compared to adjacent peritoneal tissue. 
Data are expressed as means ± SEM and analysed by student t test. 
 
Using Definiens Architect XDTM software, the tissue was first assigned as either 
lesion, peritoneum, haemorrhage or adipose tissue (figure 3.10A). Haemorrhage and 
adipose tissue were removed from the analysis and cells in the lesion and peritoneal 
tissue analysed. Subsequent images were generated which included only lesion and 
peritoneal tissue and highlighted each individual cell as a circle. These circles were 
artificially coloured dependent on the markers the cell expressed. F4/80+ cells are 
shown as blue dots, Ly6C+ cells as green dots, F4/80+ Ly6C+ cells as red dots and 
F4/80- Ly6C- cells as grey dots (figure 3.10B). These images allowed the 
distribution of cells across the tissue to be more easily visualised and demonstrated 
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that F4/80+ and F4/80+ Ly6C+ cells formed clusters throughout specific areas of the 
tissue and were not homogeneously distributed. 
 
 
Figure 3.10. Monocyte and macrophage distribution in endometriosis lesion tissue 
was not homogenous . A: Using Definiens Architect XDTM software, mouse 
endometriosis tissue biopsy samples stained for F4/80 and Ly6C were separated 
based on tissue type and defined as either endometriosis lesion (beige), peritoneum 
(dark blue), area of haemorrhage (light blue) or adipose tissue (orange). Cell 
numbers in peritoneal and lesion tissue were enumerated. B: Whole tissue image 
showing peritoneal and lesion tissue only, demonstrating the distribution of F4/80+ 
cells (blue dots), Ly6C+ cells (green dots), F4/80+ Ly6C+ cells (red dots) and 
F4/80- Ly6C- cells (grey dots) across the tissue.  F4/80+ and F4/80+ Ly6C+ cells 
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formed specific clusters throughout the tissue and were not homogeneously 
distributed within lesions.  
 
Figure 3.11 shows different areas of the tissue section from figure 3.10 and 
demonstrates the differential distribution of Ly6C+, Ly6C+ F4/80+ and F4/80+ cells 
across the tissue. Some sections were very densely infiltrated by F4/80+ 
macrophages and these areas also contained a lower number of Ly6C+ monocytes 
and Ly6C+ F4/80+ monocyte-derived macrophages (figure 3.11A (i)). Other areas of 
the tissue had dense clusters of F4/80+ macrophages, Ly6C+ monocytes and Ly6C+ 
F4/80+ monocyte-derived macrophages which interestingly clustered together at the 
edge of the lesion tissue (figure 3.11A (ii)). In the peritoneal tissue, F4/80+ 
macrophages, Ly6C+ monocytes and F4/80+ Ly6C+ monocyte-derived macrophages 
were also present throughout the tissue and smaller clusters of cells were present 
(figure 3.11A (iii)). 
 
Figure 3.11. The distribution of F4/80+, Ly6C+ and F4/80+ Ly6C+ cells in 
endometriosis lesions was heterogeneous. The distribution of F4/80+, Ly6C+ and 
F4/80+ Ly6C+ cells in endometriosis lesions was heterogeneous dependent on the 
area of the lesion A (i, ii). A (iii): The distribution of F4/80+, Ly6C+ and  F4/80+ 
Ly6C+ cells in peritoneal tissue. 
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Peritoneal endometriosis lesions analysed were heterogeneous in the 
monocyte/macrophage populations present within the tissue. Figure 3.13 shows a 
peritoneal endometriosis lesion which was largely infiltrated by F4/80+ macrophages 
and a lower number of Ly6C+ monocytes, however Ly6C+ F4/80+ monocyte-
derived macrophages were almost absent from the tissue. Lesion tissue was highly 
infiltrated with F4/80+ macrophages which were not found in adjacent peritoneal 
tissue. There appeared to be areas histologically similar to necrosis in the tissue, 
which are indicated with an asterix (figure 3.12B). F4/80+ macrophages seemed to 
be clustered around necrotic areas of tissue within the lesion (figure 3.12B). 
 
Figure 3.12. F4/80+ macrophages infiltrated lesions and accumulated around 
areas characteristic of necrotic tissue. A: Characterisation of an endometriosis 
mouse tissue biopsy using Definiens Architect XDTM software showing areas of 
endometriosis lesion tissue (beige) and peritoneal tissue (dark blue). B: Ly6C and 
F4/80 expression across the tissue section. F4/80+ cells (light blue) were higher in 
number in lesion tissue compared to peritoneal tissue and appeared to cluster 
around areas with the histological characteristic of necrotic tissue (indicated with an 
asterix). Ly6C+ cells (green) were also present in the lesion however F4/80+ Ly6C+ 
cells were of low abundance. 
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3.4 Summary 
 
In this chapter, I have demonstrated that mice with induced endometriosis have 
similar large and small peritoneal macrophage numbers to sham controls but an 
increase in the number of Ly6Chi monocytes in the peritoneal cavity. I have also 
characterised the ontogeny of lesion macrophages and revealed that this population is 
derived from endometrial tissue-resident macrophages, as well as recruited large 
peritoneal macrophages and monocyte-derived macrophages. Small peritoneal 
macrophages did not become incorporated into the endometriosis lesions in my 
model. Image analysis of Ly6C and F4/80 staining on lesion tissue revealed that 
monocytes and macrophages formed clusters throughout the tissue and were not 
homogeneously distributed. 
3.5 Discussion 
I my studies, mice with induced endometriosis had similar numbers of large and 
small peritoneal macrophages compared to sham animals. This finding contradicts a 
paper from Yuan et al which reported perturbations in peritoneal macrophage 
populations (Vigano et al., 2018). The key difference between these studies was the 
mouse model used. Yuan et al isolated naive endometrial tissue and injected this into 
the peritoneal cavity of recipient mice which had intact ovaries, however in my 
model 'menses-like' endometrial tissue was generated and injected into the peritoneal 
cavity of mice which had undergone ovariectomy and been supplemented with 
estradiol valerate (Greaves et al., 2014; Yuan et al., 2017b). In the Edinburgh mouse 
model I identified a modest increase in the LPM population and this could be due to 
the superphysiological levels of estrogen utilised in the model and the pro-
proliferative effect estrogen is known to have on macrophages (Greaves et al., 2014; 
Pepe et al., 2017). Hence, peritoneal macrophage populations may be perturbed by 
estrogen levels in our model, indeed, sham mice also demonstrated an increase in the 
LPM population, supporting this notion. It is also possible that due to the differential 
endometrial tissue utilised in these models, a divergent inflammatory response was 
generated in the peritoneal cavity. We know that ~90% of women experience cyclic 
retrograde menstruation (Sampson, 1927), meaning the peritoneal cavity may be 
consistently challenged with menses endometrial tissue. It is possible therefore that 
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peritoneal cavity immune cells are tolerogenic to menses endometrial tissue to avoid 
cyclic peritoneal inflammation in women. However, mice do not menstruate or 
experience retrograde menstruation, suggesting that this immunotolerance may be 
regulated by factors present in decidualised endometrial tissue rather than immune 
cells in the peritoneal environment.  
There was, however, an increase in peritoneal Ly6Chi inflammatory monocytes in the 
Edinburgh mouse model, suggesting that endometriosis lesions produce a 
chemotactic signal for these cells, causing their extravasation from blood vessels into 
the peritoneal cavity. In mice, the extravasation of Ly6Chi monocytes is regulated by 
CCR2 (Lu et al, 2002), and we know that peritoneal biopsies from mice with 
endometriosis show an up-regulation of CCL2 (Greaves et al., 2014), suggesting that 
CCL2 could be responsible for the increase in Ly6Chi monocytes observed in this 
model. Studies in cancer suggest that pathogenic tissue can modulate Ly6Chi 
monocyte recruitment and function to exacerbate disease. In a mouse model of breast 
cancer, Ly6Chi inflammatory monocytes were recruited to metastatic sites where they 
facilitated tumour metastasis by secretion of VEGF. Recruitment to the tumour was 
modulated by CCL2 which was secreted by the tumour and stroma (Qian et al., 
2011). It is possible therefore that endometrial stromal cells may secrete CCL2 to 
recruit inflammatory monocytes to endometriosis lesions, which may exacerbate 
disease. However, the role of this population in endometriosis lesion development 
has not been defined. 
Endometrial macrophages persist in donor endometrial tissue to constitute 16% of 
the lesion-resident macrophage population. In the endometrium, macrophages play 
roles in breakdown of the functional layer of the endometrium as well as repair and 
remodelling  (Mahmood and Templeton, 1991; Johnson et al., 2017). Endometrial 
macrophages are also implicated in angiogenesis in the endometrium by secretion of 
VEGF (Canis et al., 1997). In women, ectopic endometrial tissue (lesions) are 
vascularised and undergo cyclic shedding and repair, akin to the eutopic 
endometrium (Vercellini et al., 2006; Ek et al., 2015). It is possible therefore that 
endometrial-derived macrophages in ectopic endometrial tissue play similar roles in 
tissue remodelling and angiogenesis as they do within the eutopic endometrium. 
- 89 - 
 
Conversely, endometrial-derived macrophages in endometriosis lesions are exposed 
to a differential microenvironment compared with the eutopic endometrium. This 
novel microenvironment has the potential to modulate endometrial-derived 
macrophage phenotype and function, however the phenotype and function of 
endometrial macrophages in endometriosis lesions is currently unknown. 
In this chapter, I demonstrated that large, but not small, peritoneal macrophages 
become incorporated into endometriosis lesions. Under inflammatory stimuli, small 
peritoneal macrophages are rapidly recruited into the peritoneal cavity where they 
produce a number of pro-inflammatory cytokines to mount an inflammatory response 
(Cassado, D’Império Lima and Bortoluci, 2015; Rückerl et al., 2017). The fact that 
women and mice with endometriosis have homeostatic numbers of small peritoneal 
macrophages suggests that a traditional inflammatory response is not mounted by the 
presence of endometriosis lesions. In this way, ectopic endometrial tissue is able to 
escape immune clearance. This is analogous to the absence of small peritoneal 
macrophages in lesion tissue, and suggests that the inability of small peritoneal 
macrophages to respond to and invade ectopic endometrial tissue may contribute to 
pathology. 
Conversely, large peritoneal macrophages become incorporated into lesions and are 
found throughout the lesions. In a sterile liver injury model in mice, large peritoneal 
macrophages rapidly infiltrated the liver where they were involved in tissue 
remodelling and regeneration (Wang and Kubes, 2016). It is possible therefore that 
large peritoneal macrophages play roles in wound healing and tissue remodelling in 
lesions, potentially maintaining pathogenic endometrial tissue as opposed to 'healthy' 
peritoneal tissue. Large peritoneal macrophages in lesions form clusters which are 
frequently around circular structures. These circular regions could represent 
remodelling glands, although this has not been identified. The specific localisation of 
large peritoneal macrophages suggests that they may be fulfilling a function in this 
area of the lesion, however this is currently unknown.  
In addition, I demonstrated that monocytes and monocyte-derived macrophages 
contribute to the endometriosis lesion microenvironment. Ly6C+ inflammatory 
monocytes and Ly6C+ F4/80+ cells which are transitioning from a monocyte to 
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macrophage phenotype were found in lesion tissue at a similar frequency to the 
peritoneum. However, these results were confounded by the fact that these cells 
formed clusters within the lesion tissue, meaning that in certain regions of the lesion 
monocyte and macrophage numbers were significantly higher than the peritoneum, 
however this was attenuated by areas with little monocyte and macrophage 
infiltration. In tumours, microenvironments exist which are infiltrated by 
macrophages which play distinct roles in disease (Quatromoni and Eruslanov, 2012). 
Here I have shown multiple origins and diverse distributions of myeloid populations 
within endometriosis lesion tissue in our model, suggesting existence of difference 
phenotypes in discrete locations within lesions.  
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Chapter 4 - Ly6C+ monocytes can be 
recruited to endometriosis lesions 
independent of CCL2 
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4.1 Introduction 
In chapter 3, I demonstrated that macrophages within endometriosis lesions are 
derived from endometrial macrophages, large peritoneal macrophages and monocyte-
derived macrophages. The roles that these differential populations play in disease are 
currently unknown. The use of clodronate liposomes to deplete peritoneal phagocytic 
macrophages has been demonstrated to reduce the number of lesions which form in 
mice (Forsteret al., 2019). Large peritoneal macrophages are highly phagocytic 
compared to small peritoneal macrophages (Ghosn et al., 2010), suggesting a bias in 
depletion of this population. This depletion method also encompasses phagocytic 
monocyte-derived macrophages however and thus cannot differentiate between these 
populations. In cancer, macrophages with differential ontogenies play distinct roles 
in tumour development (Noy and Pollard, 2014; Zhu et al., 2017), suggesting that 
macrophages with different origins in endometriosis could also play diverse roles in 
disease.   
In the previous chapter I also demonstrated that mice with endometriosis exhibit  
increased peritoneal Ly6Chi monocytes. Monocytes are normally recruited into 
tissues by CCL2 (Wynn, Chawla and Pollard, 2013), a chemokine which has also 
been shown to be up-regulated in the peritoneum and lesions of mice with 
endometriosis (Greaves et al., 2014). Despite numerous descriptive studies 
identifying chemokine’s associated with endometriosis (Pizzo et al., 2002), the 
pathways that regulate monocyte and macrophage recruitment have not been 
mechanistically interrogated.. To explore the CCR2-CCL2 chemokine pathway in the 
recruitment of inflammatory monocytes/monocyte-derived macrophages to 
endometriosis lesions we used. CCR2 and CCL2 null mice.CCR2 null mice have a 
very low abundance of circulating Ly6Chi monocytes due to inhibited mobilisation 
from the bone marrow, a process regulated by CCR2 (Boring et al., 1997). These 
mice also have a very low number of peritoneal Ly6Chi monocytes, Ly6Chi 
monocyte-derived macrophages and small peritoneal macrophages, which are 
derived from Ly6Chi monocytes, due to their inability to extravasate into the cavity 
(Boring et al., 1997). CCL2 null have normal peritoneal macrophage numbers but an 
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inability to recruit Ly6Chi monocytes under inflammatory conditions (Lu et al., 
2002).  
4.2 Aims and hypotheses 
I hypothesised that macrophage populations with different ontogenies play 
differential roles in lesion development, and that CCL2 is an important chemokine 
for regulating recruitment of Ly6Chi monocytes and monocyte-derived macrophages 
in endometriosis.  
The aims of this chapter were to: 
1. Investigate the role of endometrial and peritoneal macrophages in the 
development of endometriosis lesions 
2. Determine the importance of the CCL2-CCR2 signalling pathway in the 
recruitment of Ly6Chi monocytes and monocyte-derived macrophages to 
endometriosis lesions 
4.3 Results 
4.3.1 Endometrial macrophage depletion did not affect lesion number 
To investigate the role of endometrial macrophages in endometriosis lesion 
development, CSF1R cKO mice were used as donors in our mouse model to generate 
macrophage depleted decidualised endometrial tissue (figure 4.1A). Upon treatment 
with doxycycline (2μg/ml in 5% sucrose water), Cre recombinase selectively knocked out 
the Csf1r gene, causing depletion of Csf1r expressing macrophage populations (Li et al., 
2006). Doxycycline was administered from days 15-19 in the Edinburgh mouse 
model protocol (refer to figure 1.3 for protocol timeline). These days of the protocol 
correlate with the generation of decidualised endometrial tissue through intrauterine 
injection of sesame oil and P4 pellet withdrawl. Compared to wild type mice, CSF1R 
cKO mice had a 34% (± SEM 13%) depletion in F4/80hi Ly6Clo mature macrophages 
and a 32% (± SEM 18%) depletion in F4/80lo Ly6Chi monocytes (figure 4.1B) in 
decidualized endometrial tissue. No significant changes in Ly6G+ neutrophils were 
observed (figure 4.1C). Endometriosis was induced in WT mice with either 
macrophage depleted (CSF1R cKO) or non-depleted (WT) tissue. There was no 
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significant difference in the number of lesions recovered from each group (figure 
4.1D). However, 4 out of 9 mice in the macrophage depleted group developed no 
endometriosis lesions but all mice in the group which received non-depleted tissue 
developed lesions (n=10) (figure 4.1D). Lesions recovered from mice which had 
received macrophage-depleted tissue were smaller, although not significantly, from 
the group which had received non-depleted tissue (figure 4.1E). 
  
Figure 4.1. Endometrial macrophage depletion in donor endometrial tissue did not 
significantly alter the number or size of lesions formed in mice . A: Schematic 
demonstrating study design. B: Flow cytometry data demonstrating depletion of 
macrophage populations in WT (n=4) and Csf1r cKO (n=5) donor endometrial 
tissue. Treatment of donor Csf1r cKO mice with doxycycline caused a 34% (± SEM 
13%)  depletion in the F4/80hi Ly6Clo mature macrophage population and a 32% (± 
SEM 18%) depletion in the F4/80lo Ly6Chi monocyte population in the decidualised 
endometrium. C: There were no significant differences in Ly6G+ neutrophils in WT 
(n=4) or Csf1r cKO (n=5) donor endometrial tissue. D: Lesion numbers from mice 
which had received either WT (n=10) or macrophage depleted, Csf1r cKO tissue 
(n=9). Data are shown as median + 95% confidence intervals. E: No significant 
difference in lesion size was observed between groups, however a modest reduction 
- 95 - 
 
in lesion size was observed in mice which had received Csf1r cKO macrophage 
depleted tissue. Data are expressed as means ± SEM for all graphs except for D 
where median is shown. Analysed by Mann-Whitney U test. 
 
4.3.2 Large or small peritoneal macrophage adoptive transfer did not affect 
lesion number 
 
In a gain of function experiment, the number and size of lesions formed in mice that 
had received adoptive transfer of large or small peritoneal macrophages into the 
peritoneal cavity at the time of endometrial tissue injection, was assessed. There was 
no difference in the number of lesions recovered from mice with had received 
adoptive transfer of large peritoneal macrophages, small peritoneal macrophages or 
no transfer (figure 4.2A). There was no significant difference in the size of lesions 
between groups however there was a modest reduction in the size of lesions from 
mice which had received adoptive transfer of large peritoneal macrophages (figure 
4.2B).  
 
Figure 4.2. Adoptive transfer of small or large peritoneal macrophages into the 
peritoneal cavity of endometriosis mice did not significantly affect lesion number 
or sizeA: Lesion number was similar from mice which had received adoptive transfer 
of LPM (n=9), SPM (n=7) or no transfer (n=10) 2 weeks after injection of 
endometrial tissue and cells. Data are expressed as medians with 95% confidence 
intervals. B: There was no statistical difference in lesion size from mice which had 
received adoptive transfer of LPM, SPM or no transfer, however we did observe a 
modest reduction in lesion size from mice which had received LPM. Data are 
expressed as median values in A and means ± SEM in B. Analysed by Analysis of 
variance (ANOVA).  
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4.3.3 CCR2 expression is elevated in peritoneal and lesion resident macrophages 
in mice with endometriosis 
Expression of CCR2 by F4/80+ mature macrophages in the peritoneal cavity of mice 
with endometriosis was analysed to begin to investigate the importance of CCR2 in 
macrophage recruitment to the peritoneal cavity in endometriosis. Peritoneal lavage 
fluid was isolated from naïve and sham mice and mice with induced endometriosis 
and expression of CCR2 analysed by flow cytometry. Mice with endometriosis had 
more significantly CCR2hi F4/80hi peritoneal macrophages compared to naive and 
sham mice (figure 4.3A/B).  
 
Figure 4.3. Mice with endometriosis had more CCR2+ peritoneal macrophages 
compared to sham and naive mice. A: Flow plots showing CCR2+ F4/80hi Ly6Clo 
peritoneal macrophages in the peritoneal cavity of mice with endometriosis (n=5), 
naïve (n=4) and sham (n=4) animals 2 weeks after injection of endometrial tissue. 
B: Mice with endometriosis had significantly more CCR2+ peritoneal macrophages 
compared to naïve and sham animals. Data are expressed as means ± SEM.  
Analysis of variance (ANOVA), ∗P < 0.05 and ∗∗P < 0.01. 
 
Expression of CCR2 was also determined on endometriosis lesion resident 
macrophages (figure 4.4A). Endometriosis lesions from each mouse were pooled and 
analysed by flow cytometry. All lesion macrophages were CX3CR1+. A CD11b+ 
CX3CR1+ CCR2+ population was present which represented 53% (± SEM 5%) of 
CD11b+ CX3CR1+ cells as well as a CD11b+ CX3CR1+ CCR2- population (figure 
4.4B).  To assess the contribution of CCR2+ CD11b+ cells from donor endometrial 
tissue to lesions, CCR2 expression was analysed on CD11b+ cells in donor 
endometrial tissue from Csf1r-EGFP (MacGreen) mice (figure 4.4C). 70% of 
CD11b+ cells in donor endometrial tissue expressed CCR2 (figure 4.4D). 
Endometriosis lesions were subsequently analysed from WT mice, which had 
received MacGreen donor endometrial tissue, such that endometrial-derived 
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macrophages within lesions expressed GFP, allowing endometrial macrophages to be 
specifically identified in lesions. 100% of GFP+ CD11b+ cells within endometriosis 
lesions were also CCR2+ (figure 4.4D).  
Taken together I have shown that CCR2 is elevated both in peritoneal cavity 
macrophages and macrophages in endometriosis lesions, identifying the potential for 
CCR2 to be important for macrophage chemotaxis in endometriosis.  
 
 
Figure 4.4. Lesion resident macrophages express the chemokine receptor CCR2. 
A: Schematic demonstrating study design. B: Flow plot showing CCR2+, CD11b+, 
CX3CR1+ macrophages/monocytes in mouse endometriosis lesions 2 weeks after 
endometrial tissue injection, where all CD11b+ cells in the lesions were also 
CX3CR1+. 53% (± SEM 5%) of lesion resident CD11b+ CX3CR1+ cells expressed 
CCR2. C: Flow plot of CD11b+ macrophages/monocytes in donor decidualised 
endometrial tissue from Csf1r-EGFP mice showing expression of CCR2. D: 
Expression of CCR2 on endometrial GFP+ CD11b+ cells from Csf1r-EGFP donor 
endometrial tissue (n=6) and GFP+ endometrial-derived CD11b+ cells in 
endometriosis lesions from mice which had received Csf1r-EGFP donor endometrial 
tissue (n=6 animals where lesions were pooled from each animal) using flow 
cytometry. A lower proportion of macrophages expressed CCR2 in donor 
endometrial tissue compared with endometrial macrophages, which had persisted 
into endometriosis lesions (P=<0.001, student t test). 
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4.3.4 CCR2 knockout mice develop endometriosis lesions and have an influx of 
inflammatory monocytes into the peritoneal cavity 
 
In order to mechanistically determine the importance of CCR2 on endometriosis 
lesion development and monocyte/macrophage recruitment in disease, endometriosis 
was induced in CCR2 knockout mice alongside WT mice. Peritoneal immune cell 
populations were characterised in the peritoneal lavage fluid of CCR2 knockout mice 
with endometriosis, sham and naive mice as well as respective WT controls. 
Interestingly, CCR2 knockout mice with endometriosis had more CD45+ leukocytes 
in the peritoneal lavage fluid compared to sham and naive CCR2 knockout animals, 
indicating an influx of leukocytes into the peritoneal cavity in response to the 
presence of endometriosis lesions (figure 4.5A). Lineage+ cells (B cells, T cells, 
eosinophils, NK cells) were significantly increased in the peritoneal cavity of CCR2 
knockout mice with endometriosis compared to WT mice with endometriosis, CCR2 
knockout naive and sham mice (figure 4.5B). Interestingly, in this study WT mice 
with endometriosis had an increase in Ly6G+ peritoneal neutrophils compared to WT 
naive mice, however this increase was not observed in CCR2 knockout mice (figure 
4.5C).  Ly6C+ inflammatory monocyte numbers were not significantly increased in 
WT mice with endometriosis, although significant heterogeneity was observed across 
mice. CCR2 knockout mice however did have an increase in Ly6C+ peritoneal 
inflammatory monocytes compared to CCR2 knockout sham mice (figure 4.5D). 
There were no significant differences in Ly6C- F4/80+ mature macrophages or 
Ly6C+ F4/80+ macrophages transitioning from a monocyte to macrophage 
phenotype in the peritoneal cavity of any of the groups (figure 4.5E/F).  
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Figure 4.5. CCR2 knockout mice with endometriosis had an increase in Ly6C+ 
monocytes in the peritoneal cavity. A: CD45+ leukocytes in the peritoneal cavity of 
WT animals with no treatment (n=8), CCR2 KO animals with no treatment (n=3), 
WT sham animals (n=10), CCR2 KO sham animals (n=8), WT mice with 
endometriosis (n=16) and CCR2 KO mice with endometriosis (n=8) were 
enumerated by flow cytometry. CCR2 KO mice with endometriosis had more CD45+ 
leukocytes compared to naive CCR2 KO mice and sham CCR2 KO mice. B: CCR2 
KO mice had an increase in the lineage+ population in the peritoneal lavage fluid 
compared to naive CCR2 KO mice, sham CCR2 KO mice and WT mice with 
endometriosis. The lineage channel consisted of B cells, T cells, NK cells and 
eosinophils. C: WT mice with endometriosis had more Ly6G+ neutrophils in the 
peritoneal cavity compared to naive WT mice however CCR2 KO mice with 
endometriosis had similar neutrophil numbers to sham and naive CCR2 KO mice. D: 
CCR2 KO mice had significantly more Ly6C+ F4/80- monocytes in the peritoneal 
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lavage fluid compared with CCR2 KO sham mice however WT mice with 
endometriosis had a similar number to sham. E: There was no significant difference 
in Ly6C- F4/80+ macrophages across the groups. F: There was no significant 
difference in F4/80+ Ly6C+ cells across groups. Data are expressed as means 
±SEM unless otherwise stated. Analysis of variance (ANOVA), ∗P < 0.05 and 
∗∗P < 0.01. *** P<0.001, **** P<0.0001. 
 
CCR2 knockout and WT mice with endometriosis developed a similar number of 
endometriosis lesions, which were a similar size (figure 4.6A/B). 
 
 
Figure 4.6. CCR2 knockout mice developed a similar number of lesions to WT . A: 
The number of endometriosis lesions developed in WT and CCR2 KO mice. There 
was no difference in lesion number between WT (n=7) or CCR2 KO (n=7) mice with 
endometriosis at a 2 week time point. Data are expressed as medians with 95% 
confidence intervals. B: No difference in size of lesions was observed between WT 
and CCR2 KO mice with endometriosis. Data are expressed as median values in A 
and means ±SEM in B. Analysed by student t test.  
 
In order to assess the infiltration of Ly6C+ monocytes and F4/80+ macrophages into 
endometriosis lesions, dual immunofluorescence for Ly6C and F4/80 was performed 
on lesions from CCR2 knockout and WT mice (figure 4.7A). In CCR2 knockout 
lesions, Ly6C+ monocytes and F4/80+ macrophages were detected however a low 
abundance of Ly6C+ F4/80+ transitioning cells was observed (figure 4.7A). 
Compared to WT lesions, CCR2 knockout lesions had significantly less F4/80+ 
macrophages within lesion tissue (figure 4.7A/B). Interestingly, Ly6C+ monocytes 
were of similar abundance in CCR2 knockout and WT lesions with a trend for 
increased Ly6C+ monocytes in the CCR2 knockout lesions (figure 4.7B).  
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Figure 4.7. Endometriosis lesions from CCR2 KO mice had reduced lesion F4/80+ 
macrophages compared to WT but a similar number of Ly6C+ monocytes. A: Ly6C 
F4/80 dual immunofluorescent staining on WT and CCR2 KO mouse endometriosis 
lesions. B: CCR2 KO lesions (n=3) had less F4/80+ cells than WT lesions (n=3) 
(P=0.0061). We also observed an absence of F4/80+ Ly6C+ cells in CCR2 KO 
lesions but an increase in Ly6C+ cells, although this was not significant. Data are 
expressed as median and range (due to low n number). Analysed by Mann-Whitney 
U test. 
 
4.3.5 CCL2 knockout mice develop more endometriosis lesions than WT and 
have increased CD45+ leukocytes in the peritoneal cavity 
 
In order to investigate the role of the CCR2 receptor ligand, CCL2, on the 
development of endometriosis lesions, endometriosis was induced in CCL2 knockout 
alongside WT mice. Peritoneal immune cell populations were enumerated using flow 
cytometric analysis on peritoneal lavage fluid. CCL2 knockout mice with 
endometriosis and sham mice had an increase in CD45+ peritoneal leukocytes 
compared to WT endometriosis and sham mice respectively (figure 4.8A). CCL2 
knockout mice also had an increase in lineage+ cells (B cells, T cells, eosinophils, 
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NK cells) (figure 4.8B). There were no significant increases in Ly6G+ neutrophils 
across the groups however both WT and CCL2 knockout mice with endometriosis 
exhibited heterogeneity (figure 4.8C). Ly6C+ monocyte numbers were similar across 
the groups however some WT and CCL2 knockout mice with endometriosis 
demonstrated an increase in this population, but again this was heterogeneous (figure 
4.8D). F4/80+ mature macrophage numbers were similar across the groups (figure 
4.8E). Ly6C+ F4/80+ transitioning cell numbers were similar across groups (figure 
4.8F). Notably, CCL2 knockout sham animals had homogeneously low numbers of 
Ly6C+ F4/80+ cells however CCL2 knockout mice with endometriosis had a 
heterogeneous increase in this population (figure 4.8F).  
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Figure 4.8. CCL2 knockout sham and endometriosis mice had an increase in 
peritoneal CD45+ leukocytes. A: CD45+ leukocytes in the peritoneal lavage fluid of 
WT sham animals (n=3), CCL2 KO sham animals (n=4), WT endometriosis mice 
(n=6) and CCL2 KO mice with endometriosis (n=7) were enumerated by flow 
cytometry. CCL2 KO sham animals had significantly more CD45+ leukocytes 
compared with WT sham controls. CCL2 KO mice with endometriosis also 
demonstrated a significant increase in CD45+ leukocytes compared to WT mice with 
endometriosis. B: Sham and endometriosis CCL2 KO mice had an increase in the 
lineage+ population in the peritoneal lavage fluid compared to WT sham and 
endometriosis mice respectively. The lineage channel consisted of B cells, T cells, 
NK cells and eosinophils. C: There were no significant changes in Ly6G+ neutrophil 
numbers in the peritoneal lavage fluid, however we did observe a modest increase in 
the Ly6G+ population in WT and CCL2 KO mice with endometriosis compared to the 
respective sham controls, however this was heterogeneous. D: There was no 
significant difference in Ly6C+ F4/80- monocyte numbers between groups. We did 
however observe increased monocyte numbers in mice with endometriosis compared 
to sham controls and this was seen in both WT and CCL2 KO mice. E: There was no 
difference in Ly6C- F4/80+ mature macrophage numbers across the groups. F: 
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There was no significant difference in Ly6C+ F4/80+ cells across the groups 
however we did observe a modest increase in this population between CCL2 KO 
sham and endometriosis mice. Data are expressed as means ±SEM unless otherwise 
stated. Analysis of variance (ANOVA), ∗P < 0.05 and ∗∗P < 0.01. 
 
CCL2 knockout mice with endometriosis developed more endometriosis lesions than 
WT mice (figure 4.9A). Endometriosis lesions formed in CCL2 knockout and WT 
mice were a similar size (figure 4.9B).  
 
Figure 4.9. CCL2 KO mice developed more endometriosis lesions than WT mice. 
A: CCL2 KO mice developed significantly more endometriosis lesions compared to 
WT animals at a 2 week time point (P=0.0157). Data are expressed as medians with 
95% confidence intervals. B: No difference was observed in the size of lesions 
between CCL2 KO and WT mice. Data are expressed as means ± SEM. Analysed by 
student t test.  
 
Infiltration of Ly6C+ monocytes and F4/80+ macrophages into CCL2 knockout and 
WT endometriosis lesions was investigated using dual immunofluorescence for 
Ly6C and F4/80 (figure 4.10A). Both CCL2 knockout and WT endometriosis lesions 
were infiltrated by Ly6C+ monocytes, Ly6C+ F4/80+ transitioning cells and F4/80+ 
macrophages. The number of these cell populations in CCL2 knockout and WT 
endometriosis lesions was similar (figure 4.10B).  
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Figure 4.10. Endometriosis lesions from CCL2 KO and WT mice had a similar 
number of Ly6C+, F4/80+ and Ly6C+ F4/80+ cells. A: Ly6C F4/80 dual 
immunofluorescent staining on WT and CCL2 KO mouse endometriosis lesions. B: 
CCL2 KO lesions (n=6) had a similar number of F4/80+, Ly6C+ and Ly6C+ 
F4/80+ cells compared to WT lesions (n=3). Data are expressed as median and 
range. Data analysed by Mann-Whitney U test. 
 
4.3 Summary 
In this chapter I used macrophage depletion, adoptive transfer and blocking of a key 
monocyte recruitment axis in our mouse model of induced endometriosis in order to 
investigate the role of macrophages and monocytes of different origins.  I depleted 
macrophages in donor endometrial tissue but found no significant effect on 
subsequent lesion number and size. I also characterised lesion number and size in 
mice, which had received adoptive transfer of large or small peritoneal macrophages 
and found no differences. I demonstrated CCR2 is expressed on a large proportion of 
peritoneal and lesion-resident macrophages. CCR2 knockout mice develop an equal 
number of endometriosis lesions to wild type controls but have an influx of Ly6C+ 
monocytes into the peritoneal cavity which infiltrate lesions, however F4/80+ 
macrophages in lesions are reduced. CCL2 knockout mice with endometriosis have a 
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similar number of peritoneal Ly6C+ monocytes and F4/80+ macrophages as WT 
controls and endometriosis lesions from CCL2 knockout mice exhibit no alterations 
in numbers of Ly6C+ monocytes and F4/80+ macrophages, identifying that 
recruitment of these populations in disease can occur independent of the CCR2-
CCL2 signalling pathway. 
4.4 Discussion 
In this chapter I investigated the role of the CCR2-CCL2 chemokine-signalling axis 
in the recruitment of Ly6Chi monocytes and F4/80+ macrophages to endometriosis 
lesions. In a study using a mouse model of pancreatic ductal adenocarcinoma, 
induction of disease in CCR2 knockout mice was able to significantly reduce the 
recruitment of MHC II+ monocyte-derived tumour associated macrophages (Zhu et 
al., 2017). I was able to demonstrate that endometriosis lesions from CCR2 knockout 
mice had reduced F4/80+ macrophage numbers, indicating that similarly CCR2 may 
be required for recruitment to lesions. Conversely, CCR2 knockout mice with 
endometriosis had a significant influx of Ly6Chi monocytes into the peritoneal 
cavity, which was not observed in sham controls. This indicates that in the absence 
of CCR2, Ly6Chi monocytes still receive a chemotactic signal causing their 
mobilisation from the bone marrow and subsequent extravasation into the peritoneal 
cavity in the endometriosis disease state. It has been demonstrated however that 
CCR2 is a promiscuous receptor that can bind to other chemokines such as CCL8, 
CCL13 and CCL7 (Lira and Furtado, 2012). In order to determine whether the 
effects I was seeing were actually due to the CCL2 ligand, I utilised CCL2 knockout 
mice. CCL2 knockout mice had comparable peritoneal cavity Ly6Chi monocyte 
numbers to WT mice with endometriosis, suggesting that Ly6Chi monocyte 
extravasation into the peritoneal cavity was not inhibited even in the absence of 
CCL2 in endometriosis. However, to gain a statistically significant difference in 
Ly6Chi peritoneal monocyte number between WT and CCL2 knockout animals, I 
would need 7 more mice in each group (power calculation performed using 
www.stat.ubc.ca/). This fairly small increase in N number suggests that there may 
have been a difference in Ly6Chi peritoneal monocytes between the WT and CCL2 
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KO mice, but that the sample size is too small to detect this. Thus, this may be worth 
repeating in future studies.  
Notably, CCR2 and CCL2 knockout mice with endometriosis both had increased 
peritoneal CD45+ leukocytes compared to WT controls, and this was partly 
attributed to an increase in the lineage+ population which consisted of T cells, B 
cells, NK cells and eosinophils. This confounding factor makes it difficult to 
conclude whether outcomes of the experiments such as lesion number were due to 
the absence of the CCL2 ligand or the increase in these cell populations. It is difficult 
to infer as to the mechanism behind this increase as I cannot differentiate which cell 
type the increase in CD45+ leukocytes was derived from due to the fact that the 
lineage cell markers were all conjugated to the same fluorochrome. The increased 
number of lesions in CCL2 knockout animals therefore may be attributed to 
modulation of other immune cell populations in our mouse model due to the absence 
of CCL2. For example, cytotoxic activity as well as chemotaxis of NK cells has been 
shown to be enhanced by CCL2 (Yoneda et al., 2000; Inngjerdingen, Damaj and 
Maghazachi, 2001), and we know that a reduction in NK cell cytotoxic activity is 
present in the peritoneal cavity of women with endometriosis, and this is thought to 
stimulate disease (Jeung, Cheon and Kim, 2016). It could be therefore that the 
increase in lesion number in CCL2 knockout mice is a result of modulation of the 
function and number of immune cells in the peritoneal cavity, and this may not be 
specific to monocytes/macrophages. It is thus difficult to conclude, with the current 
granularity of data, the mechanism behind increased lesion number of CCL2 
knockout animals, which have normal numbers of peritoneal and lesion Ly6Chi 
monocytes and F4/80+ macrophages.  
CCR2 knockout animals had a similar number of lesions to WT, despite a reduction 
in F4/80+ lesion macrophages. It could be that differential macrophage populations 
exist within endometriosis lesions that play distinct roles in lesion development, a 
question I begin to investigate in chapter 5. For example, in pancreatic ductal 
adenocarcinoma, recruited monocyte-derived macrophages are important for antigen 
presentation in the tumour and depletion of this population does not result in a 
change in tumour growth (Zhu et al., 2017). Thus, monocyte-derived macrophages 
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fulfil a function within the tumour microenvironment but this is not critical to the 
growth of the tumours. I cannot conclude from my data exactly which subset of 
macrophages was depleted in endometriosis lesions from CCR2 knockout animals, 
however the concept that macrophages with differential roles in disease exist within 
the lesion environment could explain why I didn't see a difference in lesion size.  
Overall, this data provides the first evidence that Ly6Chi monocytes in endometriosis 
are recruited from the bone marrow where they eventually become incorporated into 
endometriosis lesions. Importantly, I have demonstrated that this recruitment can 
occur independent of CCR2/CCL2. Whether there is a compensation effect from 
other chemokines when CCR2 or CCL2 signalling is interrupted is unknown, for 
example we also know that CCL5 is up-regulated in the peritoneal cavity of mice 
with endometriosis (Greaves et al., 2014) and that in mice CCL5 can mediate the 
chemotaxis of monocytes in steady state (Raghu et al., 2017). However, the 
chemokine pathway responsible for the recruitment of Ly6Chi monocytes in the 
absence of CCR2 or CCL2 is un-defined. Whilst the CCR2/CCL2 chemokine 
pathway may be important for recruitment of Ly6C+ monocytes in disease, this 
pathway appears to be redundant. 
Conversely, I did observe that endometriosis lesions from CCR2 knockout mice had 
a reduced number of F4/80+ macrophages. The fact monocyte number was not 
affected but macrophage number was reduced, suggests that this reduction in F4/80+ 
macrophages is derived from a population other than the monocyte-derived 
macrophages (as these are derived from Ly6C+ monocytes). In this chapter I 
demonstrated that mice with endometriosis have increased CCR2+ F4/80+ 
macrophages in the peritoneal cavity and that 53% of lesion macrophages expressed 
CCR2. It is possible therefore that this population of macrophages relies on CCR2 
for chemotaxis to endometriosis lesions, and thus, when CCR2 is abrogated, this 
recruitment is blocked. I cannot definitively say whether this population of CCR2+ 
peritoneal macrophages do become incorporated into endometriosis lesions, as I did 
not perform lineage tracing studies to interrogate this, however the fact that half of 
the lesion macrophages express CCR2 supports the notion that CCR2+ macrophages 
are recruited to lesions. It could be, therefore, that whilst CCR2 is redundant in 
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endometriosis for the recruitment of Ly6Chi monocytes, CCR2 is in fact elemental to 
the recruitment of a subset of F4/80+ macrophages to endometriosis lesions. Hence, 
inhibiting CCR2 is able to block F4/80+ macrophage accumulation in lesions. 
However, in endometriosis lesions from CCL2 knockout animals, I saw a similar 
number of F4/80+ macrophages to WT. We know that CCR2 can bind to other 
chemokines such as CCL8, CCL13 and CCL7, which can induce macrophage 
recruitment (Lira and Furtado, 2012). Thus, by knocking out CCL2, there may still 
be interaction of chemokines with CCR2 which are able to induce macrophage 
chemotaxis. As I characterised that a large proportion of lesion macrophages express 
CCR2, it is possible that CCL2 signalling is not fundamental to macrophage 
recruitment to lesions but that chemokine signalling via CCR2 is indeed responsible 
for this recruitment, be this through CCL2, CCL8, CCL13 or CCL7 (Lira and 
Furtado, 2012). Whether CCL2 is usually required for this recruitment and 
compensation from other chemokines occurs in its absence, is unclear from my data. 
I would hypothesise however that this is the case, due to the fact that CCR2-CCL2 
signalling is the classical pathway for monocyte/macrophage recruitment in steady 
state and in a number of cancers (Qian et al., 2011; Noy and Pollard, 2014; Lim et 
al., 2016). 
By disrupting the CCR2-CCL axis I was aiming to prevent monocytes from being 
recruited to lesions, however I did not achieve this due to apparent redundancy in this 
pathway. Thus, the role of Ly6Chi monocytes in endometriosis pathophysiology 
remains undefined, as to my knowledge, no other studies have investigated this.  
In this chapter I also aimed to discern the effect of endometrial macrophage depletion 
on the development of endometriosis lesions in our model. Whilst depletion was 
achieved (34% of the F4/80hi Ly6Clo macrophages and 32% of the Ly6Chi 
monocytes), this was not significantly different to WT donor endometrial tissue. Due 
to the fact that macrophages are thought to be important for the decidualisation 
process in the mouse model of menstruation (Thiruchelvam et al., 2013; Cousins et 
al., 2016), depletion of endometrial macrophage populations in donor mice is 
therefore a play off between achieving decidualisation and depleting macrophages to 
exert an effect on the development of lesions. In my studies, I was able to achieve 
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decidualisation in all of the mice whilst also depleting macrophages by dosing 
doxycycline for 4 days (days 15-19). To achieve significant macrophage depletion, 
doxycycline could be dosed for a longer time period, but it must be taken into 
account that this has the potential to disrupt the generation of donor decidualised 
endometrial tissue. In order to gain statistical significance in lesion number with the 
macrophage depletion I achieved in my studies, I would need to use 33 mice for each 
group (power calculation performed using www.stat.ubc.ca). Due to time limits and 
limited access to the CSF1R cKO mouse line, I was not able to repeat my studies. 
Next, I analysed the number and size of lesions from mice which had received 
adoptive transfer of either LPM or SPM, and thus had an increased number of either 
LPM or SPM within the peritoneal cavity. This data did not produce any significant 
differences. To gain a significant difference in lesion number between mice with no 
transfer and those which had received adoptive transfer of SPM, power calculations 
suggest that an infinite number of mice would need to be used (hence, there was no 
observable difference). To observe a significant difference in lesion number between 
mice with no transfer and mice which received transfer of LPM, 393 mice would 
need to be used for each group (power calculation performed using 
www.stat.ubc.ca). Thus, it appears highly unlikely that the transfer of LPM into the 
peritoneal cavity in my studies would be able to exert a biological effect in lesion 
development. This could be due to the number of cells transferred into the peritoneal 
cavity, as it is difficult to predict whether this is enough to exert a biological effect. 
The transfer of more LPM may address this issue, or a more definitive method to 
decipher the roles of LPM and SPM in endometriosis lesion development may be 
through depletion studies. Clodronate liposome depletion of F4/80hi and F4/80hi 
Ly6Chi peritoneal macrophages is able to decrease the number of mice which 
develop lesions in our mouse model (13 out of 14 developed lesions for non-depleted 
and 9 out of 17 for depleted) (Forster et al., 2019). It would be interesting therefore 
to discern in which peritoneal macrophage compartment this effect on lesion number 
is attributed to. Due to the fact that LPM but not SPM infiltrate lesions (data from 
chapter 3), I would hypothesise that LPM but not SPM play roles in endometriosis 
lesion development in our model. The fact that LPM are associated with more 
homeostatic, tissue reparative roles and SPM are involved in stimulating 
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inflammation and clearing foreign material, also supports this notion (Bain and 
Jenkins, 2018). Further research is thus required to discern the role of LPM and SPM 
in the development of endometriosis lesions.  
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Chapter 5 - Lesion resident 
macrophages exhibit phenotypic 
heterogeneity 
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5.1 Introduction 
Current therapies which target macrophages, largely in cancer studies, have relied 
upon the targeting of generic macrophage markers which are expressed by 
macrophage populations throughout the body (Butowski et al., 2016; Gomez-Roca et 
al., 2019). However, recent studies have indicated that macrophage populations 
within disease states are often heterogeneous, and that differential targeting of 
specific macrophage populations may provide clinical benefit without having 
significant off-target effects (Noy and Pollard, 2014). Deciphering what makes 
disease-associated macrophages 'unique' compared to healthy tissue macrophage 
populations is therefore an important research area. In endometriosis, pathological, 
disease-associated macrophages remain poorly characterised.  
In cancers, we know that macrophages become 'educated' by the tumour 
microenvironment to adopt pro-disease characteristics and a unique genetic signature 
(Cassetta et al., 2019). In endometriosis, there have been no transcriptomic studies 
on lesion macrophages and thus our understanding of macrophage education within 
endometriosis lesions is minimal. One paper by Johan et al investigated macrophage 
phenotype after incorporation in endometriosis lesions, using a mouse model where 
human endometrial tissue was grafted into immunodeficient mice harbouring a 
macrophage specific GFP gene. After incorporation into lesions, GFP+ macrophages 
became more 'M2-like', or anti-inflammatory, over time (Johan et al., 2019b). A 
limitation of this study is that only four markers were investigated by 
immunodetection to define macrophage phenotype: iNOS and MHC II for 
inflammatory macrophages, and arginase 1 and CD204 for anti-inflammatory 
macrophages. It is likely therefore that this data does not reflect the true complexities 
of macrophage phenotype within lesions and does not take into account that there 
may be multiple macrophage populations present. What this data does infer, 
however, is that macrophages do appear to become 'educated' by the lesion 
microenvironment.  
In order to characterise macrophage populations associated with disease, researchers 
commonly turn to sequencing techniques, which introduce less bias and achieve 
novel insight into the complexities of macrophage biology. Recently, single cell 
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RNA sequencing has been increasingly utilised to answer questions relating to 
macrophage heterogeneity in disease. Single cell RNA sequencing relies on 
nucleotide barcodes, which attached to the mRNA in each individual cell, such that 
mRNA transcripts can be evaluated on a cell-by-cell basis. Recently, single cell RNA 
sequencing has been used to define monocyte and macrophage populations in 
atherosclerosis and revealed novel macrophage transcriptomic signatures which are 
associated with varying stages of disease (Lin et al., 2019). Single cell studies in 
cancer have also given insight into macrophage dynamics within the tumour 
environment (Cassetta et al., 2019). Cassetta et al demonstrated that TAMs from 
women with endometrial or breast cancer clustered separately using principal 
component analysis. Gene ontology testing identified up-regulated genes involved in 
processes such as  phagocytosis, immune response, cell communication, and blood 
vessel development, identifying a divergence in gene expression of macrophages 
which had been 'educated' by the tumours (Cassetta et al., 2019). In this chapter, I 
utilise single cell RNA sequencing to reveal novel insights into macrophage 
heterogeneity in endometriosis lesions.  
5.2 Aims and hypotheses 
I hypothesised that endometriosis lesion resident macrophages are a heterogeneous 
population that have a transcriptional profile which is unique from eutopic 
endometrial macrophages or macrophages from the peritoneal cavity. 
The aims of this chapter were to: 
1. Characterise the transcriptional profiles of endometriosis lesion macrophages 
compared to eutopic endometrial macrophages and peritoneal macrophages in 
our mouse model of induced endometriosis 
2. Interrogate endometriosis lesion resident macrophage phenotype 
heterogeneity at the protein and RNA level 
3. Determine whether endometriosis lesion resident macrophages have the 
capacity to expand via in situ proliferation 
 
 
- 115 - 
 
5.3 Results 
5.3.1 Lesion resident macrophages are a heterogeneous population which 
exhibit differential expression of CCR2 and MHC II  
In order to initially determine whether lesion resident macrophages can be divided 
into sub-populations based on surface marker expression, flow cytometry was 
utilised to interrogate endometriosis macrophages within lesion tissue. Macrophages 
were analysed for expression of activation markers that are indicative of macrophage 
phenotype either as an anti-inflammatory phenotype (CX3CR1) or a pro-
inflammatory phenotype (CCR2, CD86, MHC II). To gain further insight into 
macrophage phenotype dynamics, fate mapping studies were performed which 
allowed the identification of endometrial-derived macrophage and recruited 
macrophage phenotype within endometriosis lesions.  
Initially, CD11b+ macrophage/monocyte populations were interrogated in the 
decidualised eutopic endometrium. Surface expression of CX3CR1, CCR2, MHC II 
and CD86 was analysed (figure 5.1A). Using these markers, eight sub-populations 
were identified based on differential expression of the selected markers . All 
endometrial CD11b+ cells were CX3CR1hi (figure 5.1B). The largest population, 
which accounted for 26% (± SEM 2.5%) of cells, was CD11b+, CX3CR1hi, CCR2hi, 
MHC IIlo and CD86lo (figure 5.1B). The tight variance across mice in the 
macrophage populations identified highlighted the consistency in macrophage 
phenotypic heterogeneity within the tissue (figure 5.1B). To determine the 
phenotypic heterogeneity of endometrial macrophages that had become incorporated 
into endometriosis lesions, GFP+ CD11b+ cells were analysed in endometriosis 
lesions from WT mice that had received intraperitoneal injection of MacGreen donor 
endometrial tissue. Of the GFP+ CD11b+ endometrial macrophages incorporated 
into lesions a single population was delineated which was CX3CR1hi, CCR2hi, MHC 
IIlo and CD86hi (figure 5.1C/E), suggesting phenotypic heterogeneity evident in 
endometrial macrophages is lost upon incorporation into lesions.  
Next, the phenotype of GFP-, recipient derived CD11b+ cells were analysed in 
endometriosis lesions (figure 5.1D). A total of four populations were identified based 
on differential expression of CCR2 and MHC II in the GFP- CD11b+ recipient 
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derived population, the largest population of which had the phenotype CX3CR1hi, 
CCR2hi, MHC IIlo and CD86hi. Notably, this population had the same phenotype as 
the GFP+ endometrial-derived macrophages within endometriosis lesions (figure 
5.1F). 
 
 
Figure 5.1. Lesion resident macrophages are a heterogeneous population which 
exhibit differential expression of CCR2 and MHC II. A: Flow plots of CD11b+ 
cells in donor endometrial tissue showing expression of CX3CR1, CCR2, MHC II 
- 117 - 
 
and CD86. (A) All CD11b+ cells were CX3CR1hiof which there was both a CCR2hi 
and CCR2lo population (hi and lo expression is denoted as + and - respectively on 
graphs). (B) A major population of CD11b+ MHC IIlo CD86lo cells predominated in 
the tissue however MHC IIhi CD86hi, MHC IIhi CD86lo and MHC IIlo CD86hi 
populations were also present. B:Eight populations of CD11b+ cells were identified 
in donor endometrial tissue based on expression of CX3CR1, CCR2, MHC II and 
CD86 (n=7 mice). C: Flow plots of GFP+ endometrial-derived CD11b+ cells in 
endometriosis lesions where mice had received Csf1r-EGFP donor endometrial 
tissue. (A) Endometrial-derived CD11b+ cells in lesions were CCR2hi CX3CR1hi. (B) 
Endometrial-derived lesion CD11b+ cells were MHC IIlo CD86hi. (C) Unstained 
GFP+ CD11b+ lesion cells with or without incubation with a CD86 antibody, 
demonstrating an increase in CD86 expression in the stained population. D: Flow 
plots of GFP- recipient derived CD11b+ cells in the endometriosis lesions of mice 
which had received Csf1r-EGFP donor endometrial tissue. (A) Both CCR2hi and 
CCR2lo populations were present in the GFP- CD11b+ population. (B) All GFP- 
CD11b+ cells were CX3CR1hi. (C) Both CD86hi and CD86lo recipient derived 
CD11b+ populations were present. (D) Both CD11b+ MHC IIhi and CD11b+ MHC 
IIlo populations were present. E: One population of GFP+ endometrial derived 
CD11b+ cells was identified in mouse endometriosis lesions which was CX3CR1hi 
CCR2hi MHC IIlo CD86hi(n=6 mice). F: Four populations of CD11b+ cells were 
identified in the GFP- recipient derived macrophage population in lesions based on 
expression of CX3CR1, CCR2, MHC II and CD86 (n=6 mice). The predominant 
population was CX3CR1hi CCR2hi MHC IIlo CD86hi. Data are shown as mean ±SEM. 
 
 
5.3.2 Endometriosis lesion resident macrophages are transcriptionally unique 
from eutopic endometrial and peritoneal macrophages 
 
Once I had determined that endometriosis lesion resident macrophages exhibit 
phenotypic heterogeneity and can be classed into sub-populations based on cell 
surface marker expression (figure 5.1), I wanted to assess phenotypic heterogeneity 
using a single cell RNA-Seq which introduces less bias into data collection (where 
the markers are not pre-defined) and gives greater granularity into the true 
heterogeneity of macrophages in a sample. Unbiased transcriptional profiling of 
CD45+ cells in lesions (6006 cells), donor endometrial tissue (1306 cells) and 
peritoneal lavage cells from sham (5645 cells) and endometriosis mice (6720 cells) 
was performed by Edinburgh Genomics, such that I could compare gene expression 
between the tissues and characterise macrophage heterogeneity within endometriosis 
lesions.  
 
Using Loupe Cell Browser 3.0.1 software I visualised the samples using t-distributed 
stochastic neighbour embedding (tSNE) plots. In these plots, each cell is represented 
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as a dot on the graph. The cells are distributed according to their transcriptomic 
signature, such that cells with a more similar transcriptomic signature can be found 
closer together on the graph and thus inferences can be made based on the clustering 
of cells on the tSNE plot. For this thesis, graph-based clustering was visualized using 
Loupe Cell Browser 3.0.1 software. Cell clusters produced using graph-based 
clustering were analysed for restricted or increased expression of the most highly up-
regulated genes. In some cases, the most highly up-regulated genes in a cluster did 
not exhibit restricted or increased expression to the cluster in question, suggesting 
that this did not represent a biologically distinct population (the sample may have 
been 'over-clustered'). In this manner, the sample was re-analysed such that only 
'true' clusters with up-regulated genes which could define or were up-regulated in the 
specified group of cells were taken forward for analysis.     
 
Figure 5.2 shows tSNE plots of all of the samples clustered together  based on 
library id in the aggregate tSNE plot can be visualised. In the samples, CD45+ 
leukocytes were defined based on expression of pre-defined markers expressed by 
specific leukocyte populations. Macrophages were defined based on expression of 
Csf1r, Adgre1 (F4/80) and Itgam (CD11b). B cells were defined based on expression 
of Cd19, Cd79a and Ly6d. NK and T cells clustered together and were defined based 
on expression of Gzmc, Gzme, Gzmf, Nkg7 and Thy1 (NK cells) and Cd3g, Cd3d, 
Ccl5, Il2rb (T cells). Notably, Ly6g+ neutrophils were absent from the samples and it 
has been previously noted by other researchers that neutrophils are difficult to 
sequence on the 10X Genomics system (data unpublished). Macrophages were the 
predominant cell type in all of the samples (figure 5.2B). Notably, macrophages in 
the endometriosis lesion samples demonstrated significant overlap with eutopic 
endometrial macrophages (macrophages from the donor endometrial tissue), 
suggesting that these macrophage populations are transcriptionally similar when 
compared with peritoneal macrophages. This area of overlap is indicated with a 1 in 
figure 5.2B. A population of macrophages from the endometriosis lesion sample also 
clustered with the peritoneal macrophages, suggesting that this population is 
transcriptionally similar to the peritoneal macrophages. This area is indicated with a 
2 in figure 5.2B. The fact that endometriosis lesion macrophages cluster with both 
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the endometrial and peritoneal macrophages is consistent with the data presented in 
chapter 3, which demonstrated that endometriosis lesion resident macrophages are 
derived from both endometrial and peritoneal macrophages (as well as monocyte-
derived macrophages).  
 
Figure 5.2. tSNE analysis of CD45+ cells from endometriosis lesions, decidualised 
endometrial tissue and peritoneal lavage fluid from sham and endometriosis mice. 
A: The four samples clustered together highlighting cell types across the samples. 
CD45+ leukocytes were defined based on know genes. Csf1r+, Adgre1+ and Itgam+ 
macrophages Cd19+, Cd79a+ and Ly6d+ B cells, Gzmc+, Gzme+, Gzmf+, Nkg7+ 
and Thy1+ NK cells and  Cd3g+, Cd3d+, Ccl5+, Il2rb+ T cells were present in the 
samples. Endometriosis lesion macrophages clustered with both the endometrial 
tissue macrophages (area highlighted with a 1) and the peritoneal macrophages 
(area highlighted with a 2). PF = peritoneal lavage fluid. 
 
To determine whether endometriosis lesion resident macrophages possessed a 
distinct transcriptional profile, I compared macrophages from endometriosis lesions, 
donor endometrial tissue (eutopic endometrial macrophages) and peritoneal 
macrophages. First I manually separated the Csf1r+ Adgre1+ Itgam+ macrophages 
into the three groups based on sample type using the ‘Lasso selection' function in 
Loupe Cell Browser (figure 5.3A). As the endometriosis lesion sample and 
endometrial tissue sample demonstrated significant overlap, macrophages, which 
were present in this overlapped region, were classified as endometrial tissue to avoid 
any ambiguity. Using Loupe cell browser I then interrogated locally defining genes 
to identify candidates unique to each sample. 
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I found that macrophages within the three tissues had significantly different 
transcriptional profiles. In figure 5.3B I list the 20 most up-regulated gene transcripts 
in the tissues and a full list of differentially expressed genes can be found in 
appendix 2.  
 
 
Figure 5.3. Differentially expressed genes in Csf1r+ Adgre1+ Itgam+ macrophages 
in endometrial tissue, peritoneal lavage fluid and endometriosis lesions. A: tSNE 
plot of macrophages in endometriosis lesions, endometrial tissue and peritoneal 
lavage fluid. In order to determine differential gene expression between 
macrophages in the endometrium, peritoneal lavage fluid and endometriosis lesions, 
the Csf1r+ Adgre1+ Itgam+ cells were clustered into sample type using the 'Lasso 
selection' tool in Loupe Cell Browser 3.0.1. B: shows the top 20 genes differentially 
expressed by macrophage populations in each sample. Highlighted in bold are genes 
most highly up-regulated by endometriosis lesion macrophages which are depicted 
graphically in figure 5.10. 
 
 
Gene ontology analysis (performed using http://geneontology.org/) was utilised to 
gain insight into the function of endometrial, peritoneal and endometriosis lesion 
resident macrophages in my data. Endometrial macrophages up-regulated genes 
involved in positive regulation of hematopoietic stem cell migration (>100 fold 
enrichment), tolerance induction to self antigen (60.92 fold enrichment), monocyte 
- 121 - 
 
extravasation (48.73), antigen processing and presentation of peptide antigen via 
MHC class II (45.69 fold enrichment) and tissue regeneration (14.62 fold 
enrichment). Peritoneal macrophages up-regulated genes involved in cellular 
extravasation (26.05 fold enrichment), leukocyte cell-cell adhesion (17.36 fold 
enrichment), myeloid leukocyte migration (16.03 fold enrichment) and chemokine-
mediated signalling pathways (15.44 fold enrichment). Endometriosis lesion resident 
macrophages up-regulated genes involved in positive regulation of hematopoietic 
stem cell migration (<100 fold enrichment), monocyte extravasation (92.90 fold 
enrichment), wound healing involved in inflammatory response (77.42 fold 
enrichment), cell migration involved in vasculogenesis (77.42 fold enrichment), 
regulation of macrophage inflammatory protein 1 alpha production (51.61 fold 
enrichment), positive regulation of monocyte differentiation (51.61 fold enrichment), 
macrophage proliferation (44.24 fold enrichment) and positive regulation of the 
neuroinflammatory response (38.71 fold enrichment).  
 
To gain further insight into the transcriptional diversity of eutopic endometrial 
macrophages, peritoneal macrophages and endometriosis lesion macrophages, I 
produced a heat map of log2 fold gene changes across the samples. Notably, eutopic 
endometrial macrophages and endometriosis lesion resident macrophages showed the 
highest degree of similarity in gene expression changes and peritoneal macrophages 
were distinct from both of these (figure 5.4).  
 
 
Figure 5.4. Heat map of Csf1r+ Itgam+ Adgre1+ macrophages in endometrial 
tissue, peritoneal lavage fluid and endometriosis lesions (Log2 fold changes) 
Endometrial tissue macrophages and endometriosis lesion macrophages display 
similarities in gene expression patterns. Peritoneal lavage fluid macrophages are 
more genetically distinct from the endometrial and endometriosis lesion 
macrophages.  
 
To determine the specificity of up-regulated genes in the endometriosis lesion sample 
to this tissue, the four most highly up-regulated genes were mapped to t-SNE plots of 
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all four samples (endometriosis lesions, endometrial tissue, peritoneal lavage fluid 
from sham and endometriosis mice) (figure 5.5). The tSNE plots largely 
demonstrated that expression of the Ccl8, Gas6, Mrc1 and Spp1 transcripts were 
highest in the endometriosis lesion sample. Ccl8 was largely restricted to 
endometriosis lesion macrophages but was also expressed by lesion B, T and NK 
cells. Gas6 expression was mostly restricted to endometriosis lesions however a 
population of endometrial macrophages also highly up-regulated this gene. Mrc1 and 
Spp1expression was increased in endometriosis lesions and these genes were also 
expressed at lower levels in endometrial tissue and for the Mrc1 transcript in the 
peritoneal lavage fluid sample also.  
 
 
Figure 5.5. t-SNE plots of the four Most up-regulated genes in the endometriosis 
lesion macrophages across all of the single cell samples 
Gene expression is shown where increased intensity in colour (red being most 
intense) indicates increased abundance of gene transcripts. Ccl8, Gas6, Mrc1 and 
Spp1 are significantly up-regulated in endometriosis lesion macrophages compared 
to eutopic endometrial and peritoneal macrophages. 
 
5.3.3 Endometriosis lesion resident macrophages exhibit transcriptional 
heterogeneity 
 
In order to appreciate the true complexity of macrophage transcriptional diversity 
within endometriosis lesions, I visualized this sample as a single file within Loupe, 
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As tSNE plots are generated based on the relationship of each cell to one another, 
differential clusters are generated when each sample is visualised alone. 
Initially, I visualised CD45+ leukocyte populations within the endometriosis lesions 
tissue. As expected, macrophages predominated in the tissue with smaller 
populations of B cells, NK and T cells also being present (figure 5.6A). The genes 
used to define CD45+ leukocyte clusters are listed in figure 5.6B.   
 
 
Figure 5.6. Subsets of CD45+ leukocytes in mouse endometriosis lesions 
Subsets of CD45+ leukocytes in the endometriosis lesions sample were defined using 
genes already known to be expressed by leukocyte populations in a similar manner 
as to figure 5.2. A:tSNE plot of mouse endometriosis lesions sample showing clusters 
of CD45+ leukocytes. Macrophages, B cells, NK cells and T cells were present in the 
endometriosis lesion sample. B: Genes used to define CD45+ cell types within the 
endometriosis lesion sample.  
 
Adgre1+ Csf1r+ macrophages in the endometriosis lesions sample were subjected to 
graph based clustering using Loupe 3.0.1 software and clusters which exhibited 
restricted or increased gene expression of their most highly up-regulated genes 
compared to all other clusters were taken forward for analysis. In the lesion Adgre1+ 
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Csf1r+ cells there were five main clusters of transcriptionally distinct macrophage 
populations (figure 5.7A). The top 20 up-regulated genes are listed in figure 5.7B and 
a full list of all the significantly differentially expressed genes can be found in 
appendix 1. The largest macrophage cluster, cluster 1, up-regulated a number of 
novel genes as well as genes such as Igf1, which we have recently published is 
important for macrophage-mediated neurogenesis in lesions (Forsteret al., 2019). 
Notably, the most highly up-regulated gene in cluster 1, was Gas6. The increase in 
Gas6 in lesion macrophages compared with eutopic endometrial and peritoneal 
macrophages identified in figure 5.3 can thus be attributed to this sub-population of 
macrophages within the lesion, as well as up-regulation of the Ccl8 transcript. Gene 
ontology analysis (performed using http://geneontology.org/) revealed cluster 1 up-
regulated genes involved in positive regulation of steroid hormone biosynthetic 
process (63.52 fold enrichment), regulation of neuroinflammatory responses (34.30 
fold enrichment), regulation of macrophage migration (20.92 fold enrichment) and 
tissue regeneration (17.50 fold enrichment).  
The most highly up-regulated gene in cluster 2 was Mmp12, which is classically 
associated with tissue remodelling but has also been implicated in immune cell 
suppression (specifically T cells) in a cancer setting (Qu, Yan and Du, 2011). Gene 
Ontology analysis showed up-regulation of genes involved in positive regulation of 
chemokine (C-X-C motif) ligand 2 production (92.13 fold enrichment), neutrophil 
chemotaxis (40.54 fold enrichment), granulocyte chemotaxis (37.08), chemokine-
mediated signalling pathways (28.15 fold enrichment), regulation of fibroblast 
proliferation (23.90 fold enrichment) and regulation of cytokine secretion (14.41 fold 
enrichment). Cluster 3 was the smallest macrophage cluster and up-regulated genes 
involved in positive regulation of cell-substrate adhesion (48.77 fold enrichment), 
cellular response to inorganic substances (27.84 fold enrichment), leukocyte 
migration (24.90 fold enrichment) and inflammatory response (13.89 fold 
enrichment). Cluster 4 up-regulated genes involved in cellular response to cytokine 
stimuli (11.27 fold enrichment). The most highly up-regulated gene, Retnla, codes 
for the cytokine RELMα which has been identified as a pro-inflammatory factor in a  
mouse model of colitis, where RELMα stimulated IL-6 and TNF-alpha release and 
inhibited release of the anti-inflammatory cytokine IL-10, perpetuating 
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pathology  (Munitz et al., 2008). Cluster 5 is defined by genes associated with 
proliferation, DNA replication and preventing apoptosis, for example 
2810417H13Rik, Top2a, Birc5, and Stmn1, the most highly up-regulated genes. Gene 
ontology analysis in this cluster identified that up-regulated genes are involved in 
spindle organisation (42.88 fold enrichment), nuclear division (20.42 fold 
enrichment), cell cycle (14.44 fold enrichment), mitotic cell cycle process (19.35 fold 
enrichment), cell division (14.52 fold enrichment) and chromosome organisation 
(12.20 fold enrichment). 
 
 
Figure 5.7. Subsets of Csf1r+ Adgre1+ macrophages in mouse endometriosis 
lesions 
A:tSNE plot of Adgre1+ Csf1r+ macrophages in mouse endometriosis lesions 
showing clustering of 5 transcriptomically distinct sub-populations. B: Table of the 
top 20 up-regulated genes in each cluster of Adgre+ Csf1r+ macrophages in mouse 
endometriosis lesions. The four most highly up-regulated genes are highlighted in 
bold and displayed graphically in figure 5.5. 
 
In order to demonstrate that the up-regulated genes in each macrophage cluster were 
cluster specific, the four most up-regulated genes in each population were mapped 
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onto tSNE plots to determine gene expression over the endometriosis lesion sample 
(figure 5.8).  Up-regulated genes were either up-regulated or expressed almost 
exclusively (in the cases of clusters 3 and 5) to the relevant cluster, supporting that 
the clusters produced represent 'real' transcriptionally distinct populations.  
 
Figure 5.8. t-SNE plots for most highly up-regulated genes in clusters of 
endometriosis lesion macrophages 
tSNE plots of the most highly up-regulated genes which define macrophage clusters 
1-5. Gene expression is shown where increased intensity in colour (red being most 
intense) indicates increased abundance of gene transcripts. Selected genes 
demonstrate increased gene expression in the relevant macrophage cluster or gene 
expression is largely restricted to the cluster.  
 
To further analyse the transcriptional diversity between lesion resident macrophage 
clusters, a heat map showing log2 fold changes in transcript expression was produced 
for clusters 1-5 (figure 5.9). Heat map analysis demonstrated differential expression 
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patterns between the clusters whereby clusters 2 and 4 demonstrated the highest 
degree of similarity.  
 
 
Figure 5.9. Heat map of differentially expressed genes in clusters 1-5 of 
endometriosis lesion resident macrophages (Log2 fold changes) 
Endometriosis lesion resident macrophages exhibited transcriptional heterogeneity 
which is reflected in the differential genetic profiles presented in this heat map.  
 
5.3.4 Endometriosis lesion macrophages express the Gas6 receptor Axl 
suggesting the potential for paracrine signalling 
 
Gas6 is the most highly up-regulated transcript in endometriosis lesion macrophage 
cluster 1, which is the largest macrophage cluster within the lesion tissue (refer to 
figure 5.4 for tSNE clustering). When lesion macrophages were compared with 
eutopic endometrial and peritoneal macrophages, Gas6 was the second most highly 
up-regulated gene in endometriosis lesions (figure 5.3).The Gas6 gene encodes for 
the Gas6 protein which binds with a high affinity to the Axl receptor, encoded by the 
Axl gene (Korshunov, 2012). Due to the fact that endometriosis lesion resident 
macrophages highly up-regulate the Gas6 transcript, I wanted to ascertain whether 
lesion macrophages also expressed the Gas6 receptor, Axl, in order to infer as to 
whether paracrine signalling could be occurring within the lesion microenvironment. 
tSNE plots mapping the expression of both Gas6 and Axl were produced in the 
endometriosis lesions sample which demonstrated high expression of both Gas6 and 
Axl in lesion macrophage populations (figure 5.10A/B). Gas6was largely expressed 
by cluster 1 as previously demonstrated in figure 5.5. Interestingly, Axl was highly 
expressed by lesion macrophages, residing in the other clusters, although Axl was 
also highly up-regulated in some cluster 1 cells suggesting the autocrine signalling 
might take place as well.  
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Figure 5.10. Endometriosis lesion macrophages express the Gas6 ligand and the 
Gas6 receptor Axl. Gene expression is shown where increased intensity in colour 
(red being most intense) indicates increased abundance of gene transcripts. A:tSNE 
plot of Gas6 expression across the endometriosis lesion sample. The Gas6 transcript 
is highly expressed in a large proportion of lesion macrophages (circled). B:tSNE 
plot of Axl expression across the endometriosis lesion sample. The Gas6 receptor Axl 
is highly expressed by lesion macrophages (circled).  
 
 
5.3.5A A population of lesion macrophages express the proliferation marker 
Mki67 
 
Ki67 is expressed by dividing cells and thus is commonly utilised as a marker of 
proliferation (Juríková et al., 2016). To investigate whether endometriosis lesion 
macrophages have the ability to proliferate in our model, I mapped the Mki67gene 
which codes for Ki67 onto a tSNE plot of the endometriosis lesions sample. Mki67 
was almost exclusively expressed by macrophage cluster 5 (circled), identifying that 
this population represents a sub-population of macrophages within endometriosis 
lesions which are able to proliferate in situ (figure 5.11). Cluster 5 is also defined by 
up-regulation of a number of replication specific genes, such as 2810417H13Rik 
(DNA replication and repair), Top2a (important for DNA replication), Birc5 (inhibits 
apoptosis) and Stmn1 (cell cycle regulation). Identification of ki67 at the protein 
level in macrophages in endometriosis lesions in our mouse model was attempted 
using immunohistochemistry (co-staining of ki67 and F4/80). This would provide 
additional evidence that lesional macrophages are proliferative. However, this 
staining was not successfully optimised within the time frame of my PhD (data not 
shown).  
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Figure 5.11. Cluster 5 is characterised by expression of the proliferation marker 
Mki67 
tSNE plot of mouse endometriosis lesions showing expression of the Mki67 gene with 
cluster 5 circled. Gene expression is shown where increased intensity in colour (red 
being most intense) indicates increased abundance of gene transcripts. Mki67 
expression was almost exclusively restricted to cluster 5.  
 
5.4 Summary 
In this chapter I have demonstrated that endometriosis lesion resident macrophages 
can be classified into sub-populations based on cell surface marker expression. 
Furthermore, I have used single cell RNA sequencing to show that endometriosis 
lesion resident macrophages are transcriptionally diverse from eutopic endometrial 
and peritoneal macrophages. I interrogated macrophage transcriptional heterogeneity 
within endometriosis lesions and characterised five major populations of lesion 
macrophages, demonstrating that lesion macrophages are a heterogeneous 
population.  
Using Loupe 3.0.1 software I observed that 5 key populations of macrophages are 
present in endometriosis lesions in our mouse model. I discerned that a cluster of 
lesion macrophages (cluster 5) up-regulated the proliferation marker Mki67 along 
with a number of proliferation specific genes (2810417H13Rik, Top2a, Birc5, 
Stmn1), suggesting that this population exhibits in situ proliferation. Gene ontology 
analysis of cluster 5 identified genes involved in spindle organisation, nuclear 
division, the cell cycle, mitotic cell cycle process, cell division and chromosome 
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organisation, further supporting this. One of the most highly up-regulated genes by 
the lesion macrophages was Gas6, and lesion macrophages also up-regulated the Axl 
gene which codes for the high affinity Gas6 receptor, Axl. This data suggests the 
potential for paracrine signalling between macrophage populations within 
endometriosis lesions.   
Overall, in this chapter I have characterised that endometriosis lesion macrophages 
exhibit a higher level of complexity than previously appreciated and defined up-
regulate genes that may be implicated in disease development. This data provides an 
insight into macrophage heterogeneity, signalling and proliferative renewal within 
lesions. 
5.5 Discussion 
The data presented in figure 5.1 demonstrated that macrophages in endometriosis 
lesions can be stratified into sub-populations using analysis of markers used in flow 
cytometry which have typically been used to represent 'extremes' of macrophage 
activation, either as 'anti-inflammatory' or 'pro-inflammatory' markers (Martinez and 
Gordon, 2014). Eutopic endometrial macrophages could be separated into eight 
populations using the markers CCR2, MHC II and CD86, however in endometriosis 
lesions, endometrial-derived macrophages formed only one major population. This 
suggests that heterogeneity in this macrophage population is lost upon incorporation 
into endometriosis lesions. It is possible that only one macrophage population is 
persisting in lesions, or that macrophage phenotype is modulated upon incorporation 
into the novel microenvironment of the endometriosis lesion. We know that in 
cancer, macrophage phenotype is modulated upon incorporation into the novel 
microenvironment of the tumour, where growth factors and cytokines modulate 
macrophages to a 'tumour specific' phenotype (Quatromoni and Eruslanov, 2012; Wu 
and Zheng, 2012; Cassetta et al., 2019). The fact that a large proportion of recipient 
derived, infiltrating macrophage populations also shared the same phenotype as the 
endometrial-derived macrophages suggests re-programming of macrophage 
phenotype within the endometriosis lesion microenvironment. This is depicted 
schematically in figure 5.12. A key limitation of these studies is the difficulty to infer 
as to whether the macrophage populations characterised reflects the true 
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heterogeneity or phenotypes of macrophages, due to the use of only four surface 
markers. I addressed this limitation by employing single cell RNA sequencing.  
 
Figure 5.12. Schematic Summarising Macrophage Sub-populations in Eutopic 
Endometrial Macrophages and Endometrial-derived and Recruited Macrophage 
Populations in Endometriosis Lesions 
This schematic summarises data from figure 5.1. At flow cytometric analysis, eutopic 
endometrial macrophages in the decidualised endometrium formed 8 sub-
populations based on the CCR2, MHC II and CD86 markers. Incorporation into 
endometriosis lesions lead to a reduction in the heterogeneity of this population. 
Recruited macrophage populations formed four sub-populations using the CCR2, 
MHC II and CD86 markers.  
 
I analysed macrophage populations from the decidualised eutopic endometrium, 
endometriosis lesions and peritoneal lavage fluid by single cell RNA sequencing. 
Transcriptional analysis showed that endometriosis lesion resident macrophages 
exhibit differential gene expression compared to eutopic endometrial and peritoneal 
macrophages, however they shared the highest degree of similarity to the eutopic 
endometrial macrophages. Gene ontology testing identified shared functions between 
endometrial and endometriosis lesion macrophages such as positive regulation of 
haematopoietic stem cell migration and wound healing/tissue regeneration responses. 
This analysis highlights that functionally, endometrial and lesion resident 
macrophages may be more similar, compared with peritoneal macrophages which 
up-regulated genes involved in processes such as cellular extravasation and 
leukocyte cell-cell adhesion. Functions such as wound healing and recruitment of 
haematopoietic cells may be important to the pro-disease role of macrophages in 
stimulating the growth and development of endometriosis lesions (Bacci et al., 2009; 
Greaves et al., 2015). The similarity between endometrial and lesion resident 
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macrophages is perhaps unsurprising as endometriosis lesions are derived from 
decidualised endometrial tissue in our mouse model (endometrial tissue is injected 
into the peritoneal cavity where it adheres to form lesions). Macrophages modulate 
their phenotype and gene expression based on the signals they encounter in their 
local micro-environment (Wynn, Chawla and Pollard, 2013). Thus, macrophages 
present within endometriosis lesions may encounter a more 'similar' 
microenvironment to eutopic endometrial macrophages compared with macrophages 
placed in the peritoneal cavity. The placement of endometriosis lesions in the 
peritoneal cavity in our model, most commonly on the peritoneal wall, exposes 
lesions to cytokines, chemokines and growth factors in peritoneal fluid, which likely 
modulate the macrophage transcriptome.  
To date there have been no transcriptomic studies on endometriosis lesion 
macrophages and thus this sequencing data provides a first insight into the 
transcriptional profile of these cells. The most highly up-regulated genes in the lesion 
macrophage population are Ccl8, a monocyte/macrophage chemokine (Asano et al., 
2015), Gas6, a mitogen (Loges et al., 2010), Mrc1, typically a marker of anti-
inflammatory macrophages (Martinez and Gordon, 2014), and Spp1, which is 
implicated in macrophage recruitment and modulating macrophage cytokine 
production (Castello et al., 2017). Important parallels can be drawn from the 
transcriptomic profile of endometriosis lesion macrophages and tumour associated 
macrophages, which have been shown to play similar roles such as angiogenesis and 
stimulating stromal cell proliferation and survival in a disease setting (Bacci et al., 
2009; Noy and Pollard, 2014; Shao et al., 2016). One key parallel is the up-
regulation of the mitogen Gas6.  
In this chapter I demonstrated that lesion macrophages up-regulated Gas6 and this 
was the most highly up-regulated gene in macrophage cluster 1, the largest 
macrophage cluster in lesion tissue. Lesion macrophages up-regulated both Gas6 and 
the high affinity Gas6 receptor Axl. Interestingly, expression of the Gas6 receptor 
Tyro3 was almost absent from endometriosis lesions and the Mer receptor (Mertk) 
was expressed at a low level in a small number of cells (data not shown). These 
receptors have a reduced affinity for the Gas6 ligand compared with the Axl receptor 
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(Axl>Tyro3>Mer) (Lemke and Rothlin, 2008). Gas6/Axl signalling has been 
investigated in a number of disease settings. For example, co-expression of high 
levels of Gas6 and Axl in glioma tumours is associated with reduced survival 
(Hutterer et al., 2008) and the Gas6 ligand is able to increase the proliferation and 
survival of cancer cell lines in vitro (Van Ginkel et al., 2004; Sainaghi et al., 2005). 
An elegant study by Loges et al  revealed insight into the role of macrophage-derived 
Gas6 in cancer. Using Gas6 knockout mice they demonstrated, in models of breast 
and pancreatic cancer, that infiltrating macrophages were educated by the tumour 
microenvironment to produce increased levels of Gas6, which in turn increased the 
proliferation and survival of tumour cells. They also noted that in five different 
cancer cell lines Axl was more highly expressed than the Tyro3 or Mer receptors 
(Loges et al., 2010). In my data, Gas6 was highly up-regulated in endometriosis 
lesion macrophages compared with eutopic endometrial and peritoneal macrophages. 
This suggests that this gene is specifically up-regulated within the endometriosis 
lesion micro-environment, however the mechanism by which this gene is up-
regulated or the role that Gas6/Axl signalling may play in endometriosis is entirely 
unknown.  
I investigated the heterogeneity of endometriosis lesion macrophages and 
demonstrated that five sub-populations were present within the tissue, which 
exhibited differential transcriptomic profiles. Previous investigations into 
macrophage phenotype within endometriosis lesions have largely relied on 
immunohistochemical techniques which do not appreciate the possibility for 
macrophage heterogeneity (Bacci et al., 2009; Johan et al., 2019). Notably, these 
studies have also largely relied on the M1/M2 paradigm, however in my data lesion 
macrophage populations up-regulated a number of both 'M1' and 'M2' markers, 
supporting the notion that this is a vastly over-simplified classification of 
macrophage phenotype (Martinez and Gordon, 2014). In tumours, multiple 
populations of macrophages exist (summarised in figure 5.13) which promote 
differential aspects of disease development (Qian and Pollard, 2010). In this way, 
macrophage populations are 'specialised' to promote specific aspects of disease 
development. It is possible, therefore, that transcriptionally divergent macrophage 
populations within endometriosis lesions fulfil differential roles during disease 
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development and within the lesion microenvironment. From the data presented in 
this chapter, it is possible to infer the roles that these macrophage populations may 
fulfil.  
Gene ontology analysis demonstrated that cluster 1 up-regulated genes involved in 
positive regulation of steroid hormone biosynthetic processes, regulation of 
neuroinflammatory responses, regulation of macrophage migration and tissue 
regeneration. Data from previous studies has already demonstrated that a number of 
these functions are central to endometriosis pathophysiology. For example, we know 
that endometriosis lesions locally produce estrogen, which stimulates the growth of 
lesions (Noble et al., 1997; Zeitoun et al., 1998; Attar and Bulun, 2006). We also 
know that macrophages are central to neurogenesis in lesions, which contributes to 
pain symptoms in mice and is mediated by Igf1, also up-regulated by this cluster 
(Greaves et al., 2015; Forster et al., 2019). Depletion of peritoneal macrophages 
using clodronate liposomes reduces macrophage recruitment to lesions and 
subsequently fewer endometriosis lesions are formed, highlighting the importance of 
macrophage recruitment from the peritoneal cavity in the development of lesions 
(Bacci et al., 2009; Forster et al., 2019). In a disease setting, tissue regeneration is 
commonly a 'pro-disease' function which can maintain the health of pathological 
tissue rather than eliciting an immune response to clear it (Wynn, Chawla and 
Pollard, 2013). A number of genes up-regulated by this cluster, including Gas6 and 
Ccl8, have also been implicated in supporting the growth and survival/metastasis of 
cancer cells (Loges et al., 2010; Cassetta et al., 2019). These ligands could therefore 
be important in supporting the survival and dissemination of endometrial stromal 
cells within the peritoneal cavity. Thus, it is clear that this lesion macrophage cluster 
up-regulates a number of genes which are likely to contribute to pathology, and the 
fact that cluster 1 is the largest population of lesion macrophages further emphasises 
the importance of this macrophage population within the lesion microenvironment. 
Cluster 2 represents a smaller lesion macrophage population which, at gene ontology 
analysis, up-regulated genes involved in positive regulation of chemokine (C-X-C 
motif) ligand 2 production, neutrophil chemotaxis, granulocyte chemotaxis, 
chemokine-mediated signalling pathways, regulation of fibroblast proliferation and 
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regulation of cytokine secretion. Zhang et al noted that CXCL2 was up-regulated in 
the peritoneal fluid of mice with endometriosis-like lesions (heterologous model), 
whereby CXCL2 was important for the recruitment of myeloid-derived suppressor 
cells to the peritoneal cavity (Zhang et al., 2018).  CXCL2 is also known to mediate 
the recruitment of neutrophils during tissue inflammation (De Filippo et al., 2013), 
which is synergistic to the up-regulation of genes involved in neutrophil chemotaxis 
at gene ontology analysis. Takamura et al reported that neutrophils are central to the 
growth of endometriosis lesions in a heterologous mouse model, but use of an anti-
Gr1 antibody did not account for the expression of Gr1 on mouse monocytes 
(Takamura et al., 2016). The role of neutrophils in endometriosis thus remains 
largely elusive, although my data suggests that neutrophil chemotaxis is, at least in 
part, mediated by a population of lesion resident macrophages. Interestingly, cluster 
2 also up-regulated genes involved in regulation of fibroblast proliferation. 
Fibroblasts are known to play roles in regulating the extracellular matrix and wound 
healing, and a number of diseases are associated with dysregulation in fibroblast 
function and an altered wound healing responses (McAnulty, 2007). Fibroblasts in 
the eutopic endometrium of women with endometriosis exhibit progesterone 
resistance, inhibited decidualisation and a pro-inflammatory phenotype compared to 
healthy controls, suggesting that fibroblast dysregulation is a hallmark of 
endometriosis (Barragan et al., 2016). My data therefore suggests that a macrophage-
fibroblast cross talk may occurr within endometriosis lesions, and this could have the 
potential to exacerbate disease by regulating the extracellular matrix and wound 
healing functions of fibroblasts to perpetuate survival and health of endometriosis 
lesions, although functional studies investigating this potential cross talk are 
required. Furthermore, the most highly up-regulated gene in cluster 2 is Mmp12 
(matrix metallopeptidase 12; Mmp12). Mmp12 is involved in breakdown of the 
extracellular matrix, further supporting the hypothesis that this macrophage 
population may be implicated in tissue remodelling in lesions.  
Cluster 3 is the smallest population of macrophages in endometriosis lesions in our 
mouse model, and at ontology analysis up-regulated genes involved in positive 
regulation of cell-substrate adhesion, cellular response to inorganic substances, 
leukocyte migration and inflammatory response. A number of genes up-regulated by 
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this cluster relate to modulation of the inflammatory response. The most highly up-
regulated gene in this population is Alox15, which is an enzyme involved in 
resolution of inflammation (Tian et al., 2017). In macrophages, Alox15 has been 
shown to be induced through interaction with apoptotic cells (Stables et al., 2011). 
This suggests that this macrophage population may be defined apoptotic activity. 
Alox15 is also thought to control the uptake of apoptotic cells by macrophages, 
limiting apoptotic reponses and thus preventing inappropriate immune responses 
(Uderhardt et al., 2012). It is possible that this gene could act to suppress apoptotic 
clearance of ectopic endomtrial cells by macrophages, but functional studies are 
required to investigate this. This hypothesis is supported by the fact that peritoneal 
macrophages in women with endometriosis have reduced phagocytic capacity (Wu et 
al., 2005). Saa3, the fourth most highly up-regulated gene in this cluster, is a gene 
involved in response to inflammation by recruitment of immune cells and regulation 
of the extracellular matrix, and secretion of the Saa3 protein has been shown to be 
important for tumour growth in both pancreatic and breast cancer (Djurec et al., 
2018; Ignacio et al., 2019). Cxcl13, the third most highly up-regulated gene, is 
involved in the chemotaxis of B cells, and has been implicated in the recruitment of 
B cells to tumours and subsequent stimulation of tumour development (Tan et al., 
2018), suggesting Cxcl13 could play a similar role in endometriosis lesions. Overall, 
taking into account gene ontology analysis and genes up-regulated by cluster 3, this 
macrophage population appears play roles in controlling the inflammatory response 
within lesions as well as mediating the recruitment of other leukocytes (specifically 
B cells), to lesions. Control of inflammation may be an important 'pro-disease' 
function within lesions, as escape of immune clearance in the peritoneal cavity is a 
key hallmark of endometriosis (Burney and Giudice, 2012). 
Furthermore, through gene ontology analysis cluster 4 was shown to up-regulate 
genes involved in cellular responses to cytokine stimuli. The most highly up-
regulated gene, Retnla, is implicated as a pro-inflammatory cytokine in a mouse 
model of colitis which stimualted development of pathology (Munitz et al., 2008), 
although Retnla has traditionally been defined as a 'M2' macrophage cytokine (Nair 
et al., 2009). The role this cytokine may play in endometriosis is currently unknown. 
Notably, cluster 4 up-regulated a number of genes in the S100 family of calcium-
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binding proteins, such as S100a11, S100a4 and S100a6. Dysregulated expression of 
the S100 genes is assocaited with many cancers (Bresnick, Weber and Zimmer, 
2015). In a number of cancer settings, up-regulation of S100 genes has been shown 
to stimulate stromal cell proliferation, angiogenesis, metastasis and immune evasion 
in the tumour microenvironment (Bresnick, Weber and Zimmer, 2015). In 
endometriosis, S100A4 and S100p have been shown to be up-regulated in ectopic 
endometrial deposits from women, and this was proposed to enhance invasiveness 
and establishment of lesions (Hapangama et al., 2011). These proteins could 
therefore be involved in endometriosis pathophysiology, and further research of their 
role in the aetiology of disease could be of clinical interest. Furthermore, Lsp1, the 
second most highly up-regulated gene has been shown, in rheumatoid arthritis, to be 
a negative regulator of T cell chemotaxis (Hwang et al., 2015). We know that in 
tumours, macrophages prevent the chemotaxis of T cells to the tumour in order to 
perpetuate the growth and development of tumours (Peranzoni et al., 2018), thus, it is 
possible that macrophage-T cell cross-talk is also implicated within endometriosis 
lesions to encourage the growth and development of lesions. Overall, cluster 4 up-
regulates a number of genes which have the potentail to stimulate the growth and 
development of endometriosis lesions, however functional studies are crucially 
required to discern if these genetic aberrations do indeed contribute to the 
pathophysiology of endometriosis. 
Importantly, in this chapter I established that a sub-population (cluster 5) of 
endometriosis lesion resident macrophages highly up-regulated the proliferation 
marker Mki67 along with a number of genes which are involved in cellular 
proliferation. Gene ontology analysis in this cluster revealed up-regulation of genes 
involved in many proliferation specific functions such as nuclear division, cell cycle 
associated genes and cell division. In chapter 3 I demonstrated that the lesion 
macrophage population is derived from endometrial tissue macrophages and 
infiltrating large peritoneal macrophages and Ly6C+ monocytes. I have now 
characterised that lesion macrophages are also maintained by in situ proliferation. In 
a mouse model of pancreatic ductal adenocarcinoma, tumour macrophages were 
seeded by circulating Ly6Chi monocytes but also maintained by tissue resident 
macrophages which expanded by in situ proliferation (Zhu et al., 2017). In my data 
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the origin of the proliferative cell population is un-characterised, and thus could 
incorporate any of the macrophage populations present within the lesion tissue. 
Large peritoneal macrophages are able to proliferate in the peritoneal cavity 
(Cassado, D’Império Lima and Bortoluci, 2015), however whether they maintain this 
capacity within endometriosis lesions is speculative. The proliferative capacity of 
macrophages in the endometrium is currently poorly understood. Further studies will 
therefore be important in understanding the dynamics of macrophage in situ 
proliferation within endometriosis lesions and how this population relates to disease 
development.  
 
Figure 5.13. Endometriosis lesion resident macrophages are phenotypically 
heterogeneous and  may fulfill distinct roles within the endometriosis lesion 
microenvironment. I demonstrated, using single cell RNA sequencing, that 
endometriosis lesion resident macrophages in our mouse model were phenotypically 
heterogeneous, forming 5 transcriptionally diverse macrophage populations 
(labelled 1-5 in figure, referring to cluster number). Using gene ontology analysis 
and data from studies in other disease states, I was able to hypothesise the roles 
these macrophage populations may fulfill within endometriosis lesions. Note that 
these are hypothesised and not proven roles. The possible role that these 
macrophages may play within endometriosis lesions is in black writing and the genes 
associated with this function are shown in red below.  
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Overall, in this chapter I demonstrate that, in our mouse model, endometriosis lesion 
resident macrophages are a phenotypically heterogeneous population with distinct 
transcriptional profiles. I also begin to infer as to the roles these differential 
macrophage populations may play in endometriosis pathophysiology, however 
further studies are required to (1) decipher if the populations described represent 
distinct populations at the protein level and (2) to characterise the roles these 
macrophage populations play in disease development using functional studies. 
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Chapter 6 - Discussion 
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6.1.1 Peritoneal monocyte and macrophage populations in endometriosis 
In chapter 3 I characterised peritoneal monocyte/macrophage populations in our 
mouse model and demonstrated that whilst large and small peritoneal macrophages 
remain unperturbed, Ly6Chi monocytes are increased in the peritoneal cavity at 2 
weekspost tissue injection. The increase in Ly6Chi monocytes in endometriosis thus 
illustrates the ability for endometriosis lesions to elicit extravasation of this cell 
population into the cavity. These results appear contradictory as inflammation in the 
peritoneal cavity is commonly associated with both an increase in Ly6Chi monocytes 
and small peritoneal macrophages, which are pro-inflammatory in nature (Ghosn et 
al., 2010), and endometriosis has been classically defined as an inflammatory disease 
(Burney and Giudice, 2012). In mouse models of peritonitis, we know that the 
macrophage disappearance reaction occurs in a predictable manner (Cassado et al., 
2011), however this does not appear to be the case in our mouse model of 
endometriosis. In these models, irritants such as zymosan are used to induce an 
inflammatory response in the peritoneal cavity (Cassado et al., 2011; Bain and 
Jenkins, 2018). In a mouse model of endometriosis which inoculated naive, non-
decidualised tissue into the peritoneal cavity, Yuan et al reported a decrease in LPM 
and increase in SPM in the peritoneal cavity of mice with endometriosis (Yuan et al., 
2017b). Whilst we injected decidualised endometrial tissue into the peritoneal cavity 
of mice in our mouse model, we did not see a similar inflammatory response; the key 
difference between these studies being the use of decidualised or non-decidualised 
endometrial tissue. This suggests that factors within the decidualised endometrial 
tissue are able to modulate the response of the immune system to its presence in the 
peritoneal cavity, and this is unique to endometrial tissue which has undergone 
differentiation into 'menses-like' tissue. Another factor which must be taken into 
consideration in our mouse model is the use of estradiol valerate supplementation in 
recipient mice, leading to superphysiological levels of estrogen. Estrogen has been 
shown to increase the proliferative capacity of macrophages and modulate their 
phenotype to be more 'wound-healing' like (Pepe et al., 2017). Thus, in our mouse 
model, the number and phenotype of peritoneal macrophages may be modulated such 
that the macrophage disappearance reaction may not occur in a predictable manner, 
as with other models where estrogen was not supplemented (Cassado et al., 2011; 
- 142 - 
 
Yuan et al., 2017b). I observed a significant increase in the LPM population in sham 
mice at a 1 week time point, suggesting that superphysiological levels of estrogen do 
indeed cause proliferation of this tissue resident population. A modest but not 
significant increase in the LPM population of mice with endometriosis was also 
observed at this time point. Thus, the absence of the macrophage disappearance 
reaction in our mouse model of endometriosis is likely attributed to the use of 
decidualised endometrial tissue, but also to superphysiological levels of estrogen.  
Overall, my results suggest that the presence of ectopic endometrial tissue (lesions) 
could cause the accumulation of specific subsets of immune cells (i.e. Ly6Chi 
monocytes), rather than eliciting that body's 'normal' response to an inflammatory 
stimulus. This differential immune response may potentially allow lesions to evade 
immune clearance whilst also harnessing the immune system to stimulate disease. 
The role that Ly6Chi monocytes are playing in disease however is currently 
unknown, and the mechanisms by which decidualised endometrial tissue may be able 
to modulate the immune response in the peritoneal cavity remains elusive.  
6.1.2 Lesion resident macrophages comprise endometrial-derived and recruited 
populations 
In chapter 3 I characterised the origins of lesion resident macrophages. Using fate 
maping studies, I demonstrated that 16% of lesion macrophages are derived from the 
endometrium and 84% are recruited to the tissue. In diseases such as cancer, 
macrophages within different ontogenies have been shown to play distinct roles in 
disease development (Zhu et al., 2017), therefore it is possible that macrophages of 
different origins are playing diverse roles in the development of endometriosis 
lesions.  
Endometrial macrophages are thought to play important roles in repair and 
remodelling within the eutopic endometrium (Critchley et al., 2001; Thiruchelvam et 
al., 2013). Evidence from a mouse model of menstruation (utilised to generate 
'menses-like' tissue in our model of endometriosis), identified an influx of Ly6Chi 
monocytes which differentiated into macrophages during the repair phase of the 
menstrual cycle (Cousins et al., 2016). Endometrial macrophages are also implicated 
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in regulating gland remodelling and angiogenesis by production of vascular 
endothelial growth factor (VEGF) (Sharkey et al., 2000; Garry et al., 2010). We 
know that macrophages are important for angiogenesis in endometriosis lesions 
(Bacci et al., 2009), but the macrophage population responsible for this is unknown. I 
would hypothesise that due to the reparative roles macrophages are thought to play in 
the endometrium, endometrial-derived macrophages may play similar roles within 
the endometriosis lesion microenvironment, which could exacerbate disease by 
perpetuating the survival and health of ectopic endometrial tissue in the peritoneal 
cavity. 
Using adoptive transfer experiments, I demonstrated that LPM infiltrate lesions 
whilst SPM do not. In endometriosis lesions, LPM formed discrete clusters of cells, 
suggesting they may be fulfilling localised functions within specific areas of the 
lesion. LPM are typically associated with homeostatic, tissue reparative roles during 
homeostasis in the peritoneal cavity, however it is unclear how these cells may 
behave in the microenvironment of endometriosis lesions (Ghosn et al., 2010). In a 
mouse model of sterile liver injury, LPM infiltrated damaged tissue, where they 
adopted a 'pro-reparative' phenotype and fulfilled wound healing functions such as 
clearance of necrotic cells (Wang and Kubes, 2016). Due to the fact that LPM 
infiltrate lesions, I would hypothesise that this macrophage population exacerbates 
disease, due to their wound healing and tissue homeostatic roles and proven ability to 
infiltrate peritoneal organs, however this is currently unknown. SPM are associated 
with inflammation and clearing pathogens and foreign material in the peritoneal 
cavity (Ghosn et al., 2010), thus, their inability to infiltrate lesions may contribute to 
the inefficient clearance of endometrial tissue, again, contributing to disease.  
Using immunofluorescence, I demonstrated a high abundance of Ly6Chi monocytes 
within endometriosis lesions as well as Ly6Chi F4/80hi monocyte-derived 
macrophages. Recruited macrophages are therefore largely derived from LPM and 
monocyte-derived macrophages. Currently do not know whether the Ly6C+ cells are 
a transient population that becomes educated within the lesion. Increasingly, studies 
are shedding light into the roles of monocytes and their dynamics in disease. For 
example, in atherosclerosis, Ly6Chi monocytes migrate to diseased tissue where they 
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remain in a monocytic state, undergoing proliferation and having 'stem cell-like' 
properties (Lin et al., 2019). It thus cannot be ruled out that Ly6Chi monocytes may 
play distinct roles in endometriosis. My studies in CCL2 null mice that exhibit 
modestly decreased monocytes and monocytes derived macrophages with evidence 
of increased lesion number could support this concept. However, to my knowledge 
there have been no studies that have investigated this. Monocyte-derived 
macrophages have been shown, in a number of pre-clinical mouse models of cancer, 
to constitute a proportion of tumour-associated macrophages (Qian et al., 2011; 
Madsen et al., 2017; Zhu et al., 2017). In a mouse model of breast cancer, Ly6Chi 
monocytes are recruited to the tumour via CCL2 where they differentiate into 
macrophages and stimulate metastasis (Qian et al., 2011). The tumour micro-
environment is known to educate monocyte-derived macrophages such that they 
become 'pro-disease' upon incorporation into the tumour (Wu and Zheng, 2012; Noy 
and Pollard, 2014). Thus, in disease state, the microenvironment of pathological 
tissue has the potential to modulate monocyte-derived macrophage recruitment, 
phenotype and function. In endometriosis we don't know the role that monocyte-
derived macrophages are fulfilling within the lesion microenvironment or the 
phenotype of these cells. I would hypothesise however, that local cytokines, 
chemokines and growth factors within the lesion microenvironment could modulate 
recruited Ly6Chi monocytes such that they play a 'pro-disease' role in endometriosis. 
In my data, I demonstrated that Ly6Chi F4/80hi monocyte-derived macrophages were 
largely localised in clusters across lesions, suggesting that they may be playing roles 
within distinct areas of the pathological tissue.  
Overall, I demonstrated that endometriosis lesion resident macrophages have 
multiple origins and are derived from donor endometrial tissue as well as recruited 
LPM and Ly6Chi monocytes which differentiate (at least partly) into Ly6Chi F4/80hi 
macrophages.  
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6.1.3 CCR2 is important for accumulation of F4/80+ macrophages in lesions but 
the CCR2/CCL2 signalling pathway is redundant in the recruitment of Ly6Chi 
monocytes 
In chapter 4 I began to investigate the mechanism by which Ly6Chi monocytes as 
well as peritoneal macrophage populations are recruited to endometriosis lesions. 
Using flow cytometry, I was able to characterise that mice with endometriosis had ~3 
fold more CCR2+ peritoneal macrophages than sham controls and that 53% of lesion 
macrophages express the chemokine receptor CCR2. As the CCL2/CCR2 chemokine 
pathway is the classical pathway by which Ly6Chi monocytes are recruited to tissues 
(Wynn, Chawla and Pollard, 2013), I utilised CCR2 and CCL2 knockout mice to 
decipher the effect of blocking this recruitment pathway on the development of 
endometriosis lesions in our model. Surprisingly, CCR2 knockout mice with 
endometriosis had a significant influx of Ly6Chi monocytes into the peritoneal cavity 
and developed a similar number of lesions to WT. CCL2 knockout mice with 
endometriosis also had a similar number of peritoneal Ly6Chi monocytes to WT but 
developed more lesions, however this may have been attributed to a significant 
increase in general leukocyte number in the peritoneal cavity. Importantly, 
endometriosis lesions from CCR2 and CCL2 knockout mice had a similar number of 
Ly6Chi monocytes to WT lesions at immunofluorescent analysis, but CCR2 knockout 
lesions had less F4/80+ macrophages. Together, this data provides evidence that 
endometriosis lesions produce a chemotactic signal for Ly6Chi monocytes which 
causes their mobilisation from the bone marrow and subsequent extravasation into 
lesions. In our model, recruitment of Ly6Chi monocytes can occur independent of the 
CCR2/CCL2 chemokine pathway usually required for their chemotaxis (Wynn, 
Chawla and Pollard, 2013), suggesting that this pathway is redundant in 
endometriosis. CCR2 however appears to be important for the accumulation of 
F4/80+ macrophages in lesions, as in the absence of CCR2, the number of F4/80+ 
cells in lesions was reduced. The fact that I didn't see a change in lesion F4/80+ 
macrophages in the CCL2 knockout animals suggests that macrophage chemotaxis is 
not completely reliant on the CCL2 ligand but is reliant on signalling through CCR2.  
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Overall, this data provides insight into the role of the CCR2/CCL2 recruitment 
pathway in endometriosis and demonstrates that whilst this axis is redundant in the 
recruitment of Ly6Chi monocytes, a subset of F4/80+ macrophages relies on CCR2 
for recruitment to lesions. I also showed that, in our model, the presence of 
endometriosis lesions in the peritoneal cavity causes the mobilisation of Ly6Chi 
monocytes from the bone marrow and subsequent infiltration into lesions.  
Blocking the recruitment of TAMs is a therapeutic mechanism that has been 
investigated in a number of cancer studies and has been shown to provide some 
clinical efficacy in pre-clinical mouse models (Qian et al., 2011; Svensson et al., 
2015; Lim et al., 2016). A phase 1B clinical trial in pancreatic adenocarcinoma 
patients utilised a CCR2 inhibitor to block the recruitment of monocyte-derived 
TAMs, which was dosed in combination with chemotherapy (PF-04136309). This 
feasibility trial reported that peripheral monocytes were reduced in the patients after 
CCR2 inhibitor treatment, thus diminishing the pool of monocytes available to be 
recruited to tumours. Analysis of tumour biopsies revealed that recruitment of 
monocyte-derived TAMs was significantly reduced (assessed by FACS and qPCR). 
Further trials are required to determine the clinical efficacy of treatment, but this trial 
demonstrated that inhibiting the recruitment of TAMs in humans is possible and well 
tollerated by patients (Wang-Gillam A.,et al., 2015). Thus, understanding the 
pathways which regulate the recruitment of lesion resident monocyte/macrophage 
populations could provide the opportunity to therapeutically intervene with this 
recruitment process, to demontrate clinical benefit. Currently, we have very little 
knowledge about the recruitment pathways active in endometriosis. However, in this 
thesis I have demonstrated for the first time, that the CCR2-CCL pathway is 
redundant for recruitment of monocytes but involved in chemotaxis of mature 
macrophages. This provides the basis for futher studies investigating other 
monocytes / macrophages recruitment and differentiation factors in endometriosis 
6.1.4 Lesion macrophages are a phenotypically heterogeneous population 
In chapter 5 I interrogated the transcriptomic profile of CD45+ leukocytes from 
donor endometrial tissue, endometriosis lesions as well as peritoneal cells from 
endometriosis and sham mice. Single cell RNA sequencing revealed that 
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endometriosis lesion Csf1r+ Adgre1+ macrophages had a more similar 
transcriptomic profile to eutopic endometrial macrophages than to peritoneal 
macrophages but up-regulated a number of novel genes which were specific to the 
endometriosis disease state. Lesion macrophages were transcriptomically 
heterogeneous. I identified five sub-populations based on transcriptional profile, one 
population of which up-regulated many proliferation markers including Mki67, 
identifying a population of macrophages that have the intrinsic ability to proliferate 
in situ. Importantly, in this chapter I also demonstrated that lesion macrophages can 
be stratified into sub-populations based on cell surface marker expression and flow 
cytometry analysis, providing proof that sub-populations are also present at the 
protein level. This data provides an insight into the thus far unappreciated 
heterogeneity of endometriosis lesion macrophages and sheds light on macrophage 
phenotypic 'education' within the lesion microenvironment. The fact that 
endometriosis lesion macrophages have a number of uniquely up-regulated genes 
suggests that macrophages are being educated in the endometriosis lesion 
microenvironment, akin to tumour associated macrophages once they become 
incorporated into tumours (Cassetta et al., 2019). I hypothesise that this phenotypic 
switching may be critical to the pro-disease roles we know macrophages play within 
the lesion microenvironment (Bacci et al., 2009; Greaves et al., 2015; Forster et al., 
2019). Macrophages may therefore respond to local tissue cues in the lesion 
environment which cause their subsequent development into 'pathology-associated' 
cells.  
In tumours it is known that multiple macrophage populations exist which play 
differential roles in disease, up-regulating defined surface markers and exhibiting 
differential gene expression patterns (Noy and Pollard, 2014). It is possible therefore 
that the multiple transcriptionally diverse macrophage populations I identified within 
endometriosis lesions could be playing discrete roles in the pathology of 
endometriosis. Gene ontology analysis revealed insight into the functions that the 
five transcriptionally diverse macrophage populations I identified may be playing 
within lesions. Cluster 1 up-regulated genes assocaited with neurogenesis and 
stimilating the proliferation and survival of stromal cells, functions already known to 
be fulfilled by lesion resident macrophages to exacerbate disease (Chan et al., 2017; 
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Yang et al., 2017; Forster et al., 2019). Cluster 2 up-regulated a number of genes 
involved in neutrophil chemotaxis, as well as genes involved in stimulating the 
proliferation of fibroblasts. The role of neutrophils in endometriosis remains 
undefined, but my data implies that macrophage-neutrophil signalling occurs within 
lesions. Fibroblasts have the potential to play a pro-disease role within lesions due to 
their ability to regulate the extracellular matrix and mediate wound healing 
responses, however this is currently unknown (McAnulty, 2007). This data does 
indicate that macrophage-fibroblast cross-talk may be implicated in endometriosis. 
Cluster 3 up-regulated genes associated with modulating immune responses, 
apoptotic activity and recruitment of B cells. I would hypothesise that this 
macrophage population may play a role in mediating the immune response within 
endometriosis lesions such that ectopic endometrial tissue is able to escape immune 
clearance, a key hallmark of endometriosis (Burney and Giudice, 2012), however 
this is unknown. In my single cell RNA sequencing data I identified a population of 
lesion resident B cells, but the role of this population is unknown. This data does 
suggest, however, that lesion macrophages are involved in the chemotaxis of B cells 
to lesions. Macrophage cluster 4 up-regulated genes involved in response to cytokine 
stimuli and notably up-regulated a number of the S100 genes proven to have an 
intricate role in cancer pathophysiology (Bresnick, Weber and Zimmer, 2015), as 
well as the Lsp1 gene shown to be involved in preventing T cell recruitment to 
tumours (Hwang et al., 2015). The last cluster, cluster 5, was defined by its ability to 
proliferate within lesions.  
What these ontology analyses highlight is that macrophage function is likely to be 
diverse within endometriosis lesions, and involves reciprocal signalling between 
macrophages and a number of different cell types, such as neutrophils, B cells, T 
cells, fibroblasts and stromal cells. Underpinning the roles these macrophages are 
playing and how macrophages are modulated to fulfil these roles in endometriosis, 
could facilitate the development of specific treatments which target macrophage sub-
populations known to play roles in pathology linked to adverse clinical outcomes.  
  
 
- 149 - 
 
6.2 Summary 
Overall, in this thesis I have provided novel insight into the biology of macrophage 
populations in our mouse model of endometriosis and revealed previously 
unappreciated complexity in macrophage ontogeny and transcriptomic profile within 
endometriosis lesions.  
I have demonstrated that endometriosis lesions produce a chemotactic signal for 
Ly6Chi monocytes that differentiate into macrophages within lesions, and this 
recruitment can occur independent of the classical CCR2/CCL2 pathway, but my 
results suggest that recruitment of a population of F4/80+ macrophages to lesions 
relies on CCR2. Importantly, I characterised that lesion macrophages are 
heterogeneous in both origin and transcriptional profile. Lesion macrophages are 
comprised of endometrial macrophages derived from donor endometrial tissue as 
well as recruited of LPM and monocyte-derived macrophages. A sub-population of 
lesion macrophages are also maintained by in situ proliferation. Within lesions, five 
discrete macrophage populations exist which have unique transcriptional profiles, 
and gene ontology analysis suggests that these macrophage sub-populations could 
play differential roles in pathology and interact with a number of different cell types 
within lesions. In figure 6.1 I summarise my findings from this thesis.  
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Figure 6.1 Thesis summary 
In endometriosis lesions, macrophages are derived from endometrial-derived 
macrophages, as well as recruited populations which consist of large peritoneal 
macrophages (LPM) and monocyte-derived macrophages. In our mouse model, mice 
with endometriosis have an influx of Ly6Chi monocytes into the peritoneal cavity. 
Ly6C+ monocytes infiltrate lesions where they differentiate into Ly6C+ F4/80+ 
macrophages and this recruitment can occur independent of the CCR2/CCL2 
chemokine axis. Recruitment of F4/80+ macrophages however at least partly relies 
on CCR2 signalling. At single cell RNA sequencing analysis, lesion macrophage 
form five transcriptionally unique populations and a sub-set of these up-regulate the 
proliferation marker Mki67, identifying their ability to expand by in situ 
proliferation. Overall, this thesis provides evidence of previously unappreciated 
endometriosis lesion macrophage heterogeneity, in both origin and transcriptomic 
profile.  
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Chapter 7 - Future work and impact 
of thesis 
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In this thesis I identified a previously unappreciated heterogeneity in lesion 
macrophages, both in their origin and transcriptomic profile. This has implications on 
the interpretation of previous research which has aimed to investigate endometriosis 
lesion macrophage phenotype, as these studies largely utilised immunohistochemical 
techniques to define phenotypic markers expressed by lesion macrophages (Bacci et 
al., 2009; Smith et al., 2012; Johan et al., 2019b; Yamada et al., 2019). Whilst these 
studies have provided an important insight into lesion macrophage phenotype, it is 
possible that multiple macrophage populations exist not only in our mouse model, 
but in other pre-clinical models of endometriosis. When comparing our results and 
other models of endometriosis, it must be noted that these models do not truly 
recapitulate the chronic aetiology of a lesion, and represent a more transient and 
acute disease state. Comparison of lesion macrophages across models in comparison 
to disease in humans is thus a fundamental bridge for understanding the true 
dynamics of macrophage phenotype in endometriosis.  
Moreover, functional experiments aiming to identify the roles of macrophages in 
endometriosis may have assigned these roles to generalised 'endometriosis-associated 
macrophages' when this role is actually carried out by a distinct sub-population of 
macrophages within the lesion. Defining the roles that macrophages with different 
origins and transcriptional profiles play within the disease setting is an important 
area of future research. Studies aiming to discern the roles of these populations could 
include depletion of macrophages with a different origin, or with a unique 
transcriptional profile within lesions, or adoptive transfer of said populations into the 
peritoneal cavity (gain of function), to discern the effect on lesion development. 
These studies are an important step to assess the potential efficacy of targeting 
macrophage populations therapeutically.  
In this thesis I identified a unique genetic profile for endometriosis lesion 
macrophages. The roles of genes exhibiting up-regulation by endometriosis lesion 
macrophages should be investigated in functional studies in future research to 
ascertain if these genes could play central roles in disease. Studies may include the 
use of knockout mouse or cell lines which discern the effect of negating this gene in 
the development of pathology and its associated symptoms. Thus, this work should 
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aim to elucidate the function of these genes and determine the suitability of 
candidates as therapeutic targets for women with endometriosis. Importantly, we can 
learn a lot about these targets from studies in other therapeutic areas. A prime 
example of this is Gas6, which was highly up-regulated by the largest lesion 
macrophage population. We already know from cancer studies that this gene is 
implicated in stimulating pathology in the tumour environment by promoting the 
growth and survival of cancer cells (Hutterer et al., 2008; Loges et al., 2010; 
Korshunov, 2012). We can utilise this research to generate hypotheses around how, 
for example Gas6, may be involved in endometriosis pathophysiology. Future 
research should therefore utilise studies within fields, especially the cancer field, 
which draws a lot of parallels to endometriosis (Wiegand et al., 2010; Heidemann et 
al., 2014), and employ functional studies (knock out models, in vitro analyses) to 
discern: 1) whether or not genes up-regulated by lesion macrophages are important in 
the development or exacerbation of pathology and 2) the suitability of these targets 
for providing clinical benefit whilst also promoting the long term health of the 
patient.  
I also began to investigate the recruitment pathways active in disease which are 
responsible for the recruitment of monocytes/macrophages to endometriosis lesions. 
A key difficulty in these studies was the potential for chemokines/cytokines to 
compensate for the knockout of CCR2 or CCL2, making conclusions on the 
importance of this pathway in the disease setting somewhat difficult. We know that a 
number of cytokines/chemokines are up-regulated in the peritoneal cavity of women 
with disease, but which of these is required for monocyte/macrophage recruitment is 
currently unknown (Jørgensen et al., 2017). Future research should focus on 
assessing how, in the absence of CCR2 or CCL2, monocytes are still able to be 
mobilise from the bone marrow and be recruited to endometriosis lesions. Thus, 
which chemokines/cytokines are up-regulated in lesion tissue and in the peritoneal 
cavity in the absence of CCR2 or CCL2, and whether or not this is different to 
disease state where CCR2/CCL2 are present. It would be very interesting to see if 
blocking this recruitment can have an effect on the development of endometriosis 
lesions, and would thus give insight into the role of Ly6Chi monocytes in disease. 
Future research could also utilise lineage tracing studies to define which F4/80+ 
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macrophage population is being recruited by CCR2, and use functional studies to 
determine the role that this recruited population is fulfilling within the endometriosis 
lesion microenvironment. Overall, further work is required to understand the 
mechanism by which monocytes/macrophages are recruited to lesions, and the 
importance of this recruitment in the development of pathology.  
To conclude, exploring and exploiting the heterogeneity and recruitment of 
macrophages into endometriosis lesions could lead to the development of therapeutic 
treatments which have the ability to specifically target macrophages with distinct 
roles in disease development. These treatments may be able to provide clinical 
benefit whilst avoiding unspecific targeting of macrophage populations throughout 
the body, thus promoting the long term health of the patient. Whilst realisation of 
these treatments could take many years, this thesis provides a platform for further 
research into macrophage targeted therapies for women with endometriosis.  
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Chapter 8 - Appendix 
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Appendix 1. Significant differentially expressed genes in Csf1r+ Itgam+ 
Adgre1+ macrophage sub-populations in mouse endometriosis lesions as 
determined by single cell RNA sequencing 
∗; P < 0.1, ∗∗; P < 0.05, ∗∗∗; P < 0.01 and ****; P < 0.001. P values were adjusted 
using the Benjamini-Hochberg correction for multiple tests by Loupe Cell Browser 
3.0.1 software.  
 
Cluster 1 
Gene Name Log2 fold change P value 
Gas6 +3.23 **** 
Ccl8 +3.01 **** 
Igfbp4 +2.68 **** 
Cbr2 +2.58 **** 
Wwp1 +2.47 **** 
Stab1 +2.36 **** 
Folr2 +2.34 **** 
Maf +2.24 **** 
Sepp1 +2.13 **** 
Mrc1 +2.13 **** 
F13al +2.03 **** 
Dab2 +2.00 **** 
Clec10a +1.90 **** 
Fcgrt +1.84 **** 
Serinc3 +1.68 **** 
Igf1 +1.65 **** 
Fcrls +1.52 **** 
Abca1 +1.52 **** 
Pf4 +1.49 **** 
Ly6e +1.48 **** 
Nrp1 +1.48 **** 
Cfh +1.46 **** 
C5ar1 +1.45 **** 
Cltc +1.36 **** 
Ms4a7 +1.34 **** 
Itm2b +1.31 **** 
Zfp36l1 +1.30 **** 
Marcks +1.29 **** 
Ehd4 +1.27 **** 
C1qc +1.27 **** 
C4b +1.27 **** 
Apoe +1.24 **** 
Fcgr2b +1.23 **** 
Ninj1 +1.23 **** 
Serpinb6a +1.22 **** 
Ms4a6b +1.21 **** 
Mafb +1.20 **** 
Mgl2 +1.20 **** 
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C1qa +1.19 **** 
Csf1r +1.18 **** 
Txnip +1.16 **** 
Lgmn +1.15 **** 
Ctsc +1.12 **** 
Adgre1 +1.10 **** 
Ednrb +1.05 **** 
Snx2 +1.03 **** 
Trf +1.03 **** 
Glul +1.01 **** 
C3ar1 +1.00 **** 
Grn +0.97 **** 
Pltp +0.97 *** 
Bst2 +0.94 *** 
C1qb +0.94 *** 
Ctsb +0.93 *** 
Clec4a1 +0.91 *** 
Unc93b1 +0.90 *** 
Fcgr3 +0.85 *** 
Cd81 +0.85 *** 
Wfdc17 +0.81 *** 
Lst1 +0.80 ** 
Snx5 +0.77 ** 
Picalm +0.77 ** 
Tsc22d3 +0.76 ** 
Asah1 +0.76 ** 
Timp2 +0.72 ** 
Aldh2 +0.71 ** 
Blvrb +0.70 ** 
Ptpn18 +0.67 ** 
Ly86 +0.67 ** 
Rgs10 +0.67 ** 
Snx3 +0.65 * 
Lamp1 +0.65 * 
Atp2b1 +0.64 * 
Laptm4a +0.64 * 
Hexa +0.63 * 
Aif1 +0.62 * 
Tmem176b +0.62 * 
Pld4 +0.62 * 
Vsir +0.61 * 
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Cluster 2 
Gene Name Log2 fold change P value 
Mmp12 +6.27 **** 
Alas1 +4.96 **** 
Cxcl3 +3.48 **** 
Prdx1 +2.71 **** 
Lpl +2.70 **** 
Esd +2.56 **** 
Cd9 +2.56 **** 
Gpnmb +2.55 **** 
Cstb +2.40 **** 
Spp1 +2.28 **** 
Lgals3 +2.26 **** 
Clec4d +2.17 **** 
Sod2 +2.16 **** 
Fabp5 +2.16 **** 
Capg +2.10 **** 
Pgam1 +1.99 **** 
Fn1 +1.89 **** 
Anxal +1.82 **** 
Itgb2 +1.80 **** 
Txn1 +1.79 **** 
Aldoa +1.78 *** 
Pgd +1.72 *** 
Fth1 +1.72 *** 
Anxa4 +1.70 *** 
Lilrb4a +1.70 *** 
Pkm +1.65 *** 
Lyz1 +1.64 ** 
Cxcl2 +1.60 ** 
Clec4n +1.60 *** 
Fabp4 +1.57 ** 
Creg1 +1.56 ** 
Mif +1.55 ** 
Tkt +1.44 ** 
Gngt2 +1.42 ** 
Aprt +1.40 ** 
Rnh1 +1.38 ** 
Card19 +1.35 ** 
Ccl9 +1.34 * 
Cybb +1.34 * 
S100a4 +1.30 * 
Taldo1 +1.30 * 
Lipa +1.29 * 
Eno1 +1.25 * 
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Cluster 3 
Gene Name Log2 fold change P value 
Alox15 +5.45 **** 
Prg4 +5.42 **** 
Cxcl13 +5.15 **** 
Saa3 +4.96 **** 
Prtn3 +4.75 **** 
Spi +4.61 **** 
Itcam2 +4.59 **** 
Padi4 +4.32 **** 
Lrg1 +3.96 **** 
Mcemp1 +3.81 **** 
Cd5l +3.79 **** 
Thbs1 +3.43 **** 
Fabp4 +3.17 **** 
Fn1 +3.09 **** 
Itga6 +2.90 **** 
Emilin2 +2.86 **** 
Ltc4s +2.81 **** 
Smpdl3a +2.54 *** 
Ednrb +2.20 ** 
Klf2 +2.17 ** 
 
Cluster 4 
Gene Name Log2 fold change P value 
Retnla +3.23 **** 
Lsp1 +2.42 **** 
Tmsb10 +1.78 **** 
Id2 +1.40 **** 
S100a11 +1.31 **** 
Fabp4 +1.22 ** 
Cd52 +1.10 **** 
Cxcl2 +1.07 ** 
Lyz1 +1.04 ** 
S100a4 +0.97 *** 
Clec4b1 +0.95 *** 
S100a6 +0.95 *** 
Mcemp1 +0.92 ** 
Gm8730 +0.90 ** 
Crip1 +0.87 ** 
Gm2a +0.84 ** 
Srgn +0.83 ** 
Nfkbia +0.83 ** 
Fn1 +0.82 ** 
Rplp0 +0.79 ** 
H2-DMb1 +0.79 ** 
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Cycs +0.78 ** 
Ccr2 +0.76 ** 
Fxyd5 +0.75 ** 
Thbs1 +0.75 * 
Anxa2 +0.74 * 
Actg1 +0.72 * 
Rps7 +0.72 * 
Coro1a +0.69 * 
 
Cluster 5 
Gene Name Log2 fold change P value 
2810417H13Rik +6.50 **** 
Top2a +6.30 **** 
Birc5 +6.18 **** 
Stmn1 +4.77 **** 
Tmpo +3.35 **** 
Tuba1b +2.74 **** 
Tubb5 +2.67 **** 
Pcna +2.59 **** 
Ube2s +2.40 **** 
Slpbp +2.37 **** 
H2afv +2.23 **** 
H2afz +2.10 **** 
Anp32bm +2.08 **** 
Nucks1 +2.06 **** 
Dek +2.00 **** 
Ptma +1.78 *** 
Ranbp1 +1.59 ** 
Nap111 +1.59 ** 
Ran +1.55 ** 
Srsf3 +1.37 * 
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Appendix 2. Significant differentially expressed genes in Csf1r+ Itgam+ 
Adgre1+ macrophages in mouse decidualised endometrial tissue, peritoneal 
lavage fluid and endometriosis lesions as determined by single cell RNA 
sequencing 
∗; P < 0.1, ∗∗; P < 0.05, ∗∗∗; P < 0.01 and ****; P < 0.001. P values were adjusted 
using the Benjamini-Hochberg correction for multiple tests by Loupe Cell Browser 
3.0.1 software. 
 
Endometrial Tissue 
Gene Name Log2 fold change P value 
Il1b +4.65 **** 
Ly6c2 +4.62 **** 
Ccl4 +4.35 **** 
Hspa1a +3.90 **** 
Ms4a4c +3.68 **** 
Gatm +3.00 **** 
Rgs1 +3.12 **** 
Isg15 +3.04 **** 
Cxcl2 +3.25 **** 
Cd83 +2.97 **** 
Jun +2.60 **** 
Stmn1 +2.59 **** 
Plac8 +2.58 **** 
Ms4a6b +2.50 **** 
Dnajb1 +2.58 **** 
Mmp12 +2.35 **** 
Clec4n +2.22 **** 
Fos +2.22 **** 
Plbd1 +2.22 **** 
Hsp90aa1 +2.04 **** 
Hspa1b +1.94 **** 
Pim1 +1.84 **** 
Fcgr1 +1.83 **** 
Hmox1 +1.81 **** 
Cxcl16 +1.80 **** 
Hspd1 +1.77 **** 
Efhd2 +1.76 **** 
Hspa8 +1.73 **** 
Lgals1 +1.72 **** 
Ms4a6d +1.71 **** 
Ms4a6c +1.65 **** 
Junb +1.64 **** 
Tubb5 +1.62 **** 
Coro1a +1.61 **** 
Actg1 +1.59 **** 
Litaf +1.59 **** 
Btg1 +1.59 **** 
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Lst1 +1.57 **** 
Gdi2 +1.56 **** 
Ube2s +1.56 **** 
Dnaja1 +1.56 **** 
Clec4a2 +1.55 **** 
Slc3a2 +1.53 **** 
Ptma +1.49 **** 
Hspe1 +1.48 **** 
AF251705 +1.48 **** 
Nfkbia +1.47 **** 
Fth1 +1.44 **** 
Jund +1.44 **** 
Lcp1 +1.42 **** 
Tpm4 +1.41 **** 
Ubc +1.38 **** 
Tpd52 +1.38 **** 
Cstb +1.38 **** 
Aif1 +1.36 **** 
Ran +1.36 **** 
Tmsb10 +1.34 **** 
Fcrls +1.34 **** 
H2afy +1.34 **** 
Lilrb4a +1.32 **** 
Atp5b +1.28 **** 
Mif +1.25 **** 
Tuba1b +1.25 **** 
Dusp1 +1.25 **** 
Pgam1 +1.25 **** 
Prdx1 +1.24 **** 
Hexb +1.24 **** 
Rbm3 +1.23 **** 
Lgmn +1.22 **** 
Tgfbi +1.21 **** 
Polr2l +1.20 **** 
Lgals3 +1.19 **** 
Pkm +1.18 **** 
Set +1.18 **** 
Tpi1 +1.17 **** 
Gm2a +1.17 **** 
Serinc3 +1.16 **** 
H2afz +1.16 **** 
Ms4a7 +1.16 **** 
Slc25a5 +1.15 **** 
Cycs +1.12 *** 
Snx5 +1.12 *** 
Cfl1 +1.12 *** 
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Hnrnpa2b1 +1.11 *** 
Marcksl1 +1.11 *** 
Ly86 +1.10 *** 
Sat1 +1.10 *** 
Anxa5 +1.10 *** 
Clec12a +1.10 *** 
Myl12a +1.10 *** 
Dab2 +1.10 *** 
Hcls1 +1.08 *** 
H2-DMb1 +1.07 *** 
Atp6ap2 +1.06 *** 
Ctsc +1.06 *** 
Hsp90ab1 +1.05 *** 
Bst2 +1.05 *** 
Eif4a1 +1.04 *** 
Hnrnpa3 +1.04 *** 
Clec4a3 +1.04 *** 
H2-Eb1 +1.03 *** 
Ppia +1.02 *** 
Ywhah +1.02 *** 
S100a11 +1.00 *** 
Nmp1 +0.99 *** 
Ccr2 +1.00 *** 
Psma1 +0.98 *** 
Cd209a +0.98 *** 
H3f3b +0.97 *** 
Srsf3 +0.97 *** 
Ranbp1 +0.97 *** 
Cnbp +0.95 *** 
Psma3 +0.95 *** 
Ncl +0.95 *** 
Ybx1 +0.95 *** 
Mpeg1 +0.95 *** 
Snx2 +0.95 *** 
H2-Ab1 +0.94 *** 
Picalm +0.94 *** 
H2-Aa +0.94 *** 
Syngr2 +0.94 *** 
Rnh1 +0.94 ** 
Vdac2 +0.94 ** 
Anp32b +0.93 ** 
Ddx5 +0.93 ** 
Chmp4b +0.93 ** 
Psma4 +0.92 ** 
Arl6ip1 +0.92 ** 
Abracl +0.92 ** 
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Cd74 +0.92 ** 
Atp5c1 +0.91 ** 
Tkt +0.89 ** 
Akr1a1 +0.88 ** 
Cd14 +0.87 ** 
Sirpa +0.86 ** 
Tmsb4x +0.86 ** 
Cct8 +0.86 ** 
Cct5 +0.86 ** 
Cd52 +0.84 ** 
Srsf2 +0.84 ** 
Arpc3 +0.84 ** 
Ube2d3 +0.83 ** 
Esd +0.84 ** 
Ifi27l2a +0.83 ** 
Actr3 +0.82 ** 
Lyn +0.82 ** 
Aprc4 +0.82 ** 
Aldoa +0.81 ** 
S100a9 +0.81 ** 
Ifi30 +0.81 ** 
Eif2s2 +0.81 ** 
Cct4 +0.81 ** 
Calm3 +0.80 ** 
Hnrnpk +0.78 ** 
Eif5a +0.78 ** 
Calm1 +0.78 ** 
Gapdh +0.77 ** 
Arhgdia +0.77 ** 
Atp5f1 +0.77 ** 
Spp1 +0.77 ** 
Hrnrpa1 +0.76 ** 
Psmb6 +0.76 ** 
Rab7 +0.76 * 
Psme1 +0.76 * 
Cox7b +0.76 * 
Taldo1 +0.76 * 
Capza2 +0.75 * 
Nme1 +0.75 * 
Ptprc +0.74 * 
Arpc2 +0.74 * 
Cdc42 +0.74 * 
Actb +0.74 * 
Tgfb1 +0.74 * 
Hspa5 +0.73 * 
Ywhae +0.73 * 
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Pcbp1 +0.73 * 
Anxa2 +0.73 * 
Rac1 +0.72 * 
Vim +0.72 * 
Rplp0 +0.70 * 
Serbp1 +0.69 * 
Clta +0.69 * 
Btf3 +0.69 * 
H3f3a +0.69 * 
Pfn1 +0.68 * 
 
Peritoneal Lavage Fluid 
Gene Name Log2 fold change P value 
Cxcl13 +5.57 **** 
Slpi +5.51 **** 
Alox15 +5.48 **** 
Padi4 +5.18 **** 
Prtn3 +4.78 **** 
Icam2 +4.75 **** 
Fcna +4.43 **** 
Prg4 +4.36 **** 
Saa3 +4.01 **** 
Lrg1 +3.94 **** 
Cd5l +3.90 **** 
Fabp4 +3.48 **** 
Fn1 +3.29 **** 
Ltc4s +3.16 **** 
Hgsnat +3.04 **** 
Mcemp1 +2.93 **** 
F10 +2.89 **** 
Emilin2 +2.89 **** 
Itga6 +2.88 **** 
Klf2 +2.87 **** 
Ccl24 +2.87 **** 
Lyz1 +2.76 **** 
C4b +2.68 **** 
Ecm1 +2.65 **** 
Smpdl3a +2.48 **** 
Ednrb +2.35 **** 
Hp +2.27 **** 
Cd37 +2.08 **** 
Nupr1 +1.96 **** 
Dpep2 +1.92 **** 
Ifitm6 +1.88 **** 
PycarLyz2d +1.85 **** 
Thbs1 +1.81 **** 
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Tcn2 +1.80 **** 
Tmcc1 +1.74 **** 
Fam46a +1.71 **** 
Timp2 +1.67 **** 
Trf +1.64 **** 
Msr1 +1.64 **** 
Gngt2 +1.56 **** 
Cfp +1.56 **** 
Wfdc17 +1.51 **** 
Selplg +1.51 **** 
Mgst1 +1.48 **** 
Itgb2 +1.48 **** 
Prdx5 +1.41 **** 
Tagln2 +1.37 **** 
Tln1 +1.34 **** 
Idh1 +1.29 **** 
Ccl6 +1.28 **** 
Itgam +1.27 **** 
Man2b1 +1.25 **** 
Fxyd5 +1.23 **** 
Gpx1 +1.20 **** 
Adgre5 +1.18 **** 
Ssr4 +1.12 **** 
S100a1 +1.11 **** 
Pf4 +1.08 **** 
Prr13 +1.05 **** 
Gda +1.04 **** 
Bsg +1.01 **** 
Comt +1.00 **** 
Tmed3 +1.00 **** 
Cfh +0.99 **** 
Aldh2 +0.99 **** 
Lamtor4 +0.98 **** 
Apoe +0.98 **** 
Uba52 +0.96 **** 
Gpx4 +0.92 *** 
Ninj1 +0.85 *** 
Hmha1 +0.84 *** 
Crip1 +0.84 *** 
Srgn +0.81 *** 
Ccdc12 +0.78 *** 
Cd9 +0.78 *** 
Ppib +0.76 *** 
C1qc +0.75 ** 
Gm10076 +0.73 ** 
Ifitm3 +0.72 ** 
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Gmfg +0.70 ** 
Rps19 +0.68 ** 
Shisa5 +0.66 ** 
Dbi +0.65 ** 
Emp3 +0.65 ** 
Mt-Nd1 +0.64 ** 
Sdf2l1 +0.64 ** 
C1qa +0.63 ** 
Ddost +0.63 ** 
H2-D1 +0.63 ** 
1110008F13Rik +0.63 ** 
Mrpl33 +0.62 ** 
Rps8 +0.62 ** 
Itgb1 +0.62 ** 
Ahnak +0.62 ** 
Sdc3 +0.61 ** 
Cyba +0.61 ** 
Cybb +0.59 ** 
Rpn2 +0.56 * 
Rpl8 +0.54 * 
Rpl36a +0.54 * 
Sec11c +0.53 * 
Rpl4 +0.53 * 
Rpl10-ps3 +0.53 * 
Alox5ap +0.52 * 
Rpsa +0.52 * 
Eno1 +0.52 * 
Rpl2mt-Cytb3 +0.51 * 
Dad1 +0.51 * 
Uqcr11 +0.51 * 
 
Endometriosis Lesions 
Gene Name Log2 fold change P value 
Ccl8 +5.84 **** 
Gas6 +3.99 **** 
Mrc1 +3.61 **** 
Spp1 +3.40 **** 
Ms4a7 +3.22 **** 
Marcks +3.17 **** 
Wwp1 +3.12 **** 
Abca1 +3.04 **** 
Cbr2 +3.00 **** 
Maf +2.92 **** 
Cd63 +2.83 **** 
Stab1 +2.75 **** 
Fcrls +2.56 **** 
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Clec10a +2.46 **** 
Clec4a2 +2.43 **** 
Hspa1b +2.35 **** 
Sepp1 +2.29 **** 
Clec12a +2.28 **** 
Cltc +2.22 **** 
Dab2 +2.20 **** 
F13a1 +2.13 **** 
Mgl2 +2.15 **** 
Igf1 +2.11 **** 
Folr2 +2.11 **** 
Ehd4 +2.08 **** 
Zfp36l1 +1.99 **** 
Clec4a1 +1.93 **** 
Mt-Nd4l +1.93 **** 
Clec4n +1.93 **** 
Lst1 +1.90 **** 
Sirpa +1.90 **** 
Clec4a3 +1.89 **** 
AF251705 +1.90 **** 
Serinc3 +1.85 **** 
Trem2 +1.82 **** 
Picalm +1.82 **** 
Anxa5 +1.81 **** 
Ctsc +1.81 **** 
Qk +1.81 **** 
Fos +1.76 **** 
Fcgr2b +1.73 **** 
Nrp1 +1.71 **** 
Aif1 +1.69 **** 
Ccr2 +1.66 **** 
Lgmn +1.62 **** 
Mmp12 +2.03 **** 
Itm2b +1.58 **** 
BC005537 +1.58 **** 
S100a9 +1.58 **** 
Lgals1 +1.56 **** 
S100a8 +1.55 **** 
Ms4a6b +1.54 **** 
Igfbp4 +1.53 **** 
Slc6a6 +1.53 **** 
Kctd12 +1.51 **** 
Atp2b1 +1.48 **** 
Cxcl16 +1.42 **** 
Txnip +1.38 **** 
Gm42418 +1.40 **** 
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Mpeg1 +1.38 **** 
Fcgrt +1.35 **** 
Ctsb +1.34 **** 
Serpinb6a +1.35 **** 
Ctsl +1.32 **** 
Snx5 +1.32 **** 
Psap +1.27 **** 
Lgals3 +1.27 **** 
Tpd52 +1.25 **** 
Klf6 +1.25 **** 
Jun +1.23 **** 
C3ar1 +1.21 **** 
Cyth4 +1.15 **** 
Sat1 +1.14 **** 
Actr2 +1.14 **** 
Prcp +1.13 **** 
Pla2g7 +1.12 **** 
Ptprc +1.10 **** 
Calm2 +1.10 **** 
Mbnl1 +1.09 **** 
Flt1 +1.08 **** 
Gm10116 +1.08 **** 
Cstb +1.08 **** 
Gatm +1.08 **** 
Cd83 +1.08 **** 
H2-Aa +1.04 *** 
Cd74 +1.02 *** 
Fcgr1 +1.02 *** 
Mt1 +0.99 *** 
Rtn4 +0.97 *** 
H2-DMb1 +0.96 *** 
Zfp36l2 +0.96 *** 
Tsc22d3 +0.94 *** 
Efhd2 +0.95 *** 
Aplp2 +0.93 *** 
Lpl +0.94 *** 
Sptssa +0.92 *** 
Akr1a1 +0.91 *** 
Wnk1 +0.90 *** 
Rgs1 +0.90 *** 
Lcp1 +0.89 *** 
Prdx1 +0.89 *** 
Unc93b1 +0.87 *** 
Tmem106a +0.86 *** 
Hmox1 +0.88 ** 
Celf2 +0.85 ** 
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Capza2 +0.84 ** 
Arl6ip1 +0.83 ** 
Atp6ap2 +0.83 ** 
Morf4l1 +0.82 ** 
Cd47 +0.82 ** 
Dusp1 +0.82 ** 
Cd44 +0.82 ** 
Iqgap1 +0.79 ** 
Zeb2 +0.78 ** 
Gltp +0.78 ** 
Slc3a2 +0.78 ** 
Canx +0.77 ** 
Csf1r +0.77 ** 
Ndufc2 +0.76 ** 
Cd81 +0.76 ** 
Reep5 +0.76 ** 
Ms4a6c +0.76 ** 
Sdcbp +0.75 ** 
Tmem176a +0.75 ** 
Tmem176b +0.74 ** 
C5ar1 +0.74 ** 
Hs-Dma +0.73 ** 
Asah1 +0.73 ** 
Ddx5 +0.73 ** 
Dazap2 +0.73 ** 
Anax2 +0.70 ** 
Dnajb1 +0.70 ** 
Pltp +0.69 ** 
Pld4 +0.68 * 
Atp6v1g1 +0.67 * 
Polr2l +0.67 * 
Ifngr1 +0.67 * 
Ypel3 +0.67 * 
Fcer1g +0.66 * 
Ptp4a2 +0.63 * 
mt-Co1 +0.62 * 
mt-Co2 +0.62 * 
Tmsb4x +0.61 * 
Btg1 +0.61 * 
Coro1a +0.61 * 
Vim +0.61 * 
Hsp90aa1 +0.61 * 
Gm2a +0.60 * 
Actb +0.60 * 
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